DXC Technology Co 0001688568 3/31 2021 Q3 False us-gaap:AccountingStandardsUpdate201613Member P1Y P1Y us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization us-gaap:DebtCurrent us-gaap:DebtCurrent us-gaap:LongTermDebtNoncurrent us-gaap:LongTermDebtNoncurrent 3 P1Y 0001688568 2020-04-01 2020-12-31 0001688568 us-gaap:CommonStockMember 2020-04-01 2020-12-31 0001688568 dxc:SeniorNotesDue2025OneMember 2020-04-01 2020-12-31 0001688568 dxc:SeniorNotesDue2026OneMember 2020-04-01 2020-12-31 xbrli:shares 0001688568 2021-01-29 iso4217:USD 0001688568 2020-10-01 2020-12-31 0001688568 2019-10-01 2019-12-31 0001688568 2019-04-01 2019-12-31 iso4217:USD xbrli:shares 0001688568 2020-12-31 0001688568 2020-03-31 0001688568 2019-03-31 0001688568 2019-12-31 0001688568 us-gaap:CommonStockMember 2020-09-30 0001688568 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001688568 us-gaap:RetainedEarningsMember 2020-09-30 0001688568 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-30 0001688568 us-gaap:TreasuryStockMember 2020-09-30 0001688568 us-gaap:ParentMember 2020-09-30 0001688568 us-gaap:NoncontrollingInterestMember 2020-09-30 0001688568 2020-09-30 0001688568 us-gaap:RetainedEarningsMember 2020-10-01 2020-12-31 0001688568 us-gaap:ParentMember 2020-10-01 2020-12-31 0001688568 us-gaap:NoncontrollingInterestMember 2020-10-01 2020-12-31 0001688568 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-10-01 2020-12-31 0001688568 us-gaap:AdditionalPaidInCapitalMember 2020-10-01 2020-12-31 0001688568 us-gaap:TreasuryStockMember 2020-10-01 2020-12-31 0001688568 us-gaap:CommonStockMember 2020-10-01 2020-12-31 0001688568 us-gaap:CommonStockMember 2020-12-31 0001688568 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001688568 us-gaap:RetainedEarningsMember 2020-12-31 0001688568 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001688568 us-gaap:TreasuryStockMember 2020-12-31 0001688568 us-gaap:ParentMember 2020-12-31 0001688568 us-gaap:NoncontrollingInterestMember 2020-12-31 0001688568 us-gaap:CommonStockMember 2019-09-30 0001688568 us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0001688568 us-gaap:RetainedEarningsMember 2019-09-30 0001688568 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-09-30 0001688568 us-gaap:TreasuryStockMember 2019-09-30 0001688568 us-gaap:ParentMember 2019-09-30 0001688568 us-gaap:NoncontrollingInterestMember 2019-09-30 0001688568 2019-09-30 0001688568 us-gaap:RetainedEarningsMember 2019-10-01 2019-12-31 0001688568 us-gaap:ParentMember 2019-10-01 2019-12-31 0001688568 us-gaap:NoncontrollingInterestMember 2019-10-01 2019-12-31 0001688568 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-10-01 2019-12-31 0001688568 us-gaap:AdditionalPaidInCapitalMember 2019-10-01 2019-12-31 0001688568 us-gaap:TreasuryStockMember 2019-10-01 2019-12-31 0001688568 us-gaap:CommonStockMember 2019-10-01 2019-12-31 0001688568 us-gaap:CommonStockMember 2019-12-31 0001688568 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001688568 us-gaap:RetainedEarningsMember 2019-12-31 0001688568 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001688568 us-gaap:TreasuryStockMember 2019-12-31 0001688568 us-gaap:ParentMember 2019-12-31 0001688568 us-gaap:NoncontrollingInterestMember 2019-12-31 0001688568 us-gaap:CommonStockMember 2020-03-31 0001688568 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001688568 us-gaap:RetainedEarningsMember 2020-03-31 0001688568 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0001688568 us-gaap:TreasuryStockMember 2020-03-31 0001688568 us-gaap:ParentMember 2020-03-31 0001688568 us-gaap:NoncontrollingInterestMember 2020-03-31 0001688568 2019-04-01 2020-03-31 0001688568 us-gaap:RetainedEarningsMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2020-03-31 0001688568 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:ParentMember 2020-03-31 0001688568 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2020-03-31 0001688568 us-gaap:RetainedEarningsMember 2020-04-01 2020-12-31 0001688568 us-gaap:ParentMember 2020-04-01 2020-12-31 0001688568 us-gaap:NoncontrollingInterestMember 2020-04-01 2020-12-31 0001688568 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-01 2020-12-31 0001688568 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-12-31 0001688568 us-gaap:TreasuryStockMember 2020-04-01 2020-12-31 0001688568 us-gaap:CommonStockMember 2020-04-01 2020-12-31 0001688568 us-gaap:CommonStockMember 2019-03-31 0001688568 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001688568 us-gaap:RetainedEarningsMember 2019-03-31 0001688568 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0001688568 us-gaap:TreasuryStockMember 2019-03-31 0001688568 us-gaap:ParentMember 2019-03-31 0001688568 us-gaap:NoncontrollingInterestMember 2019-03-31 0001688568 us-gaap:RetainedEarningsMember 2019-04-01 2019-12-31 0001688568 us-gaap:ParentMember 2019-04-01 2019-12-31 0001688568 us-gaap:NoncontrollingInterestMember 2019-04-01 2019-12-31 0001688568 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-04-01 2019-12-31 0001688568 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-12-31 0001688568 us-gaap:TreasuryStockMember 2019-04-01 2019-12-31 0001688568 us-gaap:CommonStockMember 2019-04-01 2019-12-31 0001688568 dxc:HumanServicesBusinessMember 2020-10-01 iso4217:EUR 0001688568 dxc:HPSBusinessMember srt:ScenarioForecastMember 2020-10-01 2021-03-31 0001688568 dxc:LuxoftHoldingInc.Member 2019-06-14 2019-06-14 xbrli:pure 0001688568 dxc:LuxoftHoldingInc.Member 2019-06-14 0001688568 dxc:LuxoftHoldingInc.Member us-gaap:CustomerRelatedIntangibleAssetsMember 2019-06-14 2019-06-14 0001688568 us-gaap:TradeNamesMember dxc:LuxoftHoldingInc.Member 2019-06-14 2019-06-14 0001688568 dxc:ComputerSoftwareIntangibleAssetDevelopedTechnologyMember dxc:LuxoftHoldingInc.Member 2019-06-14 2019-06-14 0001688568 dxc:LuxoftHoldingInc.Member dxc:ComputerSoftwareIntangibleAssetThirdPartyPurchasedSoftwareMember 2019-06-14 2019-06-14 0001688568 dxc:MilanoPurchasersMember dxc:HumanServicesBusinessMember 2020-10-01 2020-12-31 0001688568 dxc:HumanServicesBusinessMember 2020-10-01 2020-10-01 0001688568 2020-10-01 2020-10-31 0001688568 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2020-10-01 2020-10-31 iso4217:GBP 0001688568 us-gaap:CommercialPaperMember 2020-10-01 2020-10-31 0001688568 dxc:TermLoanPayableEURDue20232024Member us-gaap:NotesPayableToBanksMember 2020-10-01 2020-10-31 0001688568 us-gaap:NotesPayableToBanksMember dxc:TermLoanPayableUSDDue2025Member 2020-10-01 2020-10-31 iso4217:AUD 0001688568 us-gaap:NotesPayableToBanksMember dxc:TermLoanPayableAUDDue2022Member 2020-10-01 2020-10-31 0001688568 dxc:TermLoanPayableEURDue20222023Member us-gaap:NotesPayableToBanksMember 2020-10-01 2020-10-31 0001688568 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember dxc:HumanServicesBusinessMember 2020-12-31 0001688568 dxc:SeriesOfInsignificantDisposalGroupsMember 2020-10-01 2020-12-31 0001688568 us-gaap:EmployeeStockOptionMember 2020-10-01 2020-12-31 0001688568 us-gaap:EmployeeStockOptionMember 2019-10-01 2019-12-31 0001688568 us-gaap:EmployeeStockOptionMember 2020-04-01 2020-12-31 0001688568 us-gaap:EmployeeStockOptionMember 2019-04-01 2019-12-31 0001688568 us-gaap:RestrictedStockUnitsRSUMember 2020-10-01 2020-12-31 0001688568 us-gaap:RestrictedStockUnitsRSUMember 2019-10-01 2019-12-31 0001688568 us-gaap:RestrictedStockUnitsRSUMember 2020-04-01 2020-12-31 0001688568 us-gaap:RestrictedStockUnitsRSUMember 2019-04-01 2019-12-31 0001688568 us-gaap:PerformanceSharesMember 2020-10-01 2020-12-31 0001688568 us-gaap:PerformanceSharesMember 2019-10-01 2019-12-31 0001688568 us-gaap:PerformanceSharesMember 2020-04-01 2020-12-31 0001688568 us-gaap:PerformanceSharesMember 2019-04-01 2019-12-31 0001688568 dxc:PurchasersMember 2020-09-30 0001688568 dxc:PurchasersMember 2020-12-31 dxc:extension 0001688568 dxc:PurchasersMember 2020-04-01 2020-12-31 0001688568 dxc:PurchasersMember 2019-03-31 0001688568 dxc:PurchasersMember 2019-04-01 2019-12-31 0001688568 dxc:PurchasersMember 2019-12-31 0001688568 dxc:DEPurchasersMember 2020-12-31 0001688568 dxc:DEPurchasersMember 2020-03-31 0001688568 dxc:DEPurchasersMember 2020-04-01 2020-12-31 0001688568 srt:MinimumMember 2020-04-01 2020-12-31 0001688568 srt:MaximumMember 2020-04-01 2020-12-31 0001688568 us-gaap:RealEstateMember 2020-12-31 0001688568 us-gaap:EquipmentMember 2020-12-31 0001688568 us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2020-12-31 0001688568 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2020-12-31 0001688568 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:MoneyMarketFundsMember 2020-12-31 0001688568 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2020-12-31 0001688568 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001688568 us-gaap:FairValueInputsLevel1Member us-gaap:USTreasurySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001688568 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2020-12-31 0001688568 us-gaap:FairValueInputsLevel3Member us-gaap:USTreasurySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001688568 us-gaap:BankTimeDepositsMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001688568 us-gaap:FairValueInputsLevel1Member us-gaap:BankTimeDepositsMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001688568 us-gaap:BankTimeDepositsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2020-12-31 0001688568 us-gaap:BankTimeDepositsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001688568 us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001688568 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001688568 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2020-12-31 0001688568 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001688568 us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2020-03-31 0001688568 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2020-03-31 0001688568 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:MoneyMarketFundsMember 2020-03-31 0001688568 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2020-03-31 0001688568 us-gaap:BankTimeDepositsMember us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0001688568 us-gaap:FairValueInputsLevel1Member us-gaap:BankTimeDepositsMember us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0001688568 us-gaap:BankTimeDepositsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2020-03-31 0001688568 us-gaap:BankTimeDepositsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0001688568 us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0001688568 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0001688568 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2020-03-31 0001688568 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0001688568 us-gaap:OtherIncomeMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2020-12-31 0001688568 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-12-31 0001688568 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-03-31 0001688568 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2020-12-31 0001688568 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2020-03-31 0001688568 us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeForwardMember 2020-12-31 0001688568 us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeForwardMember 2020-03-31 0001688568 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:NetInvestmentHedgingMember 2020-10-01 2020-12-31 0001688568 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:NetInvestmentHedgingMember 2020-04-01 2020-12-31 0001688568 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:NetInvestmentHedgingMember 2019-10-01 2019-12-31 0001688568 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:NetInvestmentHedgingMember 2019-04-01 2019-12-31 0001688568 us-gaap:NondesignatedMember us-gaap:ForeignExchangeForwardMember 2020-12-31 0001688568 us-gaap:NondesignatedMember us-gaap:ForeignExchangeForwardMember 2020-03-31 0001688568 us-gaap:NondesignatedMember us-gaap:OtherOperatingIncomeExpenseMember us-gaap:ForeignExchangeForwardMember 2020-10-01 2020-12-31 0001688568 us-gaap:NondesignatedMember us-gaap:OtherOperatingIncomeExpenseMember us-gaap:ForeignExchangeForwardMember 2019-10-01 2019-12-31 0001688568 us-gaap:NondesignatedMember us-gaap:OtherOperatingIncomeExpenseMember us-gaap:ForeignExchangeForwardMember 2020-04-01 2020-12-31 0001688568 us-gaap:NondesignatedMember us-gaap:OtherOperatingIncomeExpenseMember us-gaap:ForeignExchangeForwardMember 2019-04-01 2019-12-31 0001688568 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:FairValueHedgingMember 2020-12-31 0001688568 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:FairValueHedgingMember 2020-03-31 0001688568 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:FairValueHedgingMember 2020-12-31 0001688568 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:FairValueHedgingMember 2020-03-31 0001688568 us-gaap:NondesignatedMember us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember 2020-12-31 0001688568 us-gaap:NondesignatedMember us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember 2020-03-31 0001688568 us-gaap:NondesignatedMember 2020-12-31 0001688568 us-gaap:NondesignatedMember 2020-03-31 0001688568 us-gaap:DesignatedAsHedgingInstrumentMember dxc:AccruedExpensesAndOtherCurrentLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:FairValueHedgingMember 2020-12-31 0001688568 us-gaap:DesignatedAsHedgingInstrumentMember dxc:AccruedExpensesAndOtherCurrentLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:FairValueHedgingMember 2020-03-31 0001688568 us-gaap:NondesignatedMember dxc:AccruedExpensesAndOtherCurrentLiabilitiesMember us-gaap:ForeignExchangeForwardMember 2020-12-31 0001688568 us-gaap:NondesignatedMember dxc:AccruedExpensesAndOtherCurrentLiabilitiesMember us-gaap:ForeignExchangeForwardMember 2020-03-31 dxc:counterparty 0001688568 dxc:ForeignCurrencyDenominatedDebtMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:NetInvestmentHedgingMember 2020-12-31 0001688568 dxc:ForeignCurrencyDenominatedDebtMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:NetInvestmentHedgingMember 2020-03-31 0001688568 dxc:ForeignCurrencyDenominatedDebtMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:NetInvestmentHedgingMember 2020-10-01 2020-12-31 0001688568 dxc:ForeignCurrencyDenominatedDebtMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:NetInvestmentHedgingMember 2020-04-01 2020-12-31 0001688568 us-gaap:ComputerSoftwareIntangibleAssetMember 2020-12-31 0001688568 us-gaap:CustomerRelatedIntangibleAssetsMember 2020-12-31 0001688568 us-gaap:OtherIntangibleAssetsMember 2020-12-31 0001688568 us-gaap:ComputerSoftwareIntangibleAssetMember 2020-03-31 0001688568 us-gaap:CustomerRelatedIntangibleAssetsMember 2020-03-31 0001688568 us-gaap:OtherIntangibleAssetsMember 2020-03-31 0001688568 dxc:IntangibleAssetsOtherThanTransitionAndTransformationContractCostsMember 2020-10-01 2020-12-31 0001688568 dxc:IntangibleAssetsOtherThanTransitionAndTransformationContractCostsMember 2019-10-01 2019-12-31 0001688568 dxc:IntangibleAssetsOtherThanTransitionAndTransformationContractCostsMember 2020-04-01 2020-12-31 0001688568 dxc:IntangibleAssetsOtherThanTransitionAndTransformationContractCostsMember 2019-04-01 2019-12-31 0001688568 dxc:TransitionAndTransformationContractCostsMember 2020-10-01 2020-12-31 0001688568 dxc:TransitionAndTransformationContractCostsMember 2019-10-01 2019-12-31 0001688568 dxc:TransitionAndTransformationContractCostsMember 2020-04-01 2020-12-31 0001688568 dxc:TransitionAndTransformationContractCostsMember 2019-04-01 2019-12-31 0001688568 dxc:GBSSegmentMember 2020-03-31 0001688568 dxc:GISSegmentMember 2020-03-31 0001688568 dxc:GBSSegmentMember 2020-04-01 2020-12-31 0001688568 dxc:GISSegmentMember 2020-04-01 2020-12-31 0001688568 dxc:GBSSegmentMember 2020-12-31 0001688568 dxc:GISSegmentMember 2020-12-31 0001688568 srt:MinimumMember us-gaap:CommercialPaperMember 2020-12-31 0001688568 us-gaap:CommercialPaperMember srt:MaximumMember 2020-12-31 0001688568 srt:MinimumMember dxc:FinanceLeaseLiabilityNoncurrentMember 2020-12-31 0001688568 srt:MinimumMember dxc:FinanceLeaseLiabilityCurrentMember 2020-12-31 0001688568 srt:MaximumMember dxc:FinanceLeaseLiabilityCurrentMember 2020-12-31 0001688568 dxc:FinanceLeaseLiabilityNoncurrentMember srt:MaximumMember 2020-12-31 0001688568 srt:MinimumMember us-gaap:NotesPayableToBanksMember dxc:TermLoanPayableAUDDue2022Member 2020-12-31 0001688568 srt:MaximumMember us-gaap:NotesPayableToBanksMember dxc:TermLoanPayableAUDDue2022Member 2020-12-31 0001688568 us-gaap:NotesPayableToBanksMember dxc:TermLoanPayableAUDDue2022Member 2020-12-31 0001688568 us-gaap:NotesPayableToBanksMember dxc:TermLoanPayableAUDDue2022Member 2020-03-31 0001688568 srt:MinimumMember us-gaap:NotesPayableToBanksMember dxc:TermLoanPayableGBPDue2022Member 2020-12-31 0001688568 srt:MaximumMember us-gaap:NotesPayableToBanksMember dxc:TermLoanPayableGBPDue2022Member 2020-12-31 0001688568 us-gaap:NotesPayableToBanksMember dxc:TermLoanPayableGBPDue2022Member 2020-12-31 0001688568 us-gaap:NotesPayableToBanksMember dxc:TermLoanPayableGBPDue2022Member 2020-03-31 0001688568 dxc:TermLoanPayableEURDue20222023Member us-gaap:NotesPayableToBanksMember 2020-12-31 0001688568 dxc:TermLoanPayableEURDue20222023Member us-gaap:NotesPayableToBanksMember 2020-03-31 0001688568 dxc:TermLoanPayableEURDue20232024Member us-gaap:NotesPayableToBanksMember 2020-12-31 0001688568 dxc:TermLoanPayableEURDue20232024Member us-gaap:NotesPayableToBanksMember 2020-03-31 0001688568 srt:MinimumMember us-gaap:NotesPayableToBanksMember dxc:TermLoanPayableUSDDue2025Member 2020-12-31 0001688568 srt:MaximumMember us-gaap:NotesPayableToBanksMember dxc:TermLoanPayableUSDDue2025Member 2020-12-31 0001688568 us-gaap:NotesPayableToBanksMember dxc:TermLoanPayableUSDDue2025Member 2020-12-31 0001688568 us-gaap:NotesPayableToBanksMember dxc:TermLoanPayableUSDDue2025Member 2020-03-31 0001688568 dxc:SeniorNotesDue2023Member us-gaap:SeniorNotesMember 2020-12-31 0001688568 dxc:SeniorNotesDue2023Member us-gaap:SeniorNotesMember 2020-03-31 0001688568 dxc:SeniorNotesDue2023TwoMember us-gaap:SeniorNotesMember 2020-12-31 0001688568 dxc:SeniorNotesDue2023TwoMember us-gaap:SeniorNotesMember 2020-03-31 0001688568 dxc:SeniorNotesDue2025Member us-gaap:SeniorNotesMember 2020-12-31 0001688568 dxc:SeniorNotesDue2025Member us-gaap:SeniorNotesMember 2020-03-31 0001688568 dxc:SeniorNotesDue2024Member us-gaap:SeniorNotesMember 2020-12-31 0001688568 dxc:SeniorNotesDue2024Member us-gaap:SeniorNotesMember 2020-03-31 0001688568 dxc:SeniorNotesDue2026TwoMember us-gaap:SeniorNotesMember 2020-12-31 0001688568 dxc:SeniorNotesDue2026TwoMember us-gaap:SeniorNotesMember 2020-03-31 0001688568 dxc:SeniorNotesDue2025OneMember us-gaap:SeniorNotesMember 2020-12-31 0001688568 dxc:SeniorNotesDue2025OneMember us-gaap:SeniorNotesMember 2020-03-31 0001688568 us-gaap:SeniorNotesMember dxc:SeniorNotesDue2026OneMember 2020-12-31 0001688568 us-gaap:SeniorNotesMember dxc:SeniorNotesDue2026OneMember 2020-03-31 0001688568 dxc:SeniorNotesDue2028Member us-gaap:SeniorNotesMember 2020-12-31 0001688568 dxc:SeniorNotesDue2028Member us-gaap:SeniorNotesMember 2020-03-31 0001688568 dxc:SeniorNotesDue2030Member us-gaap:SeniorNotesMember 2020-12-31 0001688568 dxc:SeniorNotesDue2030Member us-gaap:SeniorNotesMember 2020-03-31 0001688568 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2020-12-31 0001688568 us-gaap:RevolvingCreditFacilityMember srt:MaximumMember us-gaap:LineOfCreditMember 2020-12-31 0001688568 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2020-12-31 0001688568 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2020-03-31 0001688568 srt:MinimumMember us-gaap:SecuredDebtMember dxc:LeaseCreditFacilityVariousMember 2020-12-31 0001688568 srt:MaximumMember us-gaap:SecuredDebtMember dxc:LeaseCreditFacilityVariousMember 2020-12-31 0001688568 us-gaap:SecuredDebtMember dxc:LeaseCreditFacilityVariousMember 2020-12-31 0001688568 us-gaap:SecuredDebtMember dxc:LeaseCreditFacilityVariousMember 2020-03-31 0001688568 srt:MinimumMember dxc:BorrowingsForAssetsAcquiredUnderLongTermFinancingMember 2020-12-31 0001688568 srt:MaximumMember dxc:BorrowingsForAssetsAcquiredUnderLongTermFinancingMember 2020-12-31 0001688568 dxc:BorrowingsForAssetsAcquiredUnderLongTermFinancingMember 2020-12-31 0001688568 dxc:BorrowingsForAssetsAcquiredUnderLongTermFinancingMember 2020-03-31 0001688568 us-gaap:MandatorilyRedeemablePreferredStockMember 2020-12-31 0001688568 us-gaap:MandatorilyRedeemablePreferredStockMember 2020-03-31 0001688568 us-gaap:NotesPayableOtherPayablesMember 2020-12-31 0001688568 us-gaap:NotesPayableOtherPayablesMember 2020-03-31 0001688568 us-gaap:CommercialPaperMember 2020-12-31 0001688568 srt:MinimumMember dxc:TermLoanPayableEURDue20232024Member us-gaap:NotesPayableToBanksMember dxc:EURIBORMember 2020-04-01 2020-12-31 0001688568 dxc:TermLoanPayableEURDue20232024Member srt:MaximumMember us-gaap:NotesPayableToBanksMember dxc:EURIBORMember 2020-04-01 2020-12-31 0001688568 dxc:SeniorNotesDue2026TwoandSeniorNotes2024Member us-gaap:SeniorNotesMember 2020-09-30 0001688568 dxc:SeniorNotesDue2024Member us-gaap:SeniorNotesMember 2020-09-30 0001688568 dxc:SeniorNotesDue2026TwoMember us-gaap:SeniorNotesMember 2020-09-30 0001688568 dxc:TermLoanPayableEURDue2023Member us-gaap:NotesPayableToBanksMember 2020-04-01 2020-06-30 0001688568 us-gaap:NotesPayableToBanksMember dxc:TermLoanPayableGBPDue2022Member 2020-04-01 2020-06-30 0001688568 us-gaap:NotesPayableToBanksMember dxc:TermLoanPayableAUDDue2022Member 2020-04-01 2020-06-30 0001688568 us-gaap:NotesPayableToBanksMember dxc:TermLoanPayableUSDDue2025Member 2020-04-01 2020-06-30 0001688568 us-gaap:NotesPayableToBanksMember dxc:TermLoanPayableGBPDue2022Member 2020-07-01 2020-09-30 0001688568 us-gaap:NotesPayableToBanksMember 2020-10-01 2020-12-31 0001688568 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2020-07-01 2020-09-30 0001688568 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2020-04-01 2020-12-31 0001688568 country:US 2020-10-01 2020-12-31 0001688568 country:US 2019-10-01 2019-12-31 0001688568 country:US 2020-04-01 2020-12-31 0001688568 country:US 2019-04-01 2019-12-31 0001688568 country:GB 2020-10-01 2020-12-31 0001688568 country:GB 2019-10-01 2019-12-31 0001688568 country:GB 2020-04-01 2020-12-31 0001688568 country:GB 2019-04-01 2019-12-31 0001688568 dxc:OtherEuropeMember 2020-10-01 2020-12-31 0001688568 dxc:OtherEuropeMember 2019-10-01 2019-12-31 0001688568 dxc:OtherEuropeMember 2020-04-01 2020-12-31 0001688568 dxc:OtherEuropeMember 2019-04-01 2019-12-31 0001688568 country:AU 2020-10-01 2020-12-31 0001688568 country:AU 2019-10-01 2019-12-31 0001688568 country:AU 2020-04-01 2020-12-31 0001688568 country:AU 2019-04-01 2019-12-31 0001688568 dxc:OtherInternationalMember 2020-10-01 2020-12-31 0001688568 dxc:OtherInternationalMember 2019-10-01 2019-12-31 0001688568 dxc:OtherInternationalMember 2020-04-01 2020-12-31 0001688568 dxc:OtherInternationalMember 2019-04-01 2019-12-31 0001688568 2021-01-01 2020-12-31 0001688568 dxc:HumanServicesBusinessMember 2020-04-01 2020-12-31 0001688568 dxc:RestructuringPlanFiscal2020PlanMember 2020-12-31 0001688568 us-gaap:EmployeeSeveranceMember dxc:RestructuringPlanFiscal2020PlanMember 2020-12-31 0001688568 dxc:RestructuringPlanFiscal2020PlanMember us-gaap:FacilityClosingMember 2020-12-31 0001688568 dxc:RestructuringPlanFiscal2019PlanMember 2020-12-31 0001688568 us-gaap:EmployeeSeveranceMember dxc:RestructuringPlanFiscal2019PlanMember 2020-12-31 0001688568 us-gaap:FacilityClosingMember dxc:RestructuringPlanFiscal2019PlanMember 2020-12-31 0001688568 dxc:RestructuringPlanFiscal2018PlanMember 2020-12-31 0001688568 us-gaap:EmployeeSeveranceMember dxc:RestructuringPlanFiscal2018PlanMember 2020-12-31 0001688568 us-gaap:FacilityClosingMember dxc:RestructuringPlanFiscal2018PlanMember 2020-12-31 0001688568 us-gaap:EmployeeSeveranceMember dxc:RestructuringPlanFiscal2021PlanMember 2020-03-31 0001688568 us-gaap:EmployeeSeveranceMember dxc:RestructuringPlanFiscal2021PlanMember 2020-04-01 2020-12-31 0001688568 us-gaap:EmployeeSeveranceMember dxc:RestructuringPlanFiscal2021PlanMember 2020-12-31 0001688568 dxc:RestructuringPlanFiscal2021PlanMember us-gaap:FacilityClosingMember 2020-03-31 0001688568 dxc:RestructuringPlanFiscal2021PlanMember us-gaap:FacilityClosingMember 2020-04-01 2020-12-31 0001688568 dxc:RestructuringPlanFiscal2021PlanMember us-gaap:FacilityClosingMember 2020-12-31 0001688568 dxc:RestructuringPlanFiscal2021PlanMember 2020-03-31 0001688568 dxc:RestructuringPlanFiscal2021PlanMember 2020-04-01 2020-12-31 0001688568 dxc:RestructuringPlanFiscal2021PlanMember 2020-12-31 0001688568 us-gaap:EmployeeSeveranceMember dxc:RestructuringPlanFiscal2020PlanMember 2020-03-31 0001688568 us-gaap:EmployeeSeveranceMember dxc:RestructuringPlanFiscal2020PlanMember 2020-04-01 2020-12-31 0001688568 dxc:RestructuringPlanFiscal2020PlanMember us-gaap:FacilityClosingMember 2020-03-31 0001688568 dxc:RestructuringPlanFiscal2020PlanMember us-gaap:FacilityClosingMember 2020-04-01 2020-12-31 0001688568 dxc:RestructuringPlanFiscal2020PlanMember 2020-03-31 0001688568 dxc:RestructuringPlanFiscal2020PlanMember 2020-04-01 2020-12-31 0001688568 us-gaap:EmployeeSeveranceMember dxc:RestructuringPlanFiscal2019PlanMember 2020-03-31 0001688568 us-gaap:EmployeeSeveranceMember dxc:RestructuringPlanFiscal2019PlanMember 2020-04-01 2020-12-31 0001688568 us-gaap:FacilityClosingMember dxc:RestructuringPlanFiscal2019PlanMember 2020-03-31 0001688568 us-gaap:FacilityClosingMember dxc:RestructuringPlanFiscal2019PlanMember 2020-04-01 2020-12-31 0001688568 dxc:RestructuringPlanFiscal2019PlanMember 2020-03-31 0001688568 dxc:RestructuringPlanFiscal2019PlanMember 2020-04-01 2020-12-31 0001688568 us-gaap:EmployeeSeveranceMember dxc:RestructuringPlanOtherPriorYearPlansMember 2020-03-31 0001688568 us-gaap:EmployeeSeveranceMember dxc:RestructuringPlanOtherPriorYearPlansMember 2020-04-01 2020-12-31 0001688568 us-gaap:EmployeeSeveranceMember dxc:RestructuringPlanOtherPriorYearPlansMember 2020-12-31 0001688568 us-gaap:FacilityClosingMember dxc:RestructuringPlanOtherPriorYearPlansMember 2020-03-31 0001688568 us-gaap:FacilityClosingMember dxc:RestructuringPlanOtherPriorYearPlansMember 2020-04-01 2020-12-31 0001688568 us-gaap:FacilityClosingMember dxc:RestructuringPlanOtherPriorYearPlansMember 2020-12-31 0001688568 dxc:RestructuringPlanOtherPriorYearPlansMember 2020-03-31 0001688568 dxc:RestructuringPlanOtherPriorYearPlansMember 2020-04-01 2020-12-31 0001688568 dxc:RestructuringPlanOtherPriorYearPlansMember 2020-12-31 0001688568 dxc:AcquiredLiabilitiesMember us-gaap:EmployeeSeveranceMember 2020-03-31 0001688568 dxc:AcquiredLiabilitiesMember us-gaap:EmployeeSeveranceMember 2020-04-01 2020-12-31 0001688568 dxc:AcquiredLiabilitiesMember us-gaap:EmployeeSeveranceMember 2020-12-31 0001688568 dxc:AcquiredLiabilitiesMember us-gaap:FacilityClosingMember 2020-03-31 0001688568 dxc:AcquiredLiabilitiesMember us-gaap:FacilityClosingMember 2020-04-01 2020-12-31 0001688568 dxc:AcquiredLiabilitiesMember us-gaap:FacilityClosingMember 2020-12-31 0001688568 dxc:AcquiredLiabilitiesMember 2020-03-31 0001688568 dxc:AcquiredLiabilitiesMember 2020-04-01 2020-12-31 0001688568 dxc:AcquiredLiabilitiesMember 2020-12-31 0001688568 us-gaap:EmployeeSeveranceMember dxc:RestructuringPlanFiscal2020PlanMember 2019-04-01 2020-03-31 0001688568 us-gaap:PensionPlansDefinedBenefitMember us-gaap:ForeignPlanMember 2020-04-01 2020-06-30 0001688568 us-gaap:PensionPlansDefinedBenefitMember 2020-10-01 2020-12-31 0001688568 us-gaap:PensionPlansDefinedBenefitMember 2019-10-01 2019-12-31 0001688568 us-gaap:PensionPlansDefinedBenefitMember 2020-04-01 2020-12-31 0001688568 us-gaap:PensionPlansDefinedBenefitMember 2019-04-01 2019-12-31 0001688568 srt:DirectorMember 2020-04-01 2020-12-31 0001688568 dxc:HewlettPackardEnterpriseServicesMember 2020-12-31 0001688568 dxc:PerspectaMember 2020-12-31 0001688568 2017-04-03 0001688568 2018-11-08 0001688568 dxc:OpenMarketPurchasesMember 2019-04-01 2019-06-30 0001688568 dxc:AcceleratedShareRepurchaseAgreementMember 2019-04-01 2019-06-30 0001688568 2019-04-01 2019-06-30 0001688568 dxc:OpenMarketPurchasesMember 2019-07-01 2019-09-30 0001688568 dxc:AcceleratedShareRepurchaseAgreementMember 2019-07-01 2019-09-30 0001688568 2019-07-01 2019-09-30 0001688568 dxc:OpenMarketPurchasesMember 2019-10-01 2019-12-31 0001688568 dxc:AcceleratedShareRepurchaseAgreementMember 2019-10-01 2019-12-31 0001688568 us-gaap:AccumulatedTranslationAdjustmentMember 2020-03-31 0001688568 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-03-31 0001688568 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-03-31 0001688568 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-03-31 0001688568 us-gaap:AccumulatedTranslationAdjustmentMember 2020-04-01 2020-12-31 0001688568 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-04-01 2020-12-31 0001688568 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-04-01 2020-12-31 0001688568 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-04-01 2020-12-31 0001688568 us-gaap:AccumulatedTranslationAdjustmentMember 2020-12-31 0001688568 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-12-31 0001688568 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-12-31 0001688568 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-12-31 0001688568 us-gaap:AccumulatedTranslationAdjustmentMember 2019-03-31 0001688568 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-03-31 0001688568 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-03-31 0001688568 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-03-31 0001688568 us-gaap:AccumulatedTranslationAdjustmentMember 2019-04-01 2019-12-31 0001688568 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-04-01 2019-12-31 0001688568 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-04-01 2019-12-31 0001688568 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-04-01 2019-12-31 0001688568 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0001688568 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-12-31 0001688568 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-12-31 0001688568 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-12-31 0001688568 us-gaap:RestrictedStockUnitsRSUMember 2020-12-31 dxc:anniversary 0001688568 us-gaap:RestrictedStockUnitsRSUMember dxc:ServiceBasedRsusMember 2020-04-01 2020-12-31 0001688568 us-gaap:PerformanceSharesMember 2020-04-01 2020-12-31 0001688568 dxc:AnniversaryOneMember us-gaap:RestrictedStockUnitsRSUMember 2020-04-01 2020-12-31 0001688568 dxc:AnniversaryTwoMember us-gaap:RestrictedStockUnitsRSUMember 2020-04-01 2020-12-31 0001688568 us-gaap:RestrictedStockUnitsRSUMember dxc:AnniversaryThreeMember 2020-04-01 2020-12-31 0001688568 dxc:DXCSharePurchasePlanMember us-gaap:EmployeeStockMember 2020-10-01 2020-12-31 0001688568 dxc:DXCSharePurchasePlanMember us-gaap:EmployeeStockMember 2020-04-01 2020-12-31 0001688568 dxc:DXCEmployeeEquityPlanMember 2020-12-31 0001688568 dxc:DXCDirectorEquityPlanMember 2020-12-31 0001688568 dxc:DXCSharePurchasePlanMember 2020-12-31 0001688568 us-gaap:EmployeeStockOptionMember 2020-03-31 0001688568 us-gaap:EmployeeStockOptionMember 2019-04-01 2020-03-31 0001688568 us-gaap:EmployeeStockOptionMember 2020-04-01 2020-12-31 0001688568 us-gaap:EmployeeStockOptionMember 2020-12-31 0001688568 us-gaap:RestrictedStockUnitsRSUMember dxc:DXCEmployeeEquityPlanMember 2020-03-31 0001688568 dxc:DXCDirectorEquityPlanMember us-gaap:RestrictedStockUnitsRSUMember 2020-03-31 0001688568 us-gaap:RestrictedStockUnitsRSUMember dxc:DXCEmployeeEquityPlanMember 2020-04-01 2020-12-31 0001688568 dxc:DXCDirectorEquityPlanMember us-gaap:RestrictedStockUnitsRSUMember 2020-04-01 2020-12-31 0001688568 us-gaap:RestrictedStockUnitsRSUMember dxc:DXCEmployeeEquityPlanMember 2020-12-31 0001688568 dxc:DXCDirectorEquityPlanMember us-gaap:RestrictedStockUnitsRSUMember 2020-12-31 0001688568 us-gaap:RestrictedStockUnitsRSUMember 2020-04-01 2020-12-31 0001688568 us-gaap:OperatingSegmentsMember dxc:GBSSegmentMember 2020-10-01 2020-12-31 0001688568 us-gaap:OperatingSegmentsMember dxc:GISSegmentMember 2020-10-01 2020-12-31 0001688568 us-gaap:OperatingSegmentsMember 2020-10-01 2020-12-31 0001688568 us-gaap:MaterialReconcilingItemsMember 2020-10-01 2020-12-31 0001688568 us-gaap:OperatingSegmentsMember dxc:GBSSegmentMember 2019-10-01 2019-12-31 0001688568 us-gaap:OperatingSegmentsMember dxc:GISSegmentMember 2019-10-01 2019-12-31 0001688568 us-gaap:OperatingSegmentsMember 2019-10-01 2019-12-31 0001688568 us-gaap:MaterialReconcilingItemsMember 2019-10-01 2019-12-31 0001688568 us-gaap:OperatingSegmentsMember dxc:GBSSegmentMember 2020-04-01 2020-12-31 0001688568 us-gaap:OperatingSegmentsMember dxc:GISSegmentMember 2020-04-01 2020-12-31 0001688568 us-gaap:OperatingSegmentsMember 2020-04-01 2020-12-31 0001688568 us-gaap:MaterialReconcilingItemsMember 2020-04-01 2020-12-31 0001688568 us-gaap:OperatingSegmentsMember dxc:GBSSegmentMember 2019-04-01 2019-12-31 0001688568 us-gaap:OperatingSegmentsMember dxc:GISSegmentMember 2019-04-01 2019-12-31 0001688568 us-gaap:OperatingSegmentsMember 2019-04-01 2019-12-31 0001688568 us-gaap:MaterialReconcilingItemsMember 2019-04-01 2019-12-31 0001688568 dxc:SuretyBondsPerformanceGuaranteeMember 2020-12-31 0001688568 dxc:LettersOfCreditPerformanceGuaranteeMember 2020-12-31 0001688568 us-gaap:FinancialStandbyLetterOfCreditMember 2020-12-31 dxc:administrator 0001688568 dxc:StrauchFairLaborStandardsActCollectiveActionMember 2015-04-04 2015-10-02 dxc:individual 0001688568 dxc:StrauchFairLaborStandardsActCollectiveActionMember 2020-04-01 2020-12-31 0001688568 dxc:StrauchFairLaborStandardsActCollectiveActionMember 2019-08-06 2019-08-06 0001688568 dxc:StrauchFairLaborStandardsActCollectiveActionMember 2019-09-01 2019-09-30 0001688568 dxc:StrauchFairLaborStandardsActCollectiveActionMember 2020-07-01 2020-07-31 0001688568 us-gaap:SettledLitigationMember dxc:ComputerSciencesCorporationv.EricPulieretal.Member 2016-02-29 0001688568 dxc:KemperCorporateServicesInc.v.ComputerSciencesCorporationMember us-gaap:PendingLitigationMember 2015-10-01 2015-10-31 0001688568 us-gaap:SettledLitigationMember dxc:KemperCorporateServicesInc.v.ComputerSciencesCorporationMember 2015-10-01 2015-10-31 0001688568 dxc:KemperCorporateServicesInc.v.ComputerSciencesCorporationMember 2020-02-21 2020-02-21 0001688568 dxc:KemperCorporateServicesInc.v.ComputerSciencesCorporationMember 2020-02-22 2020-12-31 dxc:plaintiff 0001688568 us-gaap:PendingLitigationMember dxc:Forsythetal.v.HPInc.andHewlettPackardEnterpriseMember 2018-10-01 2018-10-31 0001688568 us-gaap:SettledLitigationMember dxc:EmployeesofFormerBusinessUnitsofHPEMember dxc:Forsythetal.v.HPInc.andHewlettPackardEnterpriseMember 2018-10-01 2018-10-31 0001688568 us-gaap:PendingLitigationMember dxc:Forsythetal.v.HPInc.andHewlettPackardEnterpriseMember 2019-06-01 2019-06-30 0001688568 us-gaap:SettledLitigationMember dxc:Forsythetal.v.HPInc.andHewlettPackardEnterpriseMember 2019-12-01 2019-12-31 0001688568 us-gaap:SettledLitigationMember dxc:EmployeesofFormerBusinessUnitsofHPEMember dxc:Forsythetal.v.HPInc.andHewlettPackardEnterpriseMember 2019-12-01 2019-12-31 dxc:lawsuit 0001688568 dxc:InreDXCTechnologyCompanySecuritiesLitigationMember 2019-03-01 2019-03-31 dxc:officer 0001688568 srt:OfficerMember dxc:InreDXCTechnologyCompanySecuritiesLitigationMember 2019-03-01 2019-03-31 dxc:joint_venture 0001688568 2017-02-02 0001688568 dxc:PerspectarelatedDisputesSeparationandDistributionAgreementMember 2019-10-01 2019-10-31 0001688568 dxc:PerspectarelatedDisputesSeparationandDistributionAgreementIncreaseOneMember 2020-04-01 2020-12-31 0001688568 dxc:PerspectarelatedDisputesSeparationandDistributionAgreementIncreaseTwoMember 2020-04-01 2020-12-31 0001688568 dxc:PerspectarelatedDisputesSeparationandDistributionAgreementIncreaseThreeMember 2020-04-01 2020-12-31 0001688568 dxc:PerspectarelatedDisputesITServicesAgreementMember 2019-06-01 2019-06-30 0001688568 dxc:PerspectarelatedDisputesITServicesAgreementMember 2020-08-01 2020-08-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)

☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended December 31, 2020
OR

☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _____________ to ____________
Commission File No.: 001-38033

| DXC TECHNOLOGY COMPANY
(Exact name of registrant as specified in its charter)

Nevada |  | 61-1800317
(State or other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification No.)
1775 Tysons Boulevard |  |  |  |  |
Tysons | , | Virginia |  | 22102
(Address of principal executive offices) |  | (Zip Code)

Registrant's telephone number, including area code: (703) 245-9675

Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered
Common Stock, $0.01 par value per share | DXC | New York Stock Exchange
2.750% Senior Notes Due 2025 | DXC 25 | New York Stock Exchange
1.750% Senior Notes Due 2026 | DXC 26 | New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d)
of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. x Yes o No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). x Yes o No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer | x |  |  | Accelerated Filer | o |  |  |
Non-accelerated Filer | o |  |  | Smaller reporting company | ☐ |
|  |  |  | Emerging growth company | ☐ |

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
☐ Yes x No
254,593,993 shares of common stock, par value $0.01 per share, were outstanding on January 29, 2021.

TABLE OF CONTENTS

Item |  |  | Page
|  | PART I - FINANCIAL INFORMATION |
1. |  | Financial Statements (unaudited) | 1
2. |  | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 50
3. |  | Quantitative and Qualitative Disclosures About Market Risk | 69
4. |  | Controls and Procedures | 69
|  | PART II - OTHER INFORMATION |
1. |  | Legal Proceedings | 72
1A. |  | Risk Factors | 72
2. |  | Unregistered Sales of Equity Securities and Use of Proceeds | 72
3. |  | Defaults Upon Senior Securities | 73
4. |  | Mine Safety Disclosure | 73
5. |  | Other Information | 73
6. |  | Exhibits | 73

PART I
ITEM 1. FINANCIAL STATEMENTS
Index to Condensed Consolidated Financial Statements

| Page
Condensed Consolidated Statements of Operations for the Three and Nine Months Ended December 31, 2020 and December 31, 2019 (unaudited) | 2
Condensed Consolidated Statements of Comprehensive (Loss) Income for the Three and Nine Months Ended December 31, 2020 and December 31, 2020 (unaudited) | 3
Condensed Consolidated Balance Sheets as of December 31, 2020 and March 31, 2020 (unaudited) | 4
Condensed Consolidated Statements of Cash Flows for the Nine Months Ended December 31, 2020 and December 31, 2019 (unaudited) | 5
Condensed Consolidated Statements of Changes in Equity for the Three and Nine Months Ended December 31, 2020 and December 31, 2019 (unaudited) | 6
Notes to Condensed Consolidated Financial Statements (unaudited) |
Note 1–Summary of Significant Accounting Policies | 8
Note 2–Recent Accounting Pronouncements | 10
Note 3–Acquisitions | 11
Note 4–Divestitures | 12
Note 5–Earnings (Loss) Per Share | 14
Note 6–Receivables | 14
Note 7–Leases | 17
Note 8–Fair Value | 20
Note 9–Derivative and Hedging Activities | 22
Note 10–Intangible Assets | 25
Note 11–Goodwill | 26
Note 12–Debt | 27
Note 13–Revenue | 28
Note 14–Restructuring Costs | 30
Note 15–Pension and Other Benefit Plans | 32
Note 16–Income Taxes | 34
Note 17–Stockholders' Equity | 35
Note 18–Stock Incentive Plans | 36
Note 19–Cash Flows | 38
Note 20–Segment Information | 39
Note 21–Commitments and Contingencies | 42

1

DXC TECHNOLOGY COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)

|  | Three Months Ended |  | Nine Months Ended
(in millions, except per-share amounts) |  | December 31, 2020 |  | December 31, 2019 |  | December 31, 2020 |  | December 31, 2019
Revenues |  | $ | 4,288 |  |  | $ | 5,021 |  |  | $ | 13,344 |  |  | $ | 14,762 |
Costs of services (excludes depreciation and amortization and restructuring costs) |  | 3,333 |  |  | 3,827 |  |  | 10,525 |  |  | 11,128 |
Selling, general, and administrative (excludes depreciation and amortization and restructuring costs) |  | 517 |  |  | 518 |  |  | 1,595 |  |  | 1,514 |
Depreciation and amortization |  | 475 |  |  | 479 |  |  | 1,492 |  |  | 1,416 |
Goodwill impairment losses |  | — |  |  | 53 |  |  | — |  |  | 2,940 |
Restructuring costs |  | 104 |  |  | 74 |  |  | 441 |  |  | 248 |
Interest expense |  | 82 |  |  | 93 |  |  | 284 |  |  | 288 |
Interest income |  | (28) |  |  | (33) |  |  | (76) |  |  | (130) |
Gain on disposition of businesses |  | (2,046) |  |  | — |  |  | (2,046) |  |  | — |
Gain on arbitration award |  | — |  |  | — |  |  | — |  |  | (632) |
Other income, net |  | (127) |  |  | (117) |  |  | (318) |  |  | (344) |
Total costs and expenses |  | 2,310 |  |  | 4,894 |  |  | 11,897 |  |  | 16,428 |
Income (loss) before income taxes |  | 1,978 |  |  | 127 |  |  | 1,447 |  |  | (1,666) |
Income tax expense |  | 875 |  |  | 37 |  |  | 789 |  |  | 191 |
Net income (loss) |  | 1,103 |  |  | 90 |  |  | 658 |  |  | (1,857) |
Less: net income attributable to non-controlling interest, net of tax |  | 5 |  |  | 8 |  |  | 9 |  |  | 17 |
Net income (loss) attributable to DXC common stockholders |  | $ | 1,098 |  |  | $ | 82 |  |  | $ | 649 |  |  | $ | (1,874) |
Earnings (loss) per common share: |  |  |  |  |  |  |  |
Basic |  | $ | 4.32 |  |  | $ | 0.32 |  |  | $ | 2.55 |  |  | $ | (7.20) |
Diluted |  | $ | 4.29 |  |  | $ | 0.32 |  |  | $ | 2.54 |  |  | $ | (7.20) |

The accompanying notes are an integral part of these condensed consolidated financial statements.
2

DXC TECHNOLOGY COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (unaudited)

|  |  |  | Three Months Ended |  | Nine Months Ended
(in millions) |  | December 31, 2020 |  | December 31, 2019 |  | December 31, 2020 |  | December 31, 2019
Net income (loss) |  | $ | 1,103 |  |  | $ | 90 |  |  | $ | 658 |  |  | $ | (1,857) |
Other comprehensive income, net of taxes: |  |  |  |  |  |  |  |
| Foreign currency translation adjustments, net of tax (1) |  | 170 |  |  | 293 |  |  | 200 |  |  | 87 |
| Cash flow hedges adjustments, net of tax (2) |  | — |  |  | (8) |  |  | 18 |  |  | (6) |
| Available-for-sale securities, net of tax (3) |  | (11) |  |  | — |  |  | (6) |  |  | 2 |
| Pension and other post-retirement benefit plans, net of tax: |  |  |  |  |  |  |  |
|  | Prior service cost, net of tax (4) |  | (1) |  |  | — |  |  | (1) |  |  | — |
|  | Amortization of prior service cost, net of tax (5) |  | (2) |  |  | (2) |  |  | (12) |  |  | (6) |
| Pension and other post-retirement benefit plans, net of tax |  | (3) |  |  | (2) |  |  | (13) |  |  | (6) |
Other comprehensive income, net of taxes |  | 156 |  |  | 283 |  |  | 199 |  |  | 77 |
Comprehensive income (loss) |  | 1,259 |  |  | 373 |  |  | 857 |  |  | (1,780) |
| Less: comprehensive income attributable to non-controlling interest |  | 6 |  |  | 39 |  |  | 12 |  |  | 26 |
Comprehensive income (loss) attributable to DXC common stockholders |  | $ | 1,253 |  |  | $ | 334 |  |  | $ | 845 |  |  | $ | (1,806) |

(1) Tax benefit related to foreign currency translation adjustments was $9 and $31 for the three and nine months ended December 31, 2020, respectively, and $15 and $2 for the three and nine months ended December 31, 2019, respectively.
(2) Tax expense related to cash flow hedge adjustments was $0 and $6 for the three and nine months ended December 31, 2020, respectively. Tax benefit related to cash flow hedge adjustments was $1 and $1 for the three and nine months ended December 31, 2019, respectively.
(3) Tax benefit related to available-for-sale securities was $4 for the three and nine months ended December 31, 2020. Tax expense related to available-for-sale securities was $0 and $1 for the three and nine months ended December 31, 2019, respectively.
(4) There was no tax benefit related to prior service costs during the three and nine months ended December 31, 2020 and December 31, 2019, respectively.
(5) Tax benefit related to amortization of prior service costs was $1 and $3 for the three and nine months ended December 31, 2020, respectively, and $0 and $1 for the three and nine months ended December 31, 2019, respectively.
The accompanying notes are an integral part of these condensed consolidated financial statements.
3

DXC TECHNOLOGY COMPANY
CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited)

|  | As of
(in millions, except per-share and share amounts) |  | December 31, 2020 |  | March 31, 2020
ASSETS |  |  |  |
Current assets: |  |  |  |
Cash and cash equivalents |  | $ | 3,919 |  |  | $ | 3,679 |
Receivables and contract assets, net of allowance of $199 and $74 |  | 4,130 |  |  | 4,392 |
Prepaid expenses |  | 586 |  |  | 646 |
Other current assets |  | 470 |  |  | 270 |
Total current assets |  | 9,105 |  |  | 8,987 |
Intangible assets, net of accumulated amortization of $4,545 and $4,347 |  | 4,019 |  |  | 5,731 |
Operating right-of-use assets, net |  | 1,459 |  |  | 1,428 |
Goodwill |  | 736 |  |  | 2,017 |
Deferred income taxes, net |  | 315 |  |  | 265 |
Property and equipment, net of accumulated depreciation of $4,295 and $3,818 |  | 3,321 |  |  | 3,547 |
Other assets |  | 4,679 |  |  | 4,031 |
Total Assets |  | $ | 23,634 |  |  | $ | 26,006 |
LIABILITIES and EQUITY |  |  |  |
Current liabilities: |  |  |  |
Short-term debt and current maturities of long-term debt |  | $ | 795 |  |  | $ | 1,276 |
Accounts payable |  | 852 |  |  | 1,598 |
Accrued payroll and related costs |  | 741 |  |  | 630 |
Current operating lease liabilities |  | 450 |  |  | 482 |
Accrued expenses and other current liabilities |  | 3,285 |  |  | 2,801 |
Deferred revenue and advance contract payments |  | 1,102 |  |  | 1,021 |
Income taxes payable |  | 1,045 |  |  | 87 |
Total current liabilities |  | 8,270 |  |  | 7,895 |
Long-term debt, net of current maturities |  | 5,444 |  |  | 8,672 |
Non-current deferred revenue |  | 666 |  |  | 735 |
Non-current operating lease liabilities |  | 1,113 |  |  | 1,063 |
Non-current income tax liabilities and deferred tax liabilities |  | 792 |  |  | 1,157 |
Other long-term liabilities |  | 1,354 |  |  | 1,355 |
Total Liabilities |  | 17,639 |  |  | 20,877 |
Commitments and contingencies |  |  |  |
DXC stockholders’ equity: |  |  |  |
Preferred stock, par value $.01 per share, 1,000,000 shares authorized, none issued as of December 31, 2020 and March 31, 2020 |  | — |  |  | — |
Common stock, par value $.01 per share, 750,000,000 shares authorized, 256,800,719 issued as of December 31, 2020 and 255,674,040 issued as of March 31, 2020 |  | 3 |  |  | 3 |
Additional paid-in capital |  | 10,748 |  |  | 10,714 |
Accumulated deficit |  | (4,533) |  |  | (5,177) |
Accumulated other comprehensive loss |  | (407) |  |  | (603) |
Treasury stock, at cost, 2,410,917 and 2,148,708 shares as of December 31, 2020 and March 31, 2020 |  | (156) |  |  | (152) |
Total DXC stockholders’ equity |  | 5,655 |  |  | 4,785 |
Non-controlling interest in subsidiaries |  | 340 |  |  | 344 |
Total Equity |  | 5,995 |  |  | 5,129 |
Total Liabilities and Equity |  | $ | 23,634 |  |  | $ | 26,006 |

The accompanying notes are an integral part of these condensed consolidated financial statements.
4

DXC TECHNOLOGY COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)

|  | Nine Months Ended
(in millions) |  | December 31, 2020 |  | December 31, 2019
Cash flows from operating activities: |  |  |  |
Net income (loss) |  | $ | 658 |  |  | $ | (1,857) |
Adjustments to reconcile net loss to net cash provided by operating activities: |  |  |  |
Depreciation and amortization |  | 1,506 |  |  | 1,429 |
Goodwill impairment losses |  | — |  |  | 2,940 |
Operating right-of-use expense |  | 463 |  |  | 506 |
Pension and other post-employment benefits, actuarial and settlement losses |  | 2 |  |  | — |
Share-based compensation |  | 42 |  |  | 57 |
Deferred taxes |  | (319) |  |  | (28) |
(Gain) loss on dispositions |  | (2,023) |  |  | 6 |
Provision for losses on accounts receivable |  | 52 |  |  | — |
Unrealized foreign currency exchange (gain) loss |  | (60) |  |  | 14 |
Impairment losses and contract write-offs |  | 68 |  |  | 20 |
Other non-cash charges, net |  | (2) |  |  | (13) |
Changes in assets and liabilities, net of effects of acquisitions and dispositions: |  |  |  |
Decrease in assets |  | 88 |  |  | 141 |
Decrease in operating lease liability |  | (463) |  |  | (506) |
Increase (decrease) in other liabilities |  | 392 |  |  | (647) |
Net cash provided by operating activities |  | 404 |  |  | 2,062 |
Cash flows from investing activities: |  |  |  |
Purchases of property and equipment |  | (215) |  |  | (240) |
Payments for transition and transformation contract costs |  | (189) |  |  | (220) |
Software purchased and developed |  | (209) |  |  | (178) |
Payments for acquisitions, net of cash acquired |  | (10) |  |  | (1,997) |
Business dispositions |  | 4,942 |  |  | — |
Cash collections related to deferred purchase price receivable |  | 159 |  |  | 513 |
Proceeds from sale of assets |  | 27 |  |  | 55 |
Short-term investing |  | — |  |  | (75) |
Other investing activities, net |  | (5) |  |  | 20 |
Net cash provided by (used in) investing activities |  | 4,500 |  |  | (2,122) |
Cash flows from financing activities: |  |  |  |
Borrowings of commercial paper |  | 854 |  |  | 4,010 |
Repayments of commercial paper |  | (1,327) |  |  | (3,893) |
Borrowings under lines of credit |  | 2,500 |  |  | — |
Repayment of borrowings under lines of credit |  | (4,000) |  |  | — |
Borrowings on long-term debt, net of discount |  | 993 |  |  | 2,198 |
Principal payments on long-term debt |  | (2,926) |  |  | (1,029) |
Payments on finance leases and borrowings for asset financing |  | (694) |  |  | (646) |
Proceeds from stock options and other common stock transactions |  | 1 |  |  | 11 |
Taxes paid related to net share settlements of share-based compensation awards |  | (5) |  |  | (15) |
Repurchase of common stock and advance payment for accelerated share repurchase |  | — |  |  | (736) |
Dividend payments |  | (53) |  |  | (161) |
Other financing activities, net |  | (14) |  |  | (44) |
Net cash used in financing activities |  | (4,671) |  |  | (305) |
Effect of exchange rate changes on cash and cash equivalents |  | 20 |  |  | 26 |
Net increase (decrease) in cash and cash equivalents including cash classified within current assets held for sale |  | 253 |  |  | (339) |
Less: cash classified within current assets held for sale |  | (13) |  |  | — |
Net increase (decrease) in cash and cash equivalents |  | 240 |  |  | (339) |
Cash and cash equivalents at beginning of year |  | 3,679 |  |  | 2,899 |
Cash and cash equivalents at end of period |  | $ | 3,919 |  |  | $ | 2,560 |

The accompanying notes are an integral part of these condensed consolidated financial statements.
5

DXC TECHNOLOGY COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (unaudited)

| Three Months Ended December 31, 2020
(in millions, except shares in thousands) | Common Stock | Additional Paid-in Capital | Retained Earnings (Accumulated Deficit) | Accumulated Other Comprehensive Loss | Treasury Stock (1) | Total DXC Equity | Non- Controlling Interest | Total Equity
Shares |  | Amount
Balance at September 30, 2020 | 256,522 |  |  | $ | 3 |  | $ | 10,746 |  | $ | (5,631) |  | $ | (562) |  | $ | (155) |  | $ | 4,401 |  | $ | 350 |  | $ | 4,751 |
Net income |  |  |  |  | 1,098 |  |  |  | 1,098 |  | 5 |  | 1,103 |
Other comprehensive income |  |  |  |  |  | 155 |  |  | 155 |  | 1 |  | 156 |
Share-based compensation expense |  |  |  | 1 |  |  |  |  | 1 |  |  | 1 |
Acquisition of treasury stock |  |  |  |  |  |  | (1) |  | (1) |  |  | (1) |
Stock option exercises and other common stock transactions | 279 |  |  |  | 1 |  |  |  |  | 1 |  |  | 1 |
Non-controlling interest distributions and other |  |  |  |  |  |  |  | — |  | (16) |  | (16) |
Balance at December 31, 2020 | 256,801 |  | $ | 3 |  | $ | 10,748 |  | $ | (4,533) |  | $ | (407) |  | $ | (156) |  | $ | 5,655 |  | $ | 340 |  | $ | 5,995 |
| Three Months Ended December 31, 2019
(in millions, except shares in thousands) | Common Stock | Additional Paid-in Capital | Retained Earnings (Accumulated Deficit) | Accumulated Other Comprehensive Loss | Treasury Stock | Total DXC Equity | Non- Controlling Interest | Total Equity
Shares |  | Amount
Balance at September 30, 2019 | 257,626 |  |  | $ | 3 |  | $ | 10,793 |  | $ | (1,668) |  | $ | (428) |  | $ | (150) |  | $ | 8,550 |  | $ | 320 |  | $ | 8,870 |
Net income |  |  |  |  | 82 |  |  |  | 82 |  | 8 |  | 90 |
Other comprehensive income |  |  |  |  |  | 252 |  |  | 252 |  | 31 |  | 283 |
Share-based compensation expense |  |  |  | 6 |  |  |  |  | 6 |  |  | 6 |
Acquisition of treasury stock |  |  |  |  |  |  | (1) |  | (1) |  |  | (1) |
Share repurchase program | (2,354) |  |  |  | (98) |  | 12 |  |  |  | (86) |  |  | (86) |
Stock option exercises and other common stock transactions | 334 |  |  |  |  |  |  |  | — |  |  | — |
Dividends declared ($0.21 per share) |  |  |  |  | (54) |  |  |  | (54) |  |  | (54) |
Non-controlling interest distributions and other |  |  |  |  |  |  |  | — |  | (7) |  | (7) |
Balance at December 31, 2019 | 255,606 |  |  | $ | 3 |  | $ | 10,701 |  | $ | (1,628) |  | $ | (176) |  | $ | (151) |  | $ | 8,749 |  | $ | 352 |  | $ | 9,101 |

The accompanying notes are an integral part of these condensed consolidated financial statements.
6

DXC TECHNOLOGY COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (unaudited)

| Nine Months Ended December 31, 2020
(in millions, except shares in thousands) | Common Stock | Additional Paid-in Capital | Retained Earnings (Accumulated Deficit) | Accumulated Other Comprehensive Loss | Treasury Stock (1) | Total DXC Equity | Non- Controlling Interest | Total Equity
Shares |  | Amount
Balance at March 31, 2020 | 255,674 |  |  | $ | 3 |  | $ | 10,714 |  | $ | (5,177) |  | $ | (603) |  | $ | (152) |  | $ | 4,785 |  | $ | 344 |  | $ | 5,129 |
Cumulative effect of adopting ASU 2016-13 |  |  |  |  | (4) |  |  |  | (4) |  |  | (4) |
Net income |  |  |  |  | 649 |  |  |  | 649 |  | 9 |  | 658 |
Other comprehensive income |  |  |  |  |  | 196 |  |  | 196 |  | 3 |  | 199 |
Share-based compensation expense |  |  |  | 33 |  |  |  |  | 33 |  |  | 33 |
Acquisition of treasury stock |  |  |  |  |  |  | (4) |  | (4) |  |  | (4) |
Stock option exercises and other common stock transactions | 1,127 |  |  |  | 1 |  |  |  |  | 1 |  |  | 1 |
Non-controlling interest distributions and other |  |  |  |  | (1) |  |  |  | (1) |  | (16) |  | (17) |
Balance at December 31, 2020 | 256,801 |  |  | $ | 3 |  | $ | 10,748 |  | $ | (4,533) |  | $ | (407) |  | $ | (156) |  | $ | 5,655 |  | $ | 340 |  | $ | 5,995 |
| Nine Months Ended December 31, 2019
(in millions, except shares in thousands) | Common Stock | Additional Paid-in Capital | Retained Earnings (Accumulated Deficit) | Accumulated Other Comprehensive Loss | Treasury Stock | Total DXC Equity | Non- Controlling Interest | Total Equity
Shares |  | Amount
Balance at March 31, 2019 | 270,214 |  |  | $ | 3 |  | $ | 11,301 |  | $ | 478 |  | $ | (244) |  | $ | (136) |  | $ | 11,402 |  | $ | 323 |  | $ | 11,725 |
Net loss |  |  |  |  | (1,874) |  |  |  | (1,874) |  | 17 |  | (1,857) |
Other comprehensive income |  |  |  |  |  | 68 |  |  | 68 |  | 9 |  | 77 |
Share-based compensation expense |  |  |  | 55 |  |  |  |  | 55 |  |  | 55 |
Acquisition of treasury stock |  |  |  |  |  |  | (15) |  | (15) |  |  | (15) |
Share repurchase program | (15,934) |  |  |  | (669) |  | (67) |  |  |  | (736) |  |  | (736) |
Stock option exercises and other common stock transactions | 1,326 |  |  |  | 14 |  |  |  |  | 14 |  |  | 14 |
Dividends declared ($0.63 per share) |  |  |  |  | (165) |  |  |  | (165) |  |  | (165) |
Non-controlling interest distributions and other |  |  |  |  |  |  |  | — |  | 3 |  | 3 |
Balance at December 31, 2019 | 255,606 |  |  | $ | 3 |  | $ | 10,701 |  | $ | (1,628) |  | $ | (176) |  | $ | (151) |  | $ | 8,749 |  | $ | 352 |  | $ | 9,101 |

(1) 2,410,917 treasury shares as of December 31, 2020.
The accompanying notes are an integral part of these condensed consolidated financial statements.
7

DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Note 1 - Summary of Significant Accounting Policies
Business
DXC Technology Company ("DXC," the "Company," "we," "us," or "our") helps global companies run their mission critical systems and operations while modernizing IT, optimizing data architectures, and ensuring security and scalability across public, private and hybrid clouds. With decades of driving innovation, the world’s largest companies trust DXC to deploy its enterprise technology stack to deliver new levels of performance, competitiveness and customer experiences.
HHS Sale
On October 1, 2020, DXC completed the sale of its U.S. State and Local Health and Human Services business ("HHS" or the "HHS Business") to Veritas Capital Fund Management, L.L.C. ("Veritas Capital") to form Gainwell Technologies. The sale was accomplished by the cash purchase of all equity interests and assets attributable to the HHS Business together with future services to be provided by the Company for a total enterprise value of $5.0 billion, subject to net working capital adjustments and assumed liabilities. See Note 4 - Divestitures for further information.
HPS Sale
On July 17, 2020, DXC entered into a purchase agreement to sell (the "HPS Sale") its healthcare provider software business ("HPS" or the "HPS Business") to Dedalus Holding S.p.A. ("Dedalus") for €459 million (approximately $525 million), subject to certain adjustments. The HPS Sale is expected to close by March 2021, subject to meeting certain closing conditions.
Luxoft Acquisition
On June 14, 2019, DXC completed its acquisition of Luxoft Holding, Inc. ("Luxoft"), a global digital strategy and software engineering firm (the "Luxoft Acquisition"). The acquisition builds on DXC’s unique value proposition as an end-to-end, mainstream IT and digital services market leader, and strengthens the Company’s ability to design and deploy transformative digital solutions for clients at scale. See Note 3 - "Acquisitions" for further information.
Basis of Presentation
In order to make this report easier to read, DXC refers throughout to (i) the interim unaudited Condensed Consolidated Financial Statements as the “financial statements,” (ii) the Condensed Consolidated Statements of Operations as the “statements of operations,” (iii) the Condensed Consolidated Statements of Comprehensive Income (Loss) as the "statements of comprehensive income," (iv) the Condensed Consolidated Balance Sheets as the “balance sheets,” and (v) the Condensed Consolidated Statements of Cash Flows as the “statements of cash flows.” In addition, references throughout to numbered “Notes” refer to the numbered Notes in these Notes to Condensed Consolidated Financial Statements, unless otherwise noted.
The accompanying financial statements include the accounts of DXC, its consolidated subsidiaries, and those business entities in which DXC maintains a controlling interest. Investments in business entities in which the Company does not have control, but has the ability to exercise significant influence over operating and financial policies, are accounted for by the equity method. Other investments are accounted for by the cost method. Non-controlling interests are presented as a separate component within equity in the balance sheets. Net earnings attributable to the non-controlling interests are presented separately in the statements of operations and comprehensive income attributable to non-controlling interests are presented separately in the statements of comprehensive income. All intercompany transactions and balances have been eliminated. Certain amounts reported in the previous year have been reclassified to conform to the current year presentation.
8

DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
The financial statements of the Company have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission for quarterly reports and accounting principles generally accepted in the United States ("GAAP"). Certain disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules. These financial statements should therefore be read in conjunction with the audited consolidated financial statements and accompanying notes included in the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2020 ("fiscal 2020").
Use of Estimates
The preparation of financial statements in conformity with GAAP requires the Company's management to make estimates and assumptions that affect amounts reported in the financial statements. The Company bases its estimates on assumptions regarding historical experience, currently available information and anticipated developments that it believes are reasonable and appropriate. However, because the use of estimates involves an inherent degree of uncertainty, actual results could differ from those estimates. The severity, magnitude and duration, as well as the economic consequences of the coronavirus disease 2019 ("COVID-19") pandemic, are uncertain, rapidly changing and difficult to predict. Therefore, accounting estimates and assumptions may change over time in response to COVID-19 and may change materially in future periods. In the opinion of the Company's management, the accompanying financial statements of DXC contain all adjustments, including normal recurring adjustments, necessary to present fairly the Company's financial statements. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full fiscal year.
Allowance for Credit Losses
Effective April 1, 2020, the Company adopted Accounting Standards Update ("ASU") 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” using the modified retrospective method. Refer to Note 2 - "Recent Accounting Pronouncements" and Note 6 - "Receivables" for further discussion of the impact of adoption and other required disclosures. The amendments in this update changed the guidance for credit losses to an expected loss model rather than an incurred loss model. Financial assets subject to impairment under an expected credit loss model include billed and unbilled receivables, other receivables, and contract assets. Certain off-balance sheet arrangements, such as financial guarantees associated with receivables securitization facilities, are also subject to the guidance of ASU 2016-13.
Under an expected credit loss model, the Company immediately recognizes an estimate of credit losses expected to occur over the remaining life of financial assets that are in the scope of ASU 2016-13. DXC considers all available relevant information when estimating expected credit losses, including past events, current market conditions and forecasts and their implications for expected credit losses.
9

DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Note 2 - Recent Accounting Pronouncements
During the nine months ended December 31, 2020, DXC adopted the following Accounting Standards Updates ("ASU") issued by the Financial Accounting Standards Board:

Date Issued and ASU | Date Adopted and Method | Description | Impact
June 2016 ASU 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” | April 1, 2020 Modified Retrospective | This update requires the measurement and recognition of expected credit losses using the current expected credit loss model for financial assets held at amortized cost, which includes the Company’s trade accounts receivable, certain financial instruments and contract assets. It replaces the existing incurred loss impairment model with an expected loss methodology. The recorded credit losses are adjusted each period for changes in expected lifetime credit losses. The standard requires a cumulative effect adjustment to the statement of financial position as of the beginning of the first reporting period in which the guidance is effective. | The Company adopted this standard using the modified retrospective approach and recorded an immaterial cumulative effect adjustment in retained earnings as of April 1, 2020.
August 2018 ASU 2018-15, "Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract" | April 1, 2020 Prospective | This update helps entities evaluate the accounting for fees paid by a customer in a cloud computing arrangement (hosting arrangement) by providing guidance for determining when the arrangement includes a software license. Entities have the option to apply this standard prospectively to all implementation costs incurred after the date of adoption or retrospectively. | The Company adopted this standard using the prospective method and determined that the adoption of ASU 2018-15 had no material impact to its condensed consolidated financial statements.

The following ASUs were recently issued but have not yet been adopted by DXC:

Date Issued and ASU | DXC Effective Date | Description | Impact
December 2019 ASU 2019-12, "Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes" | Fiscal 2022 | This update is intended to simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. Early adoption of this update is permitted. | The Company is currently evaluating the potential impact this standard may have on its financial statements in future reporting periods.

Other recently issued ASUs effective after December 31, 2020 are not expected to have a material effect on DXC's consolidated financial statements.
10

DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Note 3 - Acquisitions
Fiscal 2020 Acquisitions
Luxoft Acquisition
On June 14, 2019, DXC completed the acquisition of Luxoft, a digital service provider whose offerings encompass strategic consulting, custom software development services, and digital solution engineering for total consideration of $2.0 billion. In return, DXC received all of Luxoft's issued and outstanding Class A and Class B ordinary shares. The acquisition will combine Luxoft’s digital engineering capabilities with DXC’s expertise in IT modernization and integration. The purchase agreement (“Merger Agreement”) was entered into by DXC and Luxoft on January 6, 2019 and the transaction was closed on June 14, 2019 (the "acquisition date.")
The transaction between DXC and Luxoft is an acquisition, with DXC as the acquirer and Luxoft as the acquiree, based on the fact that DXC acquired 100% of the equity interests and voting rights in Luxoft, and that DXC is the entity that transferred the cash consideration.
The Company's allocation of the purchase price to the assets acquired and liabilities assumed as of the Luxoft acquisition date is as follows:

(in millions) |  | Fair Value
Cash and cash equivalents |  | $ | 113 |
Accounts receivable |  | 233 |
Other current assets |  | 15 |
Total current assets |  | 361 |
Property and equipment |  | 31 |
Intangible assets |  | 577 |
Other assets |  | 99 |
Total assets acquired |  | 1,068 |
Accounts payable, accrued payroll, accrued expenses, and other current liabilities |  | (121) |
Deferred revenue |  | (8) |
Long-term deferred tax liabilities and income tax payable |  | (106) |
Other liabilities |  | (72) |
Total liabilities assumed |  | (307) |
Net identifiable assets acquired |  | 761 |
Goodwill |  | 1,262 |
Total consideration transferred |  | $ | 2,023 |

Goodwill represents the excess of the purchase price over the fair value of identifiable assets acquired and liabilities assumed at the acquisition date. The goodwill recognized with the acquisition was attributable to the synergies expected to be achieved by combining the businesses of DXC and Luxoft, expected future contracts and the acquired workforce. The cost-saving opportunities are expected to include improved operating efficiencies and asset optimization. The total goodwill arising from the acquisition was allocated to Global Business Services ("GBS") and is not deductible for tax purposes.
11

DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
The Company valued current assets and liabilities using existing carrying values as an estimate of the approximate fair value of those items at the acquisition date except for certain contract receivables for which the Company determined fair value based on a cost plus margin approach. The Company valued acquired property and equipment using predominately the direct capitalization method of the income approach and in certain specific cases, the Company determined that the net book value represents the fair value. The Company valued customer relationships using the multi-period excess earnings method under the income approach and valued trade names and developed technology using a relief from royalty method under the income approach. The Company determined that the net book value of the purchased software represents the fair value.
Below are the estimated useful lives of the acquired intangibles:

|  | Estimated Useful Lives (Years)
Customer related intangibles |  | 10
Trade names |  | 20
Developed technology |  | 3
Third-party purchased software |  | 3

The Company valued deferred tax liabilities based on statutory tax rates in the jurisdictions of the legal entities where the acquired non-current assets and liabilities are taxed.
Note 4 - Divestitures
HHS Sale
On October 1, 2020, DXC completed the sale of its HHS Business to Veritas Capital. The sale was accomplished by the cash purchase of all equity interests and assets attributable to the HHS Business for a total enterprise value of $5.0 billion (including $85 million related to future services to be provided by the Company). As part of the sale of the HHS business, $272 million of repurchased receivables, previously sold under the Milano Receivables Facility ("Milano Facility') (see Note 6 - "Receivables" to the financial statements), $12 million of prepaid maintenance, and $48 million of software licenses transferred to the HHS Business. DXC made payment for these assets during the third quarter of fiscal 2021.The repurchase of receivables and payment on prepaid maintenance are reported as operating cash outflows, and the payment for software license is considered an investing cash outflow. The HHS Sale resulted in a pre-tax gain on sale of $2,041 million, net of closing costs. The sale price is subject to adjustment based on changes in actual closing net working capital. Final potential working capital adjustments are pending. The sale was not subject to any financing condition or shareholder approval.
Approximately $3.5 billion of the sale proceeds were used to prepay $1,250 million of Revolver Credit Facility, £600 million of GBP commercial paper (approximately $772 million), and the following term loan facilities: €350 million of Euro Term Loan due fiscal 2024 (approximately $410 million), $381 million of USD Term loan due fiscal 2025, A$500 million of AUD Term Loan due fiscal 2022 (approximately $358 million), and €250 million of Euro Term Loan due fiscal 2022 and 2023 (approximately $292 million). See Note 12 - "Debt" to the financial statements.
Following the transaction close, DXC retains its remaining healthcare practice, relating to the pending HPS sale.
DXC's post-divesture relationship with the HHS Business is governed by the Purchase Agreement, which provides for the allocation of assets, employees, liabilities and obligations (including property, employee benefits, litigation, and tax-related assets and liabilities) between DXC and the HHS Business attributable to periods prior to, at and after divestment. In addition, DXC and the HHS Business have service and commercial contracts that generally extend through fiscal 2023.
12

DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
As of September 30, 2020, the divestment of the HHS Business, reported as part of the GBS segment, met the requirements for presentation as assets held for sale under GAAP. However, it did not meet the requirements for presentation as discontinued operations as it did not represent a strategic shift that would have a major effect on DXC's operations and financial results and is included in income from continuing operations for the nine months ended December 31, 2020 and 2019 prior to its sale closing date.
The following is a summary of the assets and liabilities distributed as part of the HHS Sale on October 1, 2020:

(in millions) |  |
Assets: |  |
Cash and cash equivalents |  | $ | 8 |
Accounts receivable, net |  | 295 |
Prepaid expenses |  | 39 |
Other current assets |  | 2 |
Total current assets |  | 344 |
Intangible assets, net |  | 1,308 |
Operating right-of-use assets, net |  | 74 |
Goodwill |  | 1,354 |
Property and equipment, net |  | 46 |
Other assets |  | 54 |
Total non-current assets |  | 2,836 |
Total assets |  | $ | 3,180 |
Liabilities: |  |
Accounts payable |  | $ | 79 |
Accrued payroll and related costs |  | 13 |
Current operating lease liabilities |  | 27 |
Accrued expenses and other current liabilities |  | 36 |
Deferred revenue and advance contract payments |  | 20 |
Total current liabilities |  | 175 |
Non-current deferred revenue |  | 32 |
Long-term operating lease liabilities |  | 48 |
Other long term liabilities |  | 2 |
Total long-term liabilities |  | 82 |
Total liabilities |  | $ | 257 |

During the third quarter of fiscal 2021, the Company sold an insignificant business that resulted in a gain of $5 million.
13

DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Note 5 - Earnings (Loss) per Share
Basic earnings per share ("EPS") is computed using the weighted average number of shares of common stock outstanding during the period. Diluted EPS reflects the incremental shares issuable upon the assumed exercise of stock options and equity awards. The following table reflects the calculation of basic and diluted EPS:

|  | Three Months Ended |  | Nine Months Ended
(in millions, except per-share amounts) |  | December 31, 2020 |  | December 31, 2019 |  | December 31, 2020 |  | December 31, 2019
Net income (loss) attributable to DXC common shareholders: |  | $ | 1,098 |  |  | $ | 82 |  |  | $ | 649 |  |  | $ | (1,874) |
Common share information: |  |  |  |  |  |  |  |
Weighted average common shares outstanding for basic EPS |  | 254.32 |  |  | 255.09 |  |  | 254.03 |  |  | 260.24 |
Dilutive effect of stock options and equity awards |  | 1.43 |  |  | 0.96 |  |  | 1.17 |  |  | — |
Weighted average common shares outstanding for diluted EPS |  | 255.75 |  |  | 256.05 |  |  | 255.20 |  |  | 260.24 |
Earnings (loss) per share: |  |  |  |  |  |  |  |
Basic |  | $ | 4.32 |  |  | $ | 0.32 |  |  | $ | 2.55 |  |  | $ | (7.20) |
Diluted |  | $ | 4.29 |  |  | $ | 0.32 |  |  | $ | 2.54 |  |  | $ | (7.20) |

The following share-based equity awards were excluded from the computation of diluted EPS because inclusion of these awards would have had an anti-dilutive effect. The number of awards excluded were as follows:

|  | Three Months Ended |  | Nine Months Ended
|  | December 31, 2020 |  | December 31, 2019 |  | December 31, 2020 |  | December 31, 2019
Stock Options |  | 1,519,611 |  |  | 621,028 |  |  | 1,582,568 |  |  | 818,490 |
Restricted Stock Units |  | 1,418,752 |  |  | 2,125,734 |  |  | 1,628,968 |  |  | 2,116,898 |
Performance-based Restricted Stock Units |  | 836,866 |  |  | — |  |  | 723,754 |  |  | 351,410 |

14

DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Note 6 - Receivables
Receivables Facility
The Company has an accounts receivable sales facility (as amended, restated, supplemented or otherwise modified as of December 31, 2020, the "Receivables Facility") with certain unaffiliated financial institutions (the "Purchasers") for the sale of commercial accounts receivable in the United States. Under the Receivables Facility, certain of the Company's subsidiaries (the "Sellers") sell accounts receivable to DXC Receivables LLC ("Receivables SPV"), a wholly owned bankruptcy-remote entity, in a true sale. Receivables SPV subsequently sells certain of the receivables in their entirety to the Purchasers pursuant to a receivables purchase agreement. The financial obligations of Receivables SPV to the Purchasers under the Receivables Facility are limited to the assets it owns and non-recourse to the Company. Sales of receivables by Receivables SPV occur continuously and are settled on a monthly basis. During the second quarter of fiscal 2021, Receivables SPV amended the Receivables Facility (the "Amendment") to decrease the facility limit from $600 million to $500 million and extend the termination date to August 5, 2021. For the nine months ended December 31, 2020, there is no deferred purchase price ("DPP") for receivables as the entire purchase price is paid in cash when the receivables are sold to the Purchasers. DPPs were previously realized by Receivables SPV upon the ultimate collection of the underlying receivables sold to the Purchasers. Cash receipts on the DPP were classified as cash flows from investing activities.
The amount available under the Receivables Facility fluctuates over time based on the total amount of eligible receivables generated during the normal course of business after deducting excess concentrations. As of December 31, 2020, the total availability under the Receivables Facility was $403 million, and the amount sold to the Purchasers was $407 million, which was derecognized from the Company's balance sheet. As of December 31, 2020, the Company recorded a $4 million liability within accounts payable because the amount of cash proceeds received by the Company under the Receivables Facility was more than the total availability. The Receivables Facility is scheduled to terminate on August 5, 2021, but provides for one or more optional one-year extensions, if agreed to by the Purchasers. The Company uses the proceeds from the sale of receivables under the Receivables Facility for general corporate purposes.
The fair value of the sold receivables approximated book value due to the short-term nature, and as a result, no gain or loss on sale of receivables was recorded.
While the Company guarantees certain non-financial performance obligations of the Sellers, the Purchasers bear customer credit risk associated with the receivables sold under the Receivables Facility and have recourse in the event of credit-related customer non-payment solely to the assets of the Receivables SPV.
The following table is a reconciliation of the beginning and ending balance of the DPP for the Receivables Facility:

(in millions) |  |  |  | As of and for the Nine Months Ended
|  |  |  | December 31, 2019
Beginning balance |  |  |  | $ | 574 |
Transfers of receivables |  |  |  | 1,214 |
Collections |  |  |  | (1,265) |
Change in funding availability |  |  |  | 2 |
Facility amendments |  |  |  | (525) |
Ending balance |  |  |  | $ | — |

Milano Receivables Facility
On October 1, 2020, and in connection with the consummation of the sale of the HHS Business, and at the direction of the purchaser of the HHS Business, the Milano Facility was terminated. For more information, refer to Note 4 - "Divestitures."
15

DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
German Receivables Facility
On October 1, 2019, the Company executed an accounts receivable securitization facility (as amended, restated, supplemented or otherwise modified as of December 31, 2020, the "DE Receivables Facility") with certain unaffiliated financial institutions (the "DE Purchasers") for the sale of commercial accounts receivable in Germany. The DE Receivables Facility has a facility limit of €150 million (approximately $175 million as of December 31, 2020). Under the DE Receivables Facility, certain of the Company's subsidiaries organized in Germany (the "DE Sellers") sell accounts receivable to DXC ARFacility Designated Activity Company ("DE Receivables SPV"), a trust-owned bankruptcy-remote entity, in a true sale. DE Receivables SPV subsequently sells certain of the receivables in their entirety to the DE Purchasers pursuant to a receivables purchase agreement. Sales of receivables by DE Receivables SPV occur continuously and are settled on a monthly basis. During the first quarter of fiscal 2021, DE Receivables SPV amended the DE Receivables Facility ("DE Amendment"). Under the terms of the amended DE Receivables Facility, there is no longer any DPP for receivables as the entire purchase price is paid in cash when the receivables are sold to the DE Purchasers. Prior to the DE Amendment, DPPs were realized by DE Receivables SPV upon the ultimate collection of the underlying receivables sold to the DE Purchasers. Cash receipts on the DPPs were classified as cash flows from investing activities. The DPP balance was $102 million before the DE Amendment was executed. Upon execution of the DE Amendment, the DE Purchasers extinguished the DPP balance and returned title to the applicable underlying receivables to DE Receivables SPV. The DPP extinguishment was classified as a non-cash investing activity, please refer to Note 19 - "Cash Flows."
The amount available under the DE Receivables Facility fluctuates over time based on the total amount of eligible receivables generated during the normal course of business after deducting excess concentrations. As of December 31, 2020, the total availability under the DE Receivables Facility was approximately $123 million, and the amount sold to the DE Purchasers was $136 million, which was derecognized from the Company's balance sheet. As of December 31, 2020, the Company recorded a $13 million liability within accounts payable because the amount of cash proceeds received by the Company under the DE Receivables Facility was more than the total availability. The DE Receivables Facility is scheduled to terminate on September 30, 2021, but provides for one or more optional one-year extensions, if agreed to by the DE Purchasers. The Company uses the proceeds from DE Receivables SPV's sale of receivables under the DE Receivables Facility for general corporate purposes.
The fair value of the sold receivables approximated book value due to the short-term nature, and as a result, no gain or loss on sale of receivables was recorded.
Certain obligations of DE Sellers under the DE Receivables Facility and certain DXC subsidiaries located in Germany, as initial servicers, are guaranteed by the Company under a performance guaranty, made in favor of an administrative agent on behalf of the DE Purchasers. However, the performance guaranty does not cover DE Receivables SPV’s obligations to pay yield, fees or invested amounts to the administrative agent or any of the DE Purchasers.
The following table is a reconciliation of the beginning and ending balances of the DPP for the DE Receivables Facility:

(in millions) |  | As of and for the Nine Months Ended December 31, 2020
Beginning balance |  | $ | 103 |
Transfers of receivables |  | 417 |
Collections |  | (420) |
Change in funding availability |  | 2 |
Facility amendments |  | (102) |
Ending balance |  | $ | — |

16

DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Allowance
The Company calculates expected credit losses for trade accounts receivable based on historical credit loss rates for each aging category as adjusted for the current market conditions and forecasts about future economic conditions. The following table presents the activity in the allowance for doubtful accounts for trade accounts receivable:

(in millions) |  | As of and for the Nine Months Ended
|  | December 31, 2020
Beginning balance |  | $ | 74 |
Impact of adoption of the Credit Loss Standard |  | 4 |
Provisions for losses on accounts receivable |  | 52 |
Other adjustments to allowance and write-off's |  | 69 |
Ending balance |  | $ | 199 |

Note 7 - Leases
The Company has operating and finance leases for data centers, corporate offices, retail stores and certain equipment. Its leases have remaining lease terms of one to 12 years, some of which include options to extend the leases for up to 10 years, and some of which include options to terminate the leases within one to three years.
The components of lease expense were as follows:

|  | Three Months Ended |  | Nine Months Ended
(in millions) |  | December 31, 2020 |  | December 31, 2019 |  | December 31, 2020 |  | December 31, 2019
Operating lease cost |  | $ | 156 |  |  | $ | 166 |  |  | $ | 463 |  |  | $ | 506 |
Short-term lease cost |  | 14 |  |  | 17 |  |  | 40 |  |  | 41 |
Variable lease cost |  | 17 |  |  | 9 |  |  | 40 |  |  | 35 |
Sublease income |  | (10) |  |  | (9) |  |  | (32) |  |  | (28) |
Total operating costs |  | $ | 177 |  |  | $ | 183 |  |  | $ | 511 |  |  | $ | 554 |
Finance lease cost: |  |  |  |  |  |  |  |
Amortization of right-of-use assets |  | $ | 107 |  |  | $ | 90 |  |  | $ | 322 |  |  | $ | 339 |
Interest on lease liabilities |  | 10 |  |  | 16 |  |  | 35 |  |  | 50 |
Total finance lease cost |  | $ | 117 |  |  | $ | 106 |  |  | $ | 357 |  |  | $ | 389 |

Cash payments made from variable lease costs and short-term leases are not included in the measurement of operating and finance lease liabilities, and as such, are excluded from the supplemental cash flow information stated below. In addition, for the supplemental non-cash information on operating and finance leases, please refer to Note 19 - "Cash Flows."
Supplemental cash flow information related to leases was as follows:

|  | Nine Months Ended
(in millions) |  | December 31, 2020 |  | December 31, 2019
Cash paid for amounts included in the measurement of: |  |  |  |
Operating cash flows used in operating leases |  | $ | 463 |  |  | $ | 506 |
Operating cash flows used in finance leases |  | $ | 35 |  |  | $ | 50 |
Financing cash flows used in finance leases |  | $ | 430 |  |  | $ | 436 |

17

DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Supplemental balance sheet information related to leases was as follows:

|  |  |  | As of
(in millions) |  | Balance Sheet Line Item |  | December 31, 2020 |  | March 31, 2020
Assets: |  |  |  |  |  |
ROU operating lease assets |  | Operating right-of-use assets, net |  | $ | 1,459 |  |  | $ | 1,428 |
ROU finance lease assets |  | Property and Equipment, net |  | 971 |  |  | 1,220 |
Total |  |  |  | $ | 2,430 |  |  | $ | 2,648 |
Liabilities: |  |  |  |  |  |
Current |  |  |  |  |  |
Operating lease |  | Current operating lease liabilities |  | $ | 450 |  |  | $ | 482 |
Finance lease |  | Short-term debt and current maturities of long-term debt |  | 431 |  |  | 444 |
Total |  |  |  | $ | 881 |  |  | $ | 926 |
Non-current |  |  |  |  |  |
Operating lease |  | Non-current operating lease liabilities |  | $ | 1,113 |  |  | $ | 1,063 |
Finance lease |  | Long-term debt, net of current maturities |  | 545 |  |  | 602 |
Total |  |  |  | $ | 1,658 |  |  | $ | 1,665 |

The following table provides information on the weighted average remaining lease term and weighted average discount rate for operating and finance leases:

|  | As of
|  | December 31, 2020 |  | March 31, 2020
Weighted Average remaining lease term: |  | Years
Operating leases |  | 4.8 |  | 4.8
Finance leases |  | 2.7 |  | 2.7
Weighted average remaining discount rate: |  | Rate
Operating leases |  | 4.0 | % |  | 4.0 | %
Finance leases |  | 3.8 | % |  | 6.4 | %

18

DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
The following maturity analysis presents expected undiscounted cash payments for operating and finance leases on an annual basis as of December 31, 2020:

Fiscal year |  | Operating Leases |  |
(in millions) |  | Real Estate |  | Equipment |  | Finance Leases
Remainder of 2021 |  | $ | 117 |  |  | $ | 15 |  |  | $ | 128 |
2022 |  | 412 |  |  | 42 |  |  | 419 |
2023 |  | 337 |  |  | 24 |  |  | 275 |
2024 |  | 262 |  |  | 11 |  |  | 139 |
2025 |  | 192 |  |  | 5 |  |  | 48 |
Thereafter |  | 297 |  |  | 3 |  |  | 6 |
Total lease payments |  | 1,617 |  |  | 100 |  |  | 1,015 |
Less: imputed interest |  | (151) |  |  | (3) |  |  | (39) |
Total payments |  | $ | 1,466 |  |  | $ | 97 |  |  | $ | 976 |

19

DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Note 8 - Fair Value
Fair Value Measurements on a Recurring Basis
The following table presents the Company’s assets and liabilities that are measured at fair value on a recurring basis excluding pension assets and derivative assets and liabilities. See Note 9 - "Derivative and Hedging Activities" for information about the fair value of the Company's derivative assets and liabilities. There were no transfers among any of the levels during the periods presented.

|  | Fair Value Hierarchy
(in millions) |  | December 31, 2020
Assets: |  | Fair Value |  | Level 1 |  | Level 2 |  | Level 3
Money market funds and money market deposit accounts |  | $ | 262 |  |  | $ | 262 |  |  | $ | — |  |  | $ | — |
U.S. treasury bills(1) |  | 250 |  |  | 250 |  |  | — |  |  | — |
Time deposits(1) |  | 349 |  |  | 349 |  |  | — |  |  | — |
Other debt securities(2) |  | 62 |  |  | — |  |  | 59 |  |  | 3 |
Total assets |  | $ | 923 |  |  | $ | 861 |  |  | $ | 59 |  |  | $ | 3 |
Liabilities: |  |  |  |  |  |  |  |
Contingent consideration |  | $ | 40 |  |  | $ | — |  |  | $ | — |  |  | $ | 40 |
Total liabilities |  | $ | 40 |  |  | $ | — |  |  | $ | — |  |  | $ | 40 |

|  | March 31, 2020
Assets: |  | Fair Value |  | Level 1 |  | Level 2 |  | Level 3
Money market funds and money market deposit accounts |  | $ | 156 |  |  | $ | 156 |  |  | $ | — |  |  | $ | — |
Time deposits(1) |  | 595 |  |  | 595 |  |  | — |  |  | — |
Other debt securities(2) |  | 51 |  |  | — |  |  | 48 |  |  | 3 |
Deferred purchase price receivable |  | 103 |  |  | — |  |  | — |  |  | 103 |
Total assets |  | $ | 905 |  |  | $ | 751 |  |  | $ | 48 |  |  | $ | 106 |
Liabilities: |  |  |  |  |  |  |  |
Contingent consideration |  | $ | 46 |  |  | $ | — |  |  | $ | — |  |  | $ | 46 |
Total liabilities |  | $ | 46 |  |  | $ | — |  |  | $ | — |  |  | $ | 46 |

(1) Cost basis approximated fair value due to the short period of time to maturity.
(2) Other debt securities include available-for-sale investments with Level 2 inputs with cost bases of $59 million and $37 million, and unrealized gains of $0 million and $11 million, as of December 31, 2020 and March 31, 2020, respectively. During the quarter, previously held investments were sold and the proceeds were used to purchase new investments. The gain of $17 million from the sale was included in other income, net.
The fair value of money market funds, money market deposit accounts, U.S. Treasury bills with less than three months maturity and time deposits, included in cash and cash equivalents are based on quoted market prices. The fair value of other debt securities included in other long-term assets is based on actual market prices. The fair value of the DPPs included in receivables, net is determined by calculating the expected amount of cash to be received and is principally based on unobservable inputs consisting primarily of the face amount of the receivables adjusted for anticipated credit losses. The fair value of contingent consideration included in other liabilities is based on contractually defined targets of financial performance in connection with earn outs and other considerations.
20

DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Other Fair Value Disclosures
The carrying amounts of the Company’s financial instruments with short-term maturities, primarily accounts receivable, accounts payable, short-term debt, and financial liabilities included in other accrued liabilities are deemed to approximate their market values due to their short-term nature. If measured at fair value, these financial instruments would be classified as Level 2 or Level 3 within the fair value hierarchy.
The Company estimates the fair value of its long-term debt primarily by using quoted prices obtained from third-party providers such as Bloomberg and by using an expected present value technique that is based on observable market inputs for instruments with similar terms currently available to the Company. The estimated fair value of the Company's long-term debt excluding finance lease liabilities was $5.5 billion and $8.2 billion as of December 31, 2020 and March 31, 2020, respectively as compared with carrying value of $5.2 billion and $8.4 billion as of December 31, 2020 and March 31, 2020, respectively. Long-term debt excluding finance lease liabilities is classified as Level 1 or Level 2 within the fair value hierarchy.
Non-financial assets such as goodwill, tangible assets, intangible assets and other contract related long-lived assets are recorded at fair value in the period they are initially recognized, and such fair value may be adjusted in subsequent periods if an event occurs or circumstances change that indicate that the asset may be impaired. The fair value measurements in such instances would be classified as Level 3 within the fair value hierarchy. There were no significant impairments recorded during the fiscal period covered by this report.
21

DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Note 9 - Derivative and Hedging Activities
In the normal course of business, the Company is exposed to interest rate and foreign exchange rate fluctuations. As part of its risk management strategy, the Company uses derivative instruments, primarily foreign currency forward contracts and interest rate swaps, to hedge certain foreign currency and interest rate exposures. The Company’s objective is to reduce earnings volatility by offsetting gains and losses resulting from these exposures with losses and gains on the derivative contracts used to hedge them. The Company does not use derivative instruments for trading or any speculative purposes.
Derivatives Designated for Hedge Accounting
Cash flow hedges
The Company has designated certain foreign currency forward contracts as cash flow hedges to reduce foreign currency risk related to certain Indian Rupee-denominated intercompany obligations and forecasted transactions. The notional amounts of foreign currency forward contracts designated as cash flow hedges as of December 31, 2020 and March 31, 2020 were $507 million and $455 million, respectively. As of December 31, 2020, the related forecasted transactions extend through March 2023.
For the three and nine months ended December 31, 2020 and December 31, 2019, respectively, the Company performed an assessment at the inception of the cash flow hedge transactions and determined that all critical terms of the hedging instruments and hedged items matched. The Company performs an assessment of critical terms on an on-going basis throughout the hedging period. During the three and nine months ended December 31, 2020 and December 31, 2019, respectively, the Company had no cash flow hedges for which it was probable that the hedged transaction would not occur. As of December 31, 2020, $2 million of the existing amount of gain related to the cash flow hedge reported in accumulated other comprehensive loss is expected to be reclassified into earnings within the next 12 months.
The pre-tax gain (loss) on derivatives designated for hedge accounting recognized in income from operation was $0 million and $(6) million for the three and nine months ended December 31, 2020, respectively. The pre-tax gain (loss) on derivatives designated for hedge accounting recognized in other comprehensive income was $0 million and $18 million for the three and nine months ended December 31, 2020, respectively.
Derivatives Not Designated for Hedge Accounting
The derivative instruments not designated as hedges for purposes of hedge accounting include certain short-term foreign currency forward contracts. Derivatives that are not designated as hedging instruments are adjusted to fair value through earnings in the financial statement line item to which the derivative relates.
Foreign currency forward contracts
The Company manages the exposure to fluctuations in foreign currencies by using short-term foreign currency forward contracts to hedge certain foreign currency denominated assets and liabilities, including intercompany accounts and forecasted transactions. The notional amounts of the foreign currency forward contracts outstanding as of December 31, 2020 and March 31, 2020 were $1.7 billion and $2.2 billion, respectively.
The following table presents the pretax amounts impacting income related to designated and non-designated foreign currency forward contracts:

|  |  |  |  |  | For the Three Months Ended |  | For the Nine Months Ended
(in millions) |  | Statement of Operations Line Item |  |  |  |  |  | December 31, 2020 |  | December 31, 2019 |  | December 31, 2020 |  | December 31, 2019
Foreign currency forward contracts |  | Other expense (income), net |  |  |  |  |  | $ | 16 |  |  | $ | 1 |  |  | $ | 74 |  |  | $ | (21) |

22

DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Fair Value of Derivative Instruments
All derivative instruments are recorded at fair value. The Company’s accounting treatment for these derivative instruments is based on its hedge designation. The following tables present the fair values of derivative instruments included in the balance sheets:

|  | Derivative Assets |  |
|  |  |  | As of |  |  |  |
(in millions) |  | Balance Sheet Line Item |  | December 31, 2020 |  | March 31, 2020 |  |  |  |  |  |
Derivatives designated for hedge accounting: |  |  |  |  |  |  |  |
Foreign currency forward contracts |  | Other current assets |  | $ | 9 |  |  | $ | — |  |  |  |  |  |  |
Total fair value of derivatives designated for hedge accounting |  | $ | 9 |  |  | $ | — |  |  |  |  |  |  |
Derivatives not designated for hedge accounting: |  |  |  |  |  |  |  |
Foreign currency forward contracts |  | Other current assets |  | $ | 6 |  |  | $ | 16 |  |  |  |  |  |  |
Total fair value of derivatives not designated for hedge accounting |  | $ | 6 |  |  | $ | 16 |  |  |  |  |  |  |

|  |  |  | Derivative Liabilities
|  |  |  |  |  |  |  | As of
(in millions) |  |  |  |  |  |  |  | Balance Sheet Line Item |  | December 31, 2020 |  | March 31, 2020
Derivatives designated for hedge accounting: |  |  |  |
Foreign currency forward contracts |  |  |  |  |  |  |  | Accrued expenses and other current liabilities |  | $ | 5 |  |  | $ | 20 |
Total fair value of derivatives designated for hedge accounting: |  | $ | 5 |  |  | $ | 20 |
Derivatives not designated for hedge accounting: |  |  |  |
Foreign currency forward contracts |  |  |  |  |  |  |  | Accrued expenses and other current liabilities |  | $ | 17 |  |  | $ | 12 |
Total fair value of derivatives not designated for hedge accounting |  | $ | 17 |  |  | $ | 12 |

The fair value of foreign currency forward contracts represents the estimated amount required to settle the contracts using current market exchange rates and is based on the period-end foreign currency exchange rates and forward points which are classified as Level 2 inputs.
Other Risks for Derivative Instruments
The Company is exposed to the risk of losses in the event of non-performance by the counterparties to its derivative contracts. The amount subject to credit risk related to derivative instruments is generally limited to the amount, if any, by which a counterparty's obligations exceed the obligations of the Company with that counterparty. To mitigate counterparty credit risk, the Company regularly reviews its credit exposure and the creditworthiness of the counterparties. With respect to its foreign currency derivatives, as of December 31, 2020, there were seven counterparties with concentration of credit risk, and based on gross fair value, the maximum amount of loss that the Company could incur is not material.
The Company also enters into enforceable master netting arrangements with some of its counterparties. However, for financial reporting purposes, it is the Company's policy not to offset derivative assets and liabilities despite the existence of enforceable master netting arrangements. The potential effect of such netting arrangements on the Company's balance sheets is not material for the periods presented.
23

DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Non-Derivative Financial Instruments Designated for Hedge Accounting
The Company applies hedge accounting for foreign currency-denominated debt used to manage foreign currency exposures on its net investments in certain non-U.S. operations. To qualify for hedge accounting, the hedging instrument must be highly effective at reducing the risk from the exposure being hedged.
Net Investment Hedges
DXC seeks to reduce the impact of fluctuations in foreign exchange rates on its net investments in certain non-U.S. operations with foreign currency-denominated debt. For foreign currency-denominated debt designated as a hedge, the effectiveness of the hedge is assessed based on changes in spot rates. For qualifying net investment hedges, all gains or losses on the hedging instruments are included in currency translation. Gains or losses on individual net investments in non-U.S. operations are reclassified to earnings from accumulated other comprehensive income when such net investments are sold or substantially liquidated.
As of December 31, 2020, DXC had $800 million of foreign currency-denominated debt designated as hedges of net investments in non-U.S. subsidiaries. As of March 31, 2020, DXC had $1.9 billion of foreign currency-denominated debt designated as hedges of net investments in non-U.S. subsidiaries. For the three and nine months ended December 31, 2020, the pre-tax impact of gain (loss) on foreign currency-denominated debt designated for hedge accounting recognized in other comprehensive income was $(36) million and $(125) million, respectively.
24

DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Note 10 - Intangible Assets
Intangible assets consisted of the following:

|  | As of December 31, 2020
(in millions) |  | Gross Carrying Value |  | Accumulated Amortization |  | Net Carrying Value
Software |  | $ | 4,001 |  |  | $ | 2,891 |  |  | $ | 1,110 |
Customer related intangible assets |  | 4,296 |  |  | 1,606 |  |  | 2,690 |
Other intangible assets |  | 267 |  |  | 48 |  |  | 219 |
Total intangible assets |  | $ | 8,564 |  |  | $ | 4,545 |  |  | $ | 4,019 |

|  | As of March 31, 2020
(in millions) |  | Gross Carrying Value |  | Accumulated Amortization |  | Net Carrying Value
Software |  | $ | 4,048 |  |  | $ | 2,614 |  |  | $ | 1,434 |
Customer related intangible assets |  | 5,795 |  |  | 1,697 |  |  | 4,098 |
Other intangible assets |  | 235 |  |  | 36 |  |  | 199 |
Total intangible assets |  | $ | 10,078 |  |  | $ | 4,347 |  |  | $ | 5,731 |

The components of amortization expense were as follows:

|  | Three Months Ended |  | Nine Months Ended
(in millions) |  | December 31, 2020 |  | December 31, 2019 |  | December 31, 2020 |  | December 31, 2019
Intangible asset amortization |  | $ | 224 |  |  | $ | 272 |  |  | $ | 735 |  |  | $ | 747 |
Transition and transformation contract cost amortization(1) |  | 66 |  |  | 71 |  |  | 194 |  |  | 197 |
Total amortization expense |  | $ | 290 |  |  | $ | 343 |  |  | $ | 929 |  |  | $ | 944 |

(1)Transition and transformation contract costs are included within other assets on the balance sheet.
Estimated future amortization related to intangible assets as of December 31, 2020 is as follows:

Fiscal Year |  | (in millions)
Remainder of 2021 |  | $ | 236 |
2022 |  | $ | 821 |
2023 |  | $ | 740 |
2024 |  | $ | 650 |
2025 |  | $ | 535 |

25

DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Note 11 - Goodwill
The following table summarizes the changes in the carrying amount of goodwill, by segment, as of December 31, 2020.

(in millions) |  | GBS |  | GIS |  | Total
Goodwill, gross |  | $ | 6,507 |  |  | $ | 5,066 |  |  | $ | 11,573 |
Accumulated impairment losses |  | (4,490) |  |  | (5,066) |  |  | (9,556) |
Balance as of March 31, 2020, net |  | $ | 2,017 |  |  | $ | — |  |  | $ | 2,017 |
Acquisition related adjustments |  | 18 |  |  | — |  |  | 18 |
Divestitures |  | (1,355) |  |  | — |  |  | (1,355) |
Assets held for sale |  | (4) |  |  | — |  |  | (4) |
Foreign currency translation |  | 60 |  |  | — |  |  | 60 |
Goodwill, gross |  | 5,226 |  |  | 5,066 |  |  | 10,292 |
Accumulated impairment losses |  | (4,490) |  |  | (5,066) |  |  | (9,556) |
Balance as of December 31, 2020, net |  | $ | 736 |  |  | $ | — |  |  | $ | 736 |

The foreign currency translation amount reflects the impact of currency movements on non-U.S. dollar-denominated goodwill balances.
Goodwill Impairment Analyses
The Company tests goodwill for impairment on an annual basis, as of the first day of the second fiscal quarter, and between annual tests if circumstances change, or if an event occurs that would more likely than not reduce the fair value of a reporting unit below its carrying amount.
The Company's annual goodwill impairment analysis, which was performed qualitatively during the three months ended September 30, 2020, did not result in an impairment charge.
At the end of the third quarter of fiscal 2021, the Company assessed whether there were events or changes in circumstances that would more likely than not reduce the fair value of its GBS reporting unit below its carrying amount and require goodwill to be tested for impairment. The Company determined that there have been no such indicators and therefore, it was unnecessary to perform an interim goodwill impairment test as of December 31, 2020.
26

DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Note 12 - Debt
The following is a summary of the Company's debt:

| (in millions) |  | Interest Rates |  | Fiscal Year Maturities |  | December 31, 2020 |  | March 31, 2020
| Short-term debt and current maturities of long-term debt |  |  |  |  |  |  |  |
| Commercial paper(1) |  | (0.22)% - 0.44% |  | 2021 - 2022 |  | $ | 112 |  |  | $ | 542 |
| Current maturities of long-term debt |  | Various |  | 2021 - 2022 |  | 252 |  |  | 290 |
| Current maturities of finance lease liabilities |  | 0.62% - 18.47% |  | 2021 - 2022 |  | 431 |  |  | 444 |
| Short-term debt and current maturities of long-term debt |  |  |  |  |  | $ | 795 |  |  | $ | 1,276 |
| Long-term debt, net of current maturities |  |  |  |  |  |  |  |
| AUD term loan |  | 0.94% - 0.96% |  | 2022 |  | — |  |  | 489 |
| GBP term loan |  | 0.88% - 1.46% |  | 2022 |  | — |  |  | 556 |
| EUR term loan |  | 0.65% |  | 2022 - 2023 |  | — |  |  | 822 |
| EUR term loan |  | 0.80%(2) |  | 2023 - 2024 |  | 488 |  |  | 821 |
| USD term loan |  | 1.40% - 2.24% |  | 2025 |  | — |  |  | 480 |
| $274 million Senior notes |  | 4.45% |  | 2023 |  | 276 |  |  | 276 |
| $171 million Senior notes |  | 4.45% |  | 2023 |  | 172 |  |  | 172 |
| $500 million Senior notes |  | 4.25% |  | 2025 |  | 504 |  |  | 505 |
| $500 million Senior notes |  | 4.00% |  | 2024 |  | 497 |  |  | — |
| $500 million Senior notes |  | 4.13% |  | 2026 |  | 496 |  |  | — |
| £250 million Senior notes |  | 2.75% |  | 2025 |  | 339 |  |  | 307 |
| €650 million Senior notes |  | 1.75% |  | 2026 |  | 792 |  |  | 709 |
| $500 million Senior notes |  | 4.75% |  | 2028 |  | 507 |  |  | 507 |
| $234 million Senior notes |  | 7.45% |  | 2030 |  | 269 |  |  | 271 |
| Revolving credit facility |  | 1.26% - 2.08% |  | 2024 - 2025 |  | — |  |  | 1,500 |
| Lease credit facility |  | 1.15% - 1.99% |  | 2021 - 2023 |  | — |  |  | 11 |
| Finance lease liabilities |  | 0.62% - 18.47% |  | 2021 - 2027 |  | 976 |  |  | 1,046 |
| Borrowings for assets acquired under long-term financing |  | 0.00% - 6.39% |  | 2021 - 2027 |  | 742 |  |  | 802 |
| Mandatorily redeemable preferred stock outstanding |  | 6.00% |  | 2023 |  | 63 |  |  | 62 |
| Other borrowings |  | Various |  | 2021 - 2022 |  | 6 |  |  | 70 |
| Long-term debt |  |  |  |  |  | 6,127 |  |  | 9,406 |
| Less: current maturities |  |  |  |  |  | 683 |  |  | 734 |
| Long-term debt, net of current maturities |  |  |  |  |  | $ | 5,444 |  |  | $ | 8,672 |

(1)At DXC's option, DXC can borrow up to a maximum of €1 billion or its equivalent in €, £, and $.
(2) At DXC's option, the EUR term loan bears interest at the Eurocurrency Rate for a one-, two-, three-, or six-month interest period, plus a margin between 0.55% and 1.05%, based on published credit ratings of DXC.
Senior Notes and Term Loans
During the first quarter of fiscal 2021, the Company issued two senior notes with an aggregate principal of $1.0 billion consisting of (i) $500 million of 4.00% Senior Notes due fiscal 2024 and (ii) $500 million of 4.13% Senior Notes due fiscal 2026. The proceeds from these notes were applied towards the early prepayment of DXC's term loan facilities including prepayment of €500 million of Euro Term Loan due fiscal 2023, £150 million of GBP Term Loan due fiscal 2022, A$300 million of AUD Term Loan due fiscal 2022, and $100 million of USD Term Loan due fiscal 2025.
During the second quarter of fiscal 2021, the Company repaid the remaining £300 million GBP Term Loan due fiscal 2022.
During the third quarter of fiscal 2021, the Company used the proceeds from the sale of HHS Business to prepay approximately $1,441 million of term loan facilities detailed below under the heading "HHS Sale Use of Proceeds."
27

DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Interest on the Company's remaining term loan is payable monthly at DXC's election. The Company fully and unconditionally guarantees term loans issued by its 100% owned subsidiaries. The interest on the Company's senior notes is payable semi-annually in arrears except for interest on the £250 million Senior Notes due fiscal 2025 and the €650 million Senior Notes due fiscal 2026, which are payable annually in arrears. Generally, the Company's notes are redeemable at the Company's discretion at the then-applicable redemption premium plus accrued and unpaid interest.
Revolving Credit Facility
During fiscal 2021, the Company borrowed the remaining $2.5 billion under the $4.0 billion credit facility agreement ("Credit Agreement") as a precautionary measure to increase its cash position and increase financial flexibility in light of continuing uncertainty in the global economy and financial capital markets resulting from COVID-19.
The Company repaid the full $4.0 billion during the first nine months of fiscal 2021, which became available under the revolving credit facility for redraw at the request of the Company.
HHS Sale Use of Proceeds
In October 2020, DXC sold the HHS business and used approximately $3.5 billion of the proceeds to prepay $1,250 million of Revolver Credit Facility, £600 million of GBP commercial paper (approximately $772 million), and the following term loan facilities: €350 million of Euro Term Loan due fiscal 2024 (approximately $410 million), $381 million of USD Term loan due fiscal 2025, A$500 million of AUD Term Loan due fiscal 2022 (approximately $358 million), and €250 million of Euro Term Loan due fiscal 2022 and 2023 (approximately $292 million).
Note 13 - Revenue
Revenue Recognition
The following table presents DXC's revenues disaggregated by geography, based on the location of incorporation of the DXC entity providing the related goods or services:

|  | Three Months Ended |  | Nine Months Ended
(in millions) |  | December 31, 2020 |  | December 31, 2019 |  | December 31, 2020 |  | December 31, 2019
United States |  | $ | 1,290 |  |  | $ | 1,843 |  |  | $ | 4,665 |  |  | $ | 5,500 |
United Kingdom |  | 607 |  |  | 707 |  |  | 1,759 |  |  | 2,100 |
Other Europe |  | 1,335 |  |  | 1,329 |  |  | 3,784 |  |  | 3,819 |
Australia |  | 377 |  |  | 380 |  |  | 1,128 |  |  | 1,119 |
Other International |  | 679 |  |  | 762 |  |  | 2,008 |  |  | 2,224 |
Total Revenues |  | $ | 4,288 |  |  | $ | 5,021 |  |  | $ | 13,344 |  |  | $ | 14,762 |

The revenue by geography pertains to both of the Company’s reportable segments. Refer to Note 20 - "Segment Information" for the Company’s segment disclosures.
Remaining Performance Obligations
Remaining performance obligations represent the aggregate amount of the transaction price in contracts allocated to performance obligations not delivered, or partially undelivered, as of the end of the reporting period. Remaining performance obligation estimates are subject to change and are affected by several factors, including terminations, changes in the scope of contracts, periodic revalidations, adjustments for revenue that have not materialized and adjustments for currency. As of December 31, 2020, approximately $24 billion of revenue is expected to be recognized from remaining performance obligations. We expect to recognize revenue on approximately 14% of these remaining performance obligations in fiscal 2021, with the remainder of the balance recognized thereafter.
28

DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Contract Balances
The following table provides information about the balances of the Company's trade receivables and contract assets and contract liabilities:

|  | As of
(in millions) |  | December 31, 2020 |  | March 31, 2020
Trade receivables, net |  | $ | 2,785 |  |  | $ | 3,059 |
Contract assets |  | $ | 418 |  |  | $ | 454 |
Contract liabilities |  | $ | 1,768 |  |  | $ | 1,756 |

Change in contract liabilities were as follows:

|  | Nine Months Ended
(in millions) |  | December 31, 2020(1) |  | December 31, 2019
Balance, beginning of period |  | $ | 1,756 |  |  | $ | 1,886 |
Deferred revenue |  | 2,111 |  |  | 2,091 |
Recognition of deferred revenue |  | (2,137) |  |  | (2,137) |
Currency translation adjustment |  | 146 |  |  | 12 |
Other |  | (108) |  |  | (36) |
Balance, end of period |  | $ | 1,768 |  |  | $ | 1,816 |

(1)Other includes $54 million of contract liabilities related to the divested HHS business discussed in Note 4 - "Divestitures" and contract liabilities reclassified to assets held for sale.
29

DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Note 14 - Restructuring Costs
The Company recorded restructuring costs of $104 million and $74 million, net of reversals, for the three months ended December 31, 2020 and December 31, 2019, respectively. For the nine months ended December 31, 2020 and December 31, 2019, the Company recorded restructuring costs of $441 million and $248 million, net of reversals, respectively. The costs recorded during the three and six months ended December 31, 2020 were largely a result of the Fiscal 2021 Plan (defined below).
The composition of restructuring liabilities by financial statement line item is as follows:

|  | As of |  |
(in millions) |  | December 31, 2020 |  |
Accrued expenses and other current liabilities |  | $ | 261 |  |  |
Other long-term liabilities |  | 60 |  |  |
Total |  | $ | 321 |  |  |

Summary of Restructuring Plans
Fiscal 2021 Plan
During fiscal 2021, management approved global cost savings initiatives designed to better align the Company's workforce and facility structures (the "Fiscal 2021 Plan").
Fiscal 2020 Plan
During fiscal 2020, management approved cost savings initiatives designed to reduce operating costs by re-balancing its workforce and facilities structures (the "Fiscal 2020 Plan"). The Fiscal 2020 Plan includes workforce optimization programs and facilities and data center rationalization. Costs incurred to date under the Fiscal 2020 Plan total $295 million, comprising $278 million in employee severance and $17 million of facilities costs.
Fiscal 2019 Plan
During fiscal 2019, management approved global cost savings initiatives designed to better align the Company's organizational structure with its strategic initiatives and continue the integration of the Enterprise Services business of Hewlett Packard Enterprise Company ("HPES") and other acquisitions (the "Fiscal 2019 Plan"). The Fiscal 2019 Plan includes workforce optimization and rationalization of facilities and data center assets. Costs incurred to date under the Fiscal 2019 Plan total $477 million, comprising $336 million in employee severance and $141 million of facilities costs.
Other Prior Year Plans
In June 2017, management approved a post-HPES Merger (as defined below) restructuring plan to optimize the Company's operations in response to a continuing business contraction (the "Fiscal 2018 Plan"). The Fiscal 2018 Plan focuses mainly on optimizing specific aspects of global workforce, increasing the proportion of work performed in low cost offshore locations and re-balancing the organizational structure. Additionally, this plan included global facility restructuring, including a global data center restructuring program. Costs incurred to date under the Fiscal 2018 Plan total $987 million, comprising $791 million in employee severance and $196 million of facilities costs.
Acquired Restructuring Liabilities
As a result of the merger of Computer Sciences Corporation ("CSC") and HPES ("HPES Merger"), DXC acquired restructuring liabilities under restructuring plans that were initiated for HPES under plans approved by the HPE Board of Directors.
30

DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Restructuring Liability Reconciliations by Plan

|  | Restructuring Liability as of March 31, 2020 |  |  |  |  |  | Costs Expensed, Net of Reversals(1) |  | Costs Not Affecting Restructuring Liability(2) |  | Cash Paid |  | Other(3) |  | Restructuring Liability as of December 31, 2020
Fiscal 2021 Plan |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Workforce Reductions |  | $ | — |  |  |  |  |  |  | $ | 416 |  |  | $ | (9) |  |  | $ | (210) |  |  | $ | 9 |  |  | $ | 206 |
Facilities Costs |  | — |  |  |  |  |  |  | 25 |  |  | (9) |  |  | (11) |  |  | (1) |  |  | 4 |
Total |  | $ | — |  |  |  |  |  |  | $ | 441 |  |  | $ | (18) |  |  | $ | (221) |  |  | $ | 8 |  |  | $ | 210 |
Fiscal 2020 Plan |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Workforce Reductions (4) |  | $ | 74 |  |  |  |  |  |  | $ | 7 |  |  | $ | 2 |  |  | $ | (49) |  |  | $ | 5 |  |  | $ | 39 |
Facilities Costs |  | 2 |  |  |  |  |  |  | (4) |  |  | 4 |  |  | (2) |  |  | — |  |  | — |
Total |  | $ | 76 |  |  |  |  |  |  | $ | 3 |  |  | $ | 6 |  |  | $ | (51) |  |  | $ | 5 |  |  | $ | 39 |
Fiscal 2019 Plan |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Workforce Reductions |  | $ | 25 |  |  |  |  |  |  | $ | (2) |  |  | $ | (3) |  |  | $ | (13) |  |  | $ | 2 |  |  | $ | 9 |
Facilities Costs |  | 5 |  |  |  |  |  |  | (3) |  |  | 2 |  |  | — |  |  | 1 |  |  | 5 |
Total |  | $ | 30 |  |  |  |  |  |  | $ | (5) |  |  | $ | (1) |  |  | $ | (13) |  |  | $ | 3 |  |  | $ | 14 |
Other Prior Year Plans |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Workforce Reductions |  | $ | 24 |  |  |  |  |  |  | $ | 1 |  |  | $ | 2 |  |  | $ | (14) |  |  | $ | 2 |  |  | $ | 15 |
Facilities Costs |  | — |  |  |  |  |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Total |  | $ | 24 |  |  |  |  |  |  | $ | 1 |  |  | $ | 2 |  |  | $ | (14) |  |  | $ | 2 |  |  | $ | 15 |
Acquired Liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Workforce Reductions |  | $ | 39 |  |  |  |  |  |  | $ | 1 |  |  | $ | — |  |  | $ | (7) |  |  | $ | 1 |  |  | $ | 34 |
Facilities Costs |  | 11 |  |  |  |  |  |  | — |  |  | 1 |  |  | (3) |  |  | — |  |  | 9 |
Total |  | $ | 50 |  |  |  |  |  |  | $ | 1 |  |  | $ | 1 |  |  | $ | (10) |  |  | $ | 1 |  |  | $ | 43 |

(1) Costs expensed, net of reversals include $11 million, $10 million, and $3 million of costs reversed from the Fiscal 2020 Plan, Fiscal 2019 Plan and Other Prior Year Plans, respectively.
(2) Costs Not Affecting Restructuring Liability include pension benefit augmentations recorded as a pension liability, asset impairments and restructuring costs associated with right-of-use assets.
(3)Other include foreign currency translation adjustments.
(4) Fiscal 2020 workforce reductions includes a $14 million adjustment to restructuring expense related to the prior year.
31

DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Note 15 - Pension and Other Benefit Plans
The Company offers a number of pension and other post-retirement benefit ("OPEB") plans, life insurance benefits, deferred compensation and defined contribution plans. Most of the Company's pension plans are not admitting new participants, except where locally required; therefore, changes to pension liabilities are primarily due to market fluctuations of investments for existing participants and changes in interest rates.
Defined Benefit Plans
The Company sponsors a number of defined benefit and post-retirement medical benefit plans for the benefit of eligible employees. The benefit obligations of the Company's U.S. pension, U.S. OPEB, and non-U.S. OPEB represent an insignificant portion of the Company's pension and other post-retirement benefits. As a result, the disclosures below include the Company's U.S. and non-U.S. pension plans on a global consolidated basis.
During the three months ended June 30, 2020, the Company remeasured plan assets and liabilities as of June 1, 2020 under certain U.K. pension plans due to the end of a public sector contract. The remeasurement resulted in a net loss of $2 million, comprising a curtailment gain of $9 million and an actuarial loss of $11 million. The net loss was recognized within other income.
The components of net periodic pension income were:

|  |  |  |  |  |  |  | Three Months Ended |  | Nine Months Ended
(in millions) |  |  |  |  |  |  |  | December 31, 2020 |  | December 31, 2019 |  | December 31, 2020 |  | December 31, 2019
Service cost |  |  |  |  |  |  |  | $ | 23 |  |  | $ | 23 |  |  | $ | 68 |  |  | $ | 69 |
Interest cost |  |  |  |  |  |  |  | 62 |  |  | 60 |  |  | 181 |  |  | 177 |
Expected return on assets |  |  |  |  |  |  |  | (163) |  |  | (161) |  |  | (477) |  |  | (476) |
Amortization of prior service costs |  |  |  |  |  |  |  | (2) |  |  | (2) |  |  | (6) |  |  | (6) |
Contractual termination benefit |  |  |  |  |  |  |  | — |  |  | — |  |  | 3 |  |  | 17 |
Curtailment gain |  |  |  |  |  |  |  | — |  |  | — |  |  | (9) |  |  | — |
Recognition of actuarial loss |  |  |  |  |  |  |  | — |  |  | — |  |  | 11 |  |  | — |
Net periodic pension income |  |  |  |  |  |  |  | $ | (80) |  |  | $ | (80) |  |  | $ | (229) |  |  | $ | (219) |

The service cost component of net periodic pension income is presented in costs of services and selling, general and administrative and the other components of net periodic pension income are presented in other income, net, except for contractual termination benefit which is included in restructuring, in the Company’s statements of operations.
32

DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Deferred Compensation Plans
Effective as of the HPES Merger, DXC assumed sponsorship of the Computer Sciences Corporation Deferred Compensation Plan, which was renamed the “DXC Technology Company Deferred Compensation Plan” (the “DXC DCP”) and adopted HPE's Enterprise Services Executive Deferred Compensation Plan (the “ES DCP”). Both plans are non-qualified deferred compensation plans maintained for a select group of management, highly compensated employees and non-employee directors.
The DXC DCP covers eligible employees who participated in CSC’s Deferred Compensation Plan prior to the HPES Merger. The ES DCP covers eligible employees who participated in the HPE Executive Deferred Compensation Plan prior to the HPES Merger. Both plans allow participating employees to defer the receipt of current compensation to a future distribution date or event above the amounts that may be deferred under DXC’s tax-qualified 401(k) plan, the DXC Technology Matched Asset Plan. Neither plan provides for employer contributions. As of April 3, 2017, the ES DCP does not admit new participants.
Certain management and highly compensated employees are eligible to defer all, or a portion of, their regular salary that exceeds the limitation set forth in Internal Revenue Section 401(a)(17) and all or a portion of their incentive compensation. Non-employee directors are eligible to defer up to 100% of their cash compensation. The liability, which is included in other long-term liabilities in the Company's balance sheets, amounted to $45 million as of December 31, 2020 and $48 million as of March 31, 2020.
33

DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Note 16 - Income Taxes
The Company's effective tax rate ("ETR") was 44.2% and 29.1% for the three months ended December 31, 2020 and December 31, 2019, respectively, and 54.5% and (11.5)% for the nine months ended December 31, 2020 and December 31, 2019, respectively. For the three and nine months ended December 31, 2020, the primary drivers of the ETR were the gain on sale of HHS Business, global mix of income and foreign tax credits. For the three months ended December 31, 2019, the primary drivers of the ETR were the impact of previously unrecognized tax effects on the tax deductible goodwill impaired during the fiscal 2020 second quarter, the global mix of income, an increase in prior year U.S. federal research and development income tax credits, and an increase in unrecognized tax benefits primarily related to audit activity. For the nine months ended December 31, 2019, the primary drivers of the ETR were the impact of the non-deductible goodwill impairment charge, the non-taxable gain on the arbitration award, the global mix of income, an increase in unrecognized tax benefits primarily related to audit activity, and an increase in prior year U.S. federal research and development income tax credits, net.
The majority of unremitted foreign earnings have been taxed in the U.S. We expect a significant portion of the unremitted earnings of our foreign subsidiaries will no longer be subject to U.S. federal income tax upon repatriation to the U.S. However, a portion of these earnings may still be subject to foreign and U.S. state tax consequences when remitted. Earnings in India are indefinitely reinvested. Other foreign earnings are not indefinitely reinvested except for approximately $547 million that could be taxable when repatriated to the U.S. under Treasury regulations that were issued during the first quarter of fiscal 2020.
In connection with the HPES Merger, the Company entered into a tax matters agreement with HPE. HPE generally will be responsible for pre-HPES Merger tax liabilities including adjustments made by tax authorities to HPES U.S. and non-U.S. income tax returns. Likewise, DXC is liable to HPE for income tax receivables and refunds which it receives related to pre-HPES Merger periods. Pursuant to the tax matters agreement, the Company recorded a net payable of $3 million due to $48 million of tax indemnification receivable related to uncertain tax positions net of related deferred tax benefits, $79 million of tax indemnification receivable related to other tax payables and $130 million of tax indemnification payable related to other tax receivables.
In connection with the USPS Separation, the Company entered into a tax matters agreement with Perspecta. Pursuant to the tax matters agreement, the Company generally will be responsible for tax liabilities arising prior to the USPS Separation. Income tax liabilities transferred to Perspecta primarily relate to pre-HPES Merger periods, for which the Company is indemnified by HPE pursuant to the tax matters agreement between the Company and HPE. The Company remains liable to HPE for tax receivables and refunds which it receives from Perspecta related to pre-HPES Merger periods that were transferred to Perspecta. Pursuant to the tax matters agreement, the Company has recorded a tax indemnification receivable from Perspecta of $81 million and a tax indemnification payable to Perspecta of $44 million related to income tax and other tax liabilities.
The IRS is examining the Company's federal income tax returns for fiscal 2008 through the tax year ended October 31, 2018. With respect to CSC's fiscal 2008 through 2017 federal tax returns, the Company has entered into negotiations for a resolution on the years under audit through settlement with the IRS Office of Appeals. The IRS examined several issues for these years that resulted in various audit adjustments. The Company and the IRS Office of Appeals have an agreement in principle as to some of these adjustments, and we disagree with the IRS’ disallowance of certain losses and deductions resulting from restructuring costs and tax planning strategies in previous years. These matters present a potential federal and state tax cost of $410 million (excluding interest and penalties), in addition to other disagreed issues. We expect two years of these audits (fiscal 2010 and fiscal 2013) to proceed to Tax Court. We believe we will ultimately prevail on the technical merits of these issues. The Company has agreed to extend the statute of limitations for fiscal years 2008 through 2012 through August 31, 2021, and for fiscal year 2013 through March 31, 2021 to provide for IRS completion of their review. The Company has agreed to extend the statute of limitations for fiscal years 2014 through fiscal 2017 through October 31, 2021 to provide for IRS completion of their review.
34

DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
The Company expects to reach a resolution for all years no earlier than the fourth quarter of fiscal 2022 except agreed issues related to fiscal 2008 through 2010 federal tax returns, which are expected to be resolved within twelve months.
In addition, the Company may settle certain other tax examinations, have lapses in statutes of limitations, or voluntarily settle income tax positions in negotiated settlements for different amounts than the Company has accrued as uncertain tax positions. In the third quarter of fiscal 2021 the Company’s liability for uncertain tax positions decreased by $13 million (excluding interest and penalties and related tax attributes) primarily due to an audit settlement. The Company may need to accrue and ultimately pay additional amounts for tax positions that previously met a more-likely-than-not standard if such positions are not upheld. Conversely, the Company could settle positions by payment with the tax authorities for amounts lower than those that have been accrued or extinguish a position through less payment than previously estimated. The Company believes that the outcomes that are reasonably possible within the next 12 months may result in a reduction in liability for uncertain tax positions of $37 million, excluding interest, penalties and tax carry-forwards.
Note 17 - Stockholders' Equity
Share Repurchases
On April 3, 2017, DXC announced the establishment of a share repurchase program approved by the Board of Directors with an initial authorization of $2.0 billion for future repurchases of outstanding shares of DXC common stock. On November 8, 2018, DXC's Board of Directors approved an incremental $2.0 billion share repurchase authorization. An expiration date has not been established for this repurchase plan. Share repurchases may be made from time to time through various means, including in open market purchases, 10b5-1 plans, privately-negotiated transactions, accelerated stock repurchases, block trades and other transactions, in compliance with Rule 10b-18 under the Exchange Act as well as, to the extent applicable, other federal and state securities laws and other legal requirements. The timing, volume, and nature of share repurchases pursuant to the share repurchase plan are at the discretion of management and may be suspended or discontinued at any time.
The shares repurchased are retired immediately and included in the category of authorized but unissued shares. The excess of purchase price over par value of the common shares is allocated between additional paid-in capital and retained earnings. There was no share repurchase activity during the nine months ended December 31, 2020. The details of shares repurchased during the nine months ended December 31, 2019 are shown below:

|  |  |  | Fiscal 2020
Fiscal Period |  |  |  |  |  |  |  | Number of Shares Repurchased |  | Average Price Per Share |  | Amount (in millions)
1st Quarter |  |  |  |  |  |  |  |  |  |  |  |
Open market purchases |  |  |  |  |  |  |  | 5,510,415 |  |  | $ | 54.44 |  |  | $ | 300 |
Accelerated stock repurchases |  |  |  |  |  |  |  | 1,849,194 |  |  | $ | 54.08 |  |  | 100 |
1st Quarter Total |  |  |  |  |  |  |  | 7,359,609 |  |  | $ | 54.35 |  |  | 400 |
2nd Quarter |  |  |  |  |  |  |  |  |  |  |  |
Open market purchases |  |  |  |  |  |  |  | 4,414,840 |  |  | $ | 33.96 |  |  | 150 |
Accelerated stock repurchases |  |  |  |  |  |  |  | 1,805,350 |  |  | $ | 55.39 |  |  | 100 |
2nd Quarter Total |  |  |  |  |  |  |  | 6,220,190 |  |  | $ | 40.18 |  |  | 250 |
3rd Quarter |  |  |  |  |  |  |  |  |  |  |  |
Open market purchases |  |  |  |  |  |  |  | 2,353,852 |  |  | $ | 36.68 |  |  | 86 |
Accelerated stock repurchases |  |  |  |  |  |  |  | — |  |  | $ | — |  |  | — |
3rd Quarter Total |  |  |  |  |  |  |  | 2,353,852 |  |  | $ | 36.68 |  |  | 86 |
Total |  |  |  |  |  |  |  | 15,933,651 |  |  | $ | 46.21 |  |  | $ | 736 |

35

DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Accumulated Other Comprehensive Loss
The following table shows the changes in accumulated other comprehensive income (loss), net of taxes:

(in millions) |  | Foreign Currency Translation Adjustments |  | Cash Flow Hedges |  | Available-for-sale Securities |  | Pension and Other Post-retirement Benefit Plans |  | Accumulated Other Comprehensive Loss
Balance at March 31, 2020 |  | $ | (851) |  |  | $ | (20) |  |  | $ | 9 |  |  | $ | 259 |  |  | $ | (603) |
Current-period other comprehensive income |  | 197 |  |  | 12 |  |  | (6) |  |  | — |  |  | 203 |
Amounts reclassified from accumulated other comprehensive loss |  | — |  |  | 6 |  |  | — |  |  | (13) |  |  | (7) |
Balance at December 31, 2020 |  | $ | (654) |  |  | $ | (2) |  |  | $ | 3 |  |  | $ | 246 |  |  | $ | (407) |

(in millions) |  | Foreign Currency Translation Adjustments |  | Cash Flow Hedges |  | Available-for-sale Securities |  | Pension and Other Post-retirement Benefit Plans |  | Accumulated Other Comprehensive Loss
Balance at March 31, 2019 |  | $ | (517) |  |  | $ | (3) |  |  | $ | 9 |  |  | $ | 267 |  |  | $ | (244) |
Current-period other comprehensive loss |  | 78 |  |  | (4) |  |  | 2 |  |  | — |  |  | 76 |
Amounts reclassified from accumulated other comprehensive income (loss) |  | — |  |  | (2) |  |  | — |  |  | (6) |  |  | (8) |
Balance at December 31, 2019 |  | $ | (439) |  |  | $ | (9) |  |  | $ | 11 |  |  | $ | 261 |  |  | $ | (176) |

Note 18 - Stock Incentive Plans
Equity Plans
The Compensation Committee of the Board of Directors (the "Board") has broad authority to grant awards and otherwise administer the DXC Employee Equity Plan. The plan became effective March 30, 2017 and will continue in effect for a period of 10 years thereafter, unless earlier terminated by the Board. The Board has the authority to amend the plan in such respects as it deems desirable, subject to approval of DXC’s stockholders for material modifications.
Restricted stock units ("RSUs") represent the right to receive one share of DXC common stock upon a future settlement date, subject to vesting and other terms and conditions of the award, plus any dividend equivalents accrued during the award period. In general, if the employee’s status as a full-time employee is terminated prior to the vesting of the RSU grant in full, then the RSU grant is automatically canceled on the termination date and any unvested shares and dividend equivalents are forfeited. Certain executives were awarded service-based "career share" RSUs for which the shares are settled over the 10 anniversaries following the executive's separation from service as a full-time employee, provided the executive complies with certain non-competition covenants during that period. The Company also grants Performance-based restricted stock units ("PSUs"), which generally vest over a period of three years. The number of PSUs that ultimately vest is dependent upon the Company’s achievement of certain specified financial performance criteria over a three-year period. If the specified performance criteria are met, awards are settled for shares of DXC common stock and dividend equivalents upon the filing with the SEC of the Annual Report on Form 10-K for the last fiscal year of the performance period. PSU awards include the potential for up to 25% of the shares granted to be earned after the first and second fiscal years if certain of the Company's performance targets are met early, subject to vesting based on the participant's continued employment through the end of the three-year performance period.
In fiscal 2021, DXC issued awards that are considered to have a market condition. A Monte Carlo simulation model was used for the valuation of the grants. Settlement of shares for the fiscal 2021 PSU awards will be made at the end of the third fiscal year subject to certain compounded annual growth rates of the stock price and continued employment through the last day of the third fiscal year.
36

DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
The terms of the DXC Director Equity Plan allow DXC to grant RSU awards to non-employee directors of DXC. Such RSU awards vest in full at the earlier of (i) the first anniversary of the grant date or (ii) the next annual meeting date, and are automatically redeemed for DXC common stock and dividend equivalents either at that time or, if an RSU deferral election form is submitted, upon the date or event elected by the director. Distributions made upon a director’s separation from the Board may occur in either a lump sum or in annual installments over periods of 5, 10, or 15 years, per the director’s election. In addition, RSUs vest in full upon a change in control of DXC.
The DXC Share Purchase Plan allows DXC’s employees located in the United Kingdom to purchase shares of DXC’s common stock at the fair market value of such shares on the applicable purchase date. There were 12,232 and 41,425 shares purchased under this plan during the three and nine months ended December 31, 2020.
The Board has reserved for issuance shares of DXC common stock, par value $0.01 per share, under each of the plans as detailed below:

|  | As of December 31, 2020
|  | Reserved for Issuance |  | Available for Future Grants
DXC Employee Equity Plan |  | 51,200,000 |  |  | 32,794,274 |
DXC Director Equity Plan |  | 745,000 |  |  | 435,951 |
DXC Share Purchase Plan |  | 250,000 |  |  | 165,185 |
Total |  | 52,195,000 |  |  | 33,395,410 |

Stock Options

|  | Number of Option Shares |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Term |  | Aggregate Intrinsic Value (in millions)
Outstanding as of March 31, 2020 |  | 1,869,815 |  |  | $ | 29.92 |  |  | 4.27 |  | $ | — |
Granted |  | — |  |  | $ | — |  |  |  |  |
Exercised |  | (39,601) |  |  | $ | 17.43 |  |  |  |  | $ | — |
Canceled/Forfeited |  | — |  |  | $ | — |  |  |  |  |
Expired |  | (82,614) |  |  | $ | 31.24 |  |  |  |  |
Outstanding as of December 31, 2020 |  | 1,747,600 |  |  | $ | 30.11 |  |  | 3.73 |  | $ | 3 |
Vested and exercisable as of December 31, 2020 |  | 1,747,600 |  |  | $ | 30.11 |  |  | 3.73 |  | $ | 3 |

Restricted Stocks

|  | Employee Equity Plan |  | Director Equity Plan
|  | Number of Shares |  | Weighted Average Grant Date Fair Value |  | Number of Shares |  | Weighted Average Grant Date Fair Value
Outstanding as of March 31, 2020 |  | 4,174,476 |  |  | $ | 55.45 |  |  | 114,615 |  |  | $ | 37.69 |
Granted |  | 7,576,602 |  |  | $ | 18.67 |  |  | 118,500 |  |  | $ | 18.82 |
Settled |  | (1,045,190) |  |  | $ | 50.65 |  |  | (48,455) |  |  | $ | 26.90 |
Canceled/Forfeited |  | (2,042,804) |  |  | $ | 36.14 |  |  | — |  |  | $ | — |
Outstanding as of December 31, 2020 |  | 8,663,084 |  |  | $ | 28.43 |  |  | 184,660 |  |  | $ | 28.42 |

37

DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Share-Based Compensation

|  | Three Months Ended |  | Nine Months Ended |  |
(in millions) |  | December 31, 2020 |  | December 31, 2019 |  | December 31, 2020 |  | December 31, 2019 |  |  |  |
Total share-based compensation cost |  | $ | 6 |  |  | $ | 9 |  |  | $ | 42 |  |  | $ | 57 |  |  |  |  |
Related income tax benefit |  | $ | 2 |  |  | $ | (3) |  |  | $ | 7 |  |  | $ | 8 |  |  |  |  |
Total intrinsic value of options exercised |  | $ | — |  |  | $ | 1 |  |  | $ | — |  |  | $ | 8 |  |  |  |  |
Tax benefits from exercised stock options and awards |  | $ | 1 |  |  | $ | 3 |  |  | $ | 5 |  |  | $ | 13 |  |  |  |  |

As of December 31, 2020, total unrecognized compensation expense related to unvested DXC stock options and unvested DXC RSUs, net of expected forfeitures was $0 million and $146 million, respectively. The unrecognized compensation expense for unvested RSUs is expected to be recognized over a weighted-average period of 2.06 years.
Note 19 - Cash Flows
Cash payments for interest on indebtedness and income taxes and other select non-cash activities are as follows:

|  | Nine Months Ended
(in millions) |  | December 31, 2020 |  | December 31, 2019
Cash paid for: |  |  |  |
Interest |  | $ | 262 |  |  | $ | 277 |
Taxes on income, net of refunds (1) |  | $ | 159 |  |  | $ | 202 |
Non-cash activities: |  |  |  |
Operating: |  |  |  |
ROU assets obtained in exchange for lease, net (2) |  | $ | 449 |  |  | $ | 314 |
Prepaid assets acquired under long-term financing |  | $ | 46 |  |  | $ | 23 |
Investing: |  |  |  |
Capital expenditures in accounts payable and accrued expenses |  | $ | 16 |  |  | $ | 121 |
Capital expenditures through finance lease obligations |  | $ | 277 |  |  | $ | 507 |
Assets acquired under long-term financing |  | $ | 26 |  |  | $ | 282 |
(Decrease) increase in deferred purchase price receivable |  | $ | (52) |  |  | $ | 58 |
Contingent consideration |  | $ | 2 |  |  | $ | 19 |
Financing: |  |  |  |
Dividends declared but not yet paid |  | $ | — |  |  | $ | 54 |

(1) Income tax refunds were $31 million and $36 million for the nine months ended December 31, 2020 and December 31, 2019, respectively.
(2) Net of $87 million change in lease classification from operating to finance lease in fiscal 2020.
38

DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Note 20 - Segment Information
DXC has a matrix form of organization and is managed in several different and overlapping groupings including services, industries and geographic regions. As a result, and in accordance with accounting standards, operating segments are organized by the type of services provided. DXC's chief operating decision maker ("CODM"), the chief executive officer, obtains, reviews, and manages the Company’s financial performance based on these segments. The CODM uses these results, in part, to evaluate the performance of, and allocate resources to, each of the segments.
Global Business Services ("GBS")
GBS provides innovative technology solutions that help its customers address key business challenges and accelerate digital transformations tailored to each customer's industry and specific objectives. GBS enterprise technology stack offerings include:
•Analytics and Engineering. GBS's portfolio of analytics services and extensive partner ecosystem help customers gain rapid insights, automate operations, and accelerate their digital transformation journeys. GBS provides software engineering and solutions that enable businesses to run and manage their mission-critical functions, transform their operations and develop new ways of doing business.
•Applications. GBS uses advanced technologies and methods to accelerate the creation, modernization, delivery and maintenance of high-quality, secure applications allowing customers to innovate faster while reducing risk, time to market, and total cost of ownership, across industries. GBS's vertical-specific IP includes solutions for insurance; banking and capital markets; and automotive, among others.
GBS offerings also includes business process services, which include digital integration and optimization of front and back office processes, and agile process automation. This helps companies to reduce cost, and minimize business disruption, human error, and operational risk while improving customer experiences.
Global Infrastructure Services ("GIS")
GIS provides a portfolio of technology offerings that deliver predictable outcomes and measurable results, while reducing business risk and operational costs for customers. GIS enterprise stack elements include:
•Cloud and Security. GIS helps customers to rapidly modernize by adapting legacy apps to cloud, migrate the right workloads, and securely manage their multi-cloud environments. GIS's security solutions help predict attacks, proactively respond to threats, ensure compliance and protect data, applications and infrastructure.
•IT Outsourcing ("ITO"). GIS's ITO services support infrastructure, applications, and workplace IT operations, including hardware, software, physical/virtual end-user devices, collaboration tools, and IT support services. GIS helps customers securely optimize operations to ensure continuity of their systems and respond to new business and workplace demands, while achieving cost takeout, all with limited resources, expertise and budget.
GIS offerings also include workplace and mobility services to fit its customer’s employee, business and IT needs from intelligent collaboration, modern device management, digital support services, Internet of Things ("IoT") and mobility services, providing a consumer-like, digital experience.
39

DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Segment Measures
The following table summarizes operating results regularly provided to the CODM by reportable segment and a reconciliation to the financial statements:

(in millions) |  | GBS |  | GIS |  |  |  | Total Reportable Segments |  | All Other |  | Totals
Three Months Ended December 31, 2020 |  |  |  |  |  |  |  |  |  |  |  |
Revenues |  | $ | 1,921 |  |  | $ | 2,367 |  |  |  |  | $ | 4,288 |  |  | $ | — |  |  | $ | 4,288 |
Segment profit |  | $ | 273 |  |  | $ | 88 |  |  |  |  | $ | 361 |  |  | $ | (61) |  |  | $ | 300 |
Depreciation and amortization(1) |  | $ | 53 |  |  | $ | 281 |  |  |  |  | $ | 334 |  |  | $ | 27 |  |  | $ | 361 |
Three Months Ended December 31, 2019 |  |  |  |  |  |  |  |  |  |  |  |
Revenues |  | $ | 2,359 |  |  | $ | 2,662 |  |  |  |  | $ | 5,021 |  |  | $ | — |  |  | $ | 5,021 |
Segment profit |  | $ | 353 |  |  | $ | 232 |  |  |  |  | $ | 585 |  |  | $ | (57) |  |  | $ | 528 |
Depreciation and amortization(1) |  | $ | 61 |  |  | $ | 244 |  |  |  |  | $ | 305 |  |  | $ | 28 |  |  | $ | 333 |

(in millions) |  | GBS |  | GIS |  |  |  | Total Reportable Segments |  | All Other |  | Totals
Nine Months Ended December 31, 2020 |  |  |  |  |  |  |  |  |  |  |  |
Revenues |  | $ | 6,337 |  |  | $ | 7,007 |  |  |  |  | $ | 13,344 |  |  | $ | — |  |  | $ | 13,344 |
Segment profit |  | $ | 805 |  |  | $ | 147 |  |  |  |  | $ | 952 |  |  | $ | (179) |  |  | $ | 773 |
Depreciation and amortization(1) |  | $ | 162 |  |  | $ | 839 |  |  |  |  | $ | 1,001 |  |  | $ | 77 |  |  | $ | 1,078 |
Nine Months Ended December 31, 2019 |  |  |  |  |  |  |  |  |  |  |  |
Revenues |  | $ | 6,803 |  |  | $ | 7,959 |  |  |  |  | $ | 14,762 |  |  | $ | — |  |  | $ | 14,762 |
Segment profit |  | $ | 1,078 |  |  | $ | 815 |  |  |  |  | $ | 1,893 |  |  | $ | (184) |  |  | $ | 1,709 |
Depreciation and amortization(1) |  | $ | 128 |  |  | $ | 771 |  |  |  |  | $ | 899 |  |  | $ | 82 |  |  | $ | 981 |

(1) Depreciation and amortization as presented excludes amortization of acquired intangible assets of $114 million and $146 million for the three months ended December 31, 2020 and 2019, respectively, and $414 million and $435 million for the nine months ended December 31, 2020 and 2019, respectively.
40

DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Reconciliation of Reportable Segment Profit to Consolidated Total
The Company's management uses segment profit as the measure for assessing performance of its segments. Segment profit is defined as segment revenue less costs of services, segment selling, general and administrative, depreciation and amortization, and other income (excluding the movement in foreign currency exchange rates on DXC's foreign currency denominated assets and liabilities and the related economic hedges). The Company does not allocate to its segments certain operating expenses managed at the corporate level. These unallocated costs include certain corporate function costs, stock-based compensation expense, pension and OPEB actuarial and settlement gains and losses, restructuring costs, transaction, separation and integration-related costs and amortization of acquired intangible assets.

|  | Three Months Ended |  | Nine Months Ended
(in millions) |  | December 31, 2020 |  | December 31, 2019 |  | December 31, 2020 |  | December 31, 2019
Profit |  |  |  |  |  |  |  |
Total profit for reportable segments |  | $ | 361 |  |  | $ | 585 |  |  | 952 |  |  | $ | 1,893 |
All other loss |  | (61) |  |  | (57) |  |  | (179) |  |  | (184) |
Interest income |  | 28 |  |  | 33 |  |  | 76 |  |  | 130 |
Interest expense |  | (82) |  |  | (93) |  |  | (284) |  |  | (288) |
Restructuring costs |  | (104) |  |  | (74) |  |  | (441) |  |  | (248) |
Transaction, separation and integration-related costs |  | (96) |  |  | (68) |  |  | (307) |  |  | (226) |
Amortization of acquired intangible assets |  | (114) |  |  | (146) |  |  | (414) |  |  | (435) |
Gain on disposition of businesses |  | 2,046 |  |  | — |  |  | 2,046 |  |  | — |
Pension and OPEB actuarial and settlement losses |  | — |  |  | — |  |  | (2) |  |  | — |
Goodwill impairment losses |  | — |  |  | (53) |  |  | — |  |  | (2,940) |
Gain on arbitration award |  | — |  |  | — |  |  | — |  |  | 632 |
Income (loss) before income taxes |  | $ | 1,978 |  |  | $ | 127 |  |  | $ | 1,447 |  |  | $ | (1,666) |

Management does not use total assets by segment to evaluate segment performance or allocate resources. As a result, assets are not tracked by segment and therefore, total assets by segment is not disclosed.
41

DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Note 21 - Commitments and Contingencies
Commitments
The Company signed long-term purchase agreements with certain software, hardware, telecommunication, and other service providers to obtain favorable pricing and terms for services, and products that are necessary for the operations of business activities. Under the terms of these agreements, the Company is contractually committed to purchase specified minimums over periods ranging from one to five years. If the Company does not meet the specified minimums, the Company would have an obligation to pay the service provider all, or a portion, of the shortfall. Minimum purchase commitments as of December 31, 2020 were as follows:

Fiscal year |  | Minimum Purchase Commitment (1)
(in millions) |
Remainder of 2021 |  | $ | 1,339 |
2022 |  | 1,093 |
2023 |  | 817 |
2024 |  | 227 |
Total |  | $ | 3,476 |

(1)A portion of the minimum purchase commitments for fiscal 2021 relates to the amounts committed under the HPE preferred vendor agreements.
In the normal course of business, the Company may provide certain clients with financial performance guarantees, and at times performance letters of credit or surety bonds. In general, the Company would only be liable for the amounts of these guarantees in the event that non-performance by the Company permits termination of the related contract by the Company’s client. The Company believes it is in compliance with its performance obligations under all service contracts for which there is a financial performance guarantee, and the ultimate liability, if any, incurred in connection with these guarantees will not have a material adverse effect on its consolidated results of operations or financial position.
The Company also uses stand-by letters of credit, in lieu of cash, to support various risk management insurance policies. These letters of credit represent a contingent liability and the Company would only be liable if it defaults on its payment obligations on these policies. The following table summarizes the expiration of the Company’s financial guarantees and stand-by letters of credit outstanding as of December 31, 2020:

(in millions) |  | Remainder of Fiscal 2021 |  | Fiscal 2022 |  | Fiscal 2023 and Thereafter |  | Totals
Surety bonds |  | $ | 14 |  |  | $ | 93 |  |  | $ | 87 |  |  | $ | 194 |
Letters of credit |  | 37 |  |  | 147 |  |  | 527 |  |  | 711 |
Stand-by letters of credit |  | 36 |  |  | 41 |  |  | 31 |  |  | 108 |
Totals |  | $ | 87 |  |  | $ | 281 |  |  | $ | 645 |  |  | $ | 1,013 |

The Company generally indemnifies licensees of its proprietary software products against claims brought by third parties alleging infringement of their intellectual property rights, including rights in patents (with or without geographic limitations), copyrights, trademarks, and trade secrets. DXC’s indemnification of its licensees relates to costs arising from court awards, negotiated settlements, and the related legal and internal costs of those licensees. The Company maintains the right, at its own cost, to modify or replace software in order to eliminate any infringement. The Company has not incurred any significant costs related to licensee software indemnification.
42

DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Contingencies
Strauch Fair Labor Standards Act Collective Action: On July 1, 2014, several plaintiffs filed an action in the U.S. District Court for the District of Connecticut on behalf of themselves and a putative nationwide collective of CSC system administrators, alleging CSC’s failure to properly classify these employees as non-exempt under the federal Fair Labor Standards Act ("FLSA"). Plaintiffs alleged similar state-law Rule 23 class claims pursuant to Connecticut and California statutes. Plaintiffs claimed double overtime damages, liquidated damages, and other amounts and remedies.
In 2015 the Court entered an order granting conditional certification under the FLSA of the collective of over 4,000 system administrators. Approximately 1,000 system administrators filed consents with the Court to participate in the FLSA collective. The class/collective action is currently made up of approximately 800 individuals who held the title of associate professional or professional system administrator.
In June 2017, the Court granted Rule 23 certification of a Connecticut state-law class and a California state-law class consisting of professional system administrators and associate professional system administrators. Senior professional system administrators were found not to qualify for Rule 23 certification under the state-law claims. CSC sought permission to appeal the Rule 23 decision to the Second Circuit Court of Appeals, which was denied.
In December 2017, a jury trial was held and a verdict was returned in favor of plaintiffs. On August 6, 2019, the Court issued an order awarding plaintiffs $18.75 million in damages. In September 2019, Plaintiffs filed a motion seeking $14.1 million in attorneys’ fees and costs. In July 2020, the Court issued an order awarding Plaintiffs $8.1 million in attorneys’ fees and costs. The Company disagrees with the jury verdict, the damages award, and the fee award, and is appealing the judgment of the Court.
In October 2020, the Company reached an agreement in principle with the plaintiffs to resolve the matter. The Company is finalizing a settlement agreement, which once executed, will be submitted to the Court for approval.
Computer Sciences Corporation v. Eric Pulier, et al.: On May 12, 2015, CSC filed a civil complaint in the Court of Chancery of the State of Delaware against Eric Pulier, the former CEO of Service Mesh Inc. ("SMI"), which CSC had acquired in November 2013. The complaint asserted claims for fraud, breach of contract and breach of fiduciary duty, based on allegations that Mr. Pulier had engaged in fraudulent transactions with two employees of the Commonwealth Bank of Australia Ltd. (“CBA”). The Court dismissed CSC’s claim for breach of the implied covenant of good faith, but allowed substantially all of the remaining claims to proceed. Mr. Pulier asserted counter-claims for breach of contract, fraud, negligent representation, rescission, and violations of the California Blue Sky securities law, all of which the Court dismissed in whole or in part, except for claims for breach of Mr. Pulier’s retention agreement.
In July 2017, the Court granted a motion by the United States for a 90-day stay of discovery pending the completion of a criminal investigation by the U.S. Attorney’s Office for the Central District of California. In September 2017, a federal grand jury returned an indictment against Mr. Pulier, charging him with conspiracy, securities and wire fraud, obstruction of justice, and other violations of federal law (United States v. Eric Pulier, CR 17-599-AB). The Government sought an extension of the stay which the Delaware Chancery Court granted.
In December 2018, the Government filed an application to dismiss the indictment against Mr. Pulier, which was granted, and the indictment was dismissed with prejudice. In March 2019, the Delaware Chancery Court lifted the stay and denied CSC’s motion for a temporary restraining order and preliminary injunction with respect to certain of Mr. Pulier’s assets.
In August 2019, the Company entered into an agreement with Mr. Pulier, resolving all claims and counterclaims in the Delaware litigation through the division of amounts previously held in escrow for post-closing disputes.
The Securities and Exchange Commission (“SEC”) has filed a complaint against Mr. Pulier alleging various claims, including for fraud and falsifying books and records (Securities and Exchange Commission v. Eric Pulier, Case No. 2:17-cv-07124). The case is scheduled for trial in April 2021.
43

DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
In February 2016, Mr. Pulier filed a complaint in Delaware Chancery Court seeking advancement of his legal fees and costs in the civil and criminal actions, pursuant to the terms of his agreements with SMI. The Court ruled that CSC Agility Platform - as the successor to SMI - is liable for advancing 80% of Mr. Pulier’s fees and costs in the civil and criminal actions. Pursuant to agreements with SMI, Mr. Pulier is obligated to repay all amounts advanced to him if it should ultimately be determined that he is not entitled to indemnification.
The Company remains obligated to advance amounts for Mr. Pulier’s legal fees and costs to defend the SEC action against him.
Kemper Corporate Services, Inc. v. Computer Sciences Corporation: In October 2015, Kemper Corporate Services, Inc. (“Kemper”) filed a demand for arbitration against CSC with the American Arbitration Association (“AAA”), alleging that CSC breached the terms of a 2009 Master Software License and Services Agreement and related Work Orders (the “Agreement”) by failing to complete a software translation and implementation plan by certain contractual deadlines. Kemper claimed breach of contract, seeking approximately $100 million in damages. CSC answered the demand for arbitration denying Kemper’s claims and asserting a counterclaim for unpaid invoices for services rendered by CSC.
A single arbitrator conducted an evidentiary hearing on the merits of the claims and counterclaims in April 2017. In October 2017, the arbitrator issued a partial final award, finding for Kemper on its breach of contract theory, awarding Kemper $84.2 million in compensatory damages plus prejudgment interest, denying Kemper’s claim for rescission as moot, and denying CSC’s counterclaim. Kemper moved to confirm the award in federal district court in Texas.
CSC moved to vacate the award, and in August 2018, the Magistrate Judge issued its Report and Recommendation denying CSC's vacatur motion. In September 2018, the District Court summarily accepted the Report and Recommendation without further briefing and entered a Final Judgment in the case. The Company promptly filed a notice of appeal to the Fifth Circuit Court of Appeals. Following the submission of briefs, oral argument was held on September 5, 2019. On January 10, 2020, the Court of Appeals issued a decision denying the Company’s appeal. On January 24, 2020, the Company filed a Petition for Rehearing, seeking review by the entire en banc Court of Appeals. On February 14, 2020, the Court of Appeals denied the Company's Petition.
The Company has been pursuing coverage for the full scope of the award, interest, and legal fees and expenses, under the Company's applicable insurance policies. Certain carriers have accepted coverage while others have denied coverage. On February 21, 2020, the Company paid the balance of the judgment, which net of insurance recovery totalled $60 million. The Company has since recovered an additional $12.5 million from its insurance carriers. The Company continues to pursue recovery with its insurance carriers.
Forsyth, et al. v. HP Inc. and Hewlett Packard Enterprise: On August 18, 2016, this purported class and collective action was filed in the U.S. District Court for the Northern District of California, against HP and HPE alleging violations of the Federal Age Discrimination in Employment Act (“ADEA”), the California Fair Employment and Housing Act, California public policy and the California Business and Professions Code. Former business units of HPE now owned by the Company may be proportionately liable for any recovery by plaintiffs in this matter.
Plaintiffs seek to certify a nationwide class action under the ADEA comprised of all U.S. residents employed by defendants who had their employment terminated pursuant to a work force reduction (“WFR”) plan and who were 40 years of age or older at the time of termination. The class seeks to cover those impacted by WFRs on or after December 2014. Plaintiffs also seek to represent a Rule 23 class under California law comprised of all persons 40 years of age or older employed by defendants in the state of California and terminated pursuant to a WFR plan on or after August 18, 2012.
44

DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
In January 2017, defendants filed a partial motion to dismiss and a motion to compel arbitration of claims by certain named and opt-in plaintiffs who had signed release agreements as part of their WFR packages. In September 2017, the Court denied the partial motion to dismiss without prejudice, but granted defendants’ motions to compel arbitration for those named and opt-in plaintiffs. The Court stayed the entire action pending arbitration for these individuals and administratively closed the case.
A mediation was held in October 2018 with the 16 named and opt-in plaintiffs who were involved in the case at that time. A settlement was reached, which included seven plaintiffs who were employed by former business units of HPE that are now owned by the Company. In June 2019, a second mediation was held with 145 additional opt-in plaintiffs who were compelled to arbitration pursuant to their release agreements. In December 2019, a settlement was reached with 142 of the opt-in plaintiffs, 35 of whom were employed by former business units of HPE that are now owned by the Company, and for which the Company was liable.
In December 2020, Plaintiffs filed a motion for preliminary certification of the collective action, which Defendants intend to oppose. A hearing on the motion has been scheduled for April 15, 2021.
Former business units of the Company now owned by Perspecta may be proportionately liable for any recovery by plaintiffs in this matter.
Oracle America, Inc., et al. v. Hewlett Packard Enterprise Company: On March 22, 2016, Oracle filed a complaint against HPE in the Northern District of California, alleging copyright infringement, interference with contract, intentional interference with prospective economic relations, and unfair competition. The litigation relates in part to former business units of HPE that are now owned by the Company. The Company may be required to indemnify HPE for a portion of any recovery by Oracle in the litigation related to these business units.
Oracle’s claims arise primarily out of HPE’s prior relationship with a third-party maintenance provider named Terix Computer Company, Inc. (“Terix”). Oracle claims that Terix infringed its copyrights while acting as HPE’s subcontractor for certain customers of HPE’s multivendor support business. Oracle claims that HPE is liable for vicarious and contributory infringement arising from the alleged actions of Terix and for direct infringement arising from its own alleged conduct.
On January 29, 2019, the court granted HPE’s motion for summary judgment and denied Oracle’s motion for summary judgment, resolving the matter in HPE’s favor. Oracle appealed the judgment to the U.S. Court of Appeals for the Ninth Circuit. In August 2020, the court granted Oracle’s appeal in part. The case has been remanded to the District Court for further proceedings.
In re DXC Technology Company Securities Litigation: On December 27, 2018, a purported class action lawsuit was filed in the United States District Court for the Eastern District of Virginia against the Company and two of its current officers. The lawsuit asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended, and is premised on allegedly false and/or misleading statements, and alleged non-disclosure of material facts, regarding the Company’s business, operations, prospects and performance during the proposed class period of February 8, 2018 to November 6, 2018. The Company moved to dismiss the claims in their entirety, and on June 2, 2020, the court granted the Company’s motion, dismissing all claims and entering judgment in the Company’s favor. On July 1, 2020, the plaintiffs filed a notice of appeal to the U.S. Court of Appeals for the Fourth Circuit. The appeal remains pending.
In March 2019, three related shareholder derivative lawsuits were filed in the Eighth Judicial District Court of the State of Nevada, in and for Clark County, against one of the Company’s current officers and a former officer as well as members of the Company’s board of directors, asserting claims for breach of fiduciary duty, waste of corporate assets, and unjust enrichment. By agreement of the parties and order of the court, those lawsuits were consolidated on July 18, 2019, and are presently stayed pending the outcome of the appeal of the Eastern District of Virginia matter.
45

DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
On August 20, 2019, a purported class action lawsuit was filed in the Superior Court of the State of California, County of Santa Clara, against the Company, directors of the Company, and a former officer of the Company, among other defendants. On September 16, 2019, a substantially similar purported class action lawsuit was filed in the United States District Court for the Northern District of California against the Company, directors of the Company, and a former officer of the Company, among other defendants. On November 8, 2019, a third purported class action lawsuit was filed in the Superior Court of the State of California, County of San Mateo, against the Company, directors of the Company, and a former officer of the Company, among other defendants. The third lawsuit was voluntarily dismissed by the plaintiff and re-filed in the Superior Court of the State of California, County of Santa Clara on November 26, 2019, and thereafter was consolidated with the earlier-filed action in the same court on December 10, 2019. The California lawsuits assert claims under Sections 11, 12 and 15 of the Securities Act of 1933, as amended, and are premised on allegedly false and/or misleading statements, and alleged non-disclosure of material facts, regarding the Company’s prospects and expected performance. Plaintiff in the federal action filed an amended complaint on January 8, 2020. The putative class of plaintiffs in these cases includes all persons who acquired shares of the Company’s common stock pursuant to the offering documents filed with the Securities and Exchange Commission in connection with the April 2017 transaction that formed DXC. On July 15, 2020, the Superior Court of California, County of Santa Clara, denied the Company’s motion to stay the state court case but extended the Company’s deadline to seek dismissal of the state action, until after a decision on the Company’s motion to dismiss the federal action. The Company has since moved to dismiss the state action, and the court has continued the motion until after the outcome of the federal action. On July 27, 2020, the United States District Court for the Northern District of California granted the Company’s motion to dismiss the federal action. The Court’s order permitted plaintiffs to amend and refile their complaint within 60 days, and on September 25, 2020, the plaintiffs filed an amended complaint. On November 12, 2020, the Company filed a motion to dismiss the amended complaint. A hearing on the motion is scheduled for April 29, 2021.
On October 2, 2019, a shareholder derivative lawsuit was filed in the Eighth Judicial District Court of the State of Nevada, in and for Clark County, asserting various claims, including for breach of fiduciary duty and unjust enrichment, and challenging certain sales of securities by officers under Rule 10b5-1 plans. The shareholder filed this action after making a demand on the board of directors, alleging breaches of fiduciary duty, corporate waste and disclosure violations, and demanding that the Board take certain actions to evaluate the allegations and respond. The Company’s board of directors analyzed the demand, and has determined to defer its decision on the demand pending developments in the securities and derivative lawsuits described above. The Company moved to dismiss the complaint on the basis that the Board’s decision to defer action was not a refusal of the demand and was within its discretion. The Company’s motion to dismiss was denied on January 22, 2020. By agreement of the parties and order of the court, the case is presently stayed, pending the outcome of the appeal of the Eastern District of Virginia matter.
On March 31, 2020, a group of individual shareholders filed a complaint in the United States District Court for the Northern District of California, asserting non-class claims based on allegations substantially similar to those at issue in the earlier-filed putative class action complaints pending in the Northern District of California and Eastern District of Virginia. The plaintiffs assert claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended, and under Sections 11 and 15 of the Securities Act of 1933, as amended. On April 29, 2020, the court granted an administrative motion to relate the case with the earlier-filed putative class action pending in the Northern District of California. And on May 13, 2020, the parties filed a stipulation requesting to stay the case subject to resolution of the motions to dismiss in the Northern District of California and Eastern District of Virginia class actions.
The Company believes that the lawsuits described above are without merit, and it intends to vigorously defend them.
Voluntary Disclosure of Certain Possible Sanctions Law Violations: On February 2, 2017, CSC submitted an initial notification of voluntary disclosure to the U.S. Department of Treasury, Office of Foreign Assets Control ("OFAC") regarding certain possible violations of U.S. sanctions laws pertaining to insurance premium data and claims data processed by two partially-owned joint ventures of Xchanging, which CSC acquired during the first quarter of fiscal 2017. A copy of the disclosure was also provided to Her Majesty’s Treasury Office of Financial Sanctions Implementation in the United Kingdom. The Company has substantially completed its internal investigation. The Company provided supplemental information to OFAC on January 31, 2020 and continues to work with OFAC on these issues.
46

DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Perspecta Arbitration: In October 2019, Perspecta Inc. (“Perspecta”) submitted a demand for arbitration claiming that in June 2018 DXC breached certain obligations under the Separation and Distribution Agreement ("SDA") between Perspecta and DXC and seeking at least $120 million in alleged damages. During the course of discovery, Perspecta increased the amount of its alleged damages, first to $500 million and then to over $800 million. Perspecta has since increased its damages calculations to include interest, bringing its total claim to $990 million. The Company believes there is no valid basis for Perspecta's claims for these amounts.
In its arbitration demand, Perspecta also challenges $39 million in invoices issued by DXC in June 2019 under its IT Services Agreement with Perspecta ("ITSA"). Perspecta subsequently challenged an additional $31 million sought by DXC in August 2020 under the ITSA. DXC believes the invoices were properly issued and the amounts are owed by Perspecta.
In October 2020, a hearing was held before an arbitration panel, during which the Company and Perspecta each presented evidence on the claims at issue. In December 2020, the parties presented closing arguments and the case was submitted. The parties are awaiting a decision from the arbitration panel.
In addition to the matters noted above, the Company is currently subject in the normal course of business to various claims and contingencies arising from, among other things, disputes with customers, vendors, employees, contract counterparties and other parties, as well as securities matters, environmental matters, matters concerning the licensing and use of intellectual property, and inquiries and investigations by regulatory authorities and government agencies. Some of these disputes involve or may involve litigation. The financial statements reflect the treatment of claims and contingencies based on management's view of the expected outcome. DXC consults with outside legal counsel on issues related to litigation and regulatory compliance and seeks input from other experts and advisors with respect to matters in the ordinary course of business. Although the outcome of these and other matters cannot be predicted with certainty, and the impact of the final resolution of these and other matters on the Company’s results of operations in a particular subsequent reporting period could be material and adverse, management does not believe based on information currently available to the Company, that the resolution of any of the matters currently pending against the Company will have a material adverse effect on the financial position of the Company or the ability of the Company to meet its financial obligations as they become due. Unless otherwise noted, the Company is unable to determine at this time a reasonable estimate of a possible loss or range of losses associated with the foregoing disclosed contingent matters.
47

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
All statements and assumptions contained in this Quarterly Report on Form 10-Q and in the documents incorporated by reference that do not directly and exclusively relate to historical facts constitute “forward-looking statements.” Forward-looking statements often include words such as “anticipates,” “believes,” “estimates,” “expects,” “forecast,” “goal,” “intends,” “objective,” “plans,” “projects,” “strategy,” “target,” and “will” and words and terms of similar substance in discussions of future operating or financial performance. These statements represent current expectations and beliefs, and no assurance can be given that the results described in such statements will be achieved.
Forward-looking statements include, among other things, statements with respect to our financial condition, results of operations, cash flows, business strategies, operating efficiencies or synergies, divestitures, competitive position, growth opportunities, share repurchases, dividend payments, plans and objectives of management and other matters. Such statements are subject to numerous assumptions, risks, uncertainties and other factors that could cause actual results to differ materially from those described in such statements, many of which are outside of our control. Furthermore, many of these risks and uncertainties are currently amplified by and may continue to be amplified by or may, in the future, be amplified by, the coronavirus disease 2019 (“COVID-19”) pandemic and the impact of varying private and governmental responses that affect our customers, employees, vendors and the economies and communities where they operate.
Important factors that could cause actual results to differ materially from those described in forward-looking statements include, but are not limited to:
•the uncertainty of the magnitude, duration, geographic reach, impact on the global economy and current and potential travel restrictions, stay-at-home orders, economic restrictions implemented to address the COVID-19 pandemic;
•the current, and uncertain future, impact of the COVID-19 pandemic, as well as other emerging developments and disruption to economic activity, and their resulting impact on our clients that may affect our business, growth, prospects, financial condition, operating results, cash flows and liquidity;
•changes in governmental regulations or the adoption of new laws or regulations that may make it more difficult or expensive to operate our business;
•changes in senior management, the loss of key employees or the ability to retain and hire key personnel and maintain relationships with key business partners;
•the risk of liability or damage to our reputation resulting from security breaches, cyber-attacks or disclosure of sensitive data or failure to comply with data protection laws and regulations, including the ransomware attack recently experienced by our subsidiary, Xchanging;
•business interruptions in connection with our technology systems;
•the competitive pressures faced by our business;
•the effects of macroeconomic and geopolitical trends and events;
•the need to manage third-party suppliers and the effective distribution and delivery of our products and services;
•the protection of our intellectual property assets, including intellectual property licensed from third parties;
•the risks associated with international operations;
•the development and transition of new products and services and the enhancement of existing products and services to meet customer needs, respond to emerging technological trends and maintain and grow our customer relationships over time;
48

•the ability to succeed in our strategic objectives, including strategic alternatives material for our business;
•the ability to achieve the expected benefits of our restructuring plans;
•the ability to maintain and grow our customer relationships over time and to comply with customer contracts or government contracting regulations or requirements;
•the execution and performance of contracts by us and our suppliers, customers, clients and partners;
•our credit rating and the ability to manage working capital, refinance and raise additional capital for future needs;
•our substantial amount of indebtedness;
•our ability to remediate any material weakness and maintain effective internal control over financial reporting;
•the resolution of pending investigations, claims and disputes;
•the integration of Computer Sciences Corporation's ("CSC") and Enterprise Services business of Hewlett Packard Enterprise Company's ("HPES") businesses, operations, and culture and the ability to operate as effectively and efficiently as expected, and the combined company's ability to successfully manage and integrate acquisitions generally;
•the ability to realize the synergies and benefits expected to result from the merger of CSC and HPES (the "HPES Merger") within the anticipated time frame or in the anticipated amounts;
•other risks related to the HPES Merger including anticipated tax treatment, unforeseen liabilities, and future capital expenditures;
•the spin-off of our former U.S. public sector business and its related mergers with Vencore Holding Corp. and KeyPoint Government Solutions to form Perspecta Inc. (the "USPS") Separation and Mergers could result in substantial tax liability to DXC and our stockholders;
•risks relating to the respective abilities of the parties to our acquisition of Luxoft Holding, Inc. to achieve the expected results therefrom;
•risks relating to the consummation of sale of our healthcare provider software business to Dedalus, and the ability to achieve the expected results therefrom; and
•the other factors described in Part I Item 1A "Risk Factors" of our Annual Report on Form 10-K for the fiscal year ended March 31, 2020 and Part II Item 1A "Risk Factors" of our Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2020, September 30, 2020 and of this Quarterly Report on Form 10-Q.
No assurance can be given that any goal or plan set forth in any forward-looking statement can or will be achieved, and readers are cautioned not to place undue reliance on such statements which speak only as of the date they are made. We do not undertake any obligation to update or release any revisions to any forward-looking statement or to report any events or circumstances after the date of this Quarterly Report on Form 10-Q or to reflect the occurrence of unanticipated events, except as required by law.
49

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Introduction
The purpose of the MD&A is to present information that management believes is relevant to an assessment and understanding of our results of operations and cash flows for the third quarter and first nine months of fiscal 2021 and our financial condition as of December 31, 2020. The MD&A is provided as a supplement to, and should be read in conjunction with, our financial statements and accompanying notes.
The MD&A is organized into the following sections:
•Background
•Results of Operations
•Liquidity and Capital Resources
•Off-Balance Sheet Arrangements
•Contractual Obligations
•Critical Accounting Policies and Estimates
The following discussion includes a comparison of our results of operations and liquidity and capital resources for the third quarters and first nine months of fiscal 2021 and fiscal 2020.
Background
DXC Technology helps global companies run their mission critical systems and operations while modernizing IT, optimizing data architectures, and ensuring security and scalability across public, private and hybrid clouds. With decades of driving innovation, the world’s largest companies trust DXC to deploy our enterprise technology stack to deliver new levels of performance, competitiveness and customer experiences.
We generate revenue by offering a wide range of information technology services and solutions primarily in North America, Europe, Asia and Australia. We operate through two segments: Global Business Services ("GBS") and Global Infrastructure Services ("GIS"). We market and sell our services directly to clients through our direct sales force operating out of sales offices around the world. Our clients include commercial businesses of many sizes and in many industries and public sector enterprises.
50

Results of Operations
The following table sets forth certain financial data for the third quarters and first nine months of fiscal 2021 and fiscal 2020:

|  | Three Months Ended |  | Nine Months Ended
(In millions, except per-share amounts) |  | December 31, 2020 |  | December 31, 2019 |  | December 31, 2020 |  | December 31, 2019
Revenues |  | $ | 4,288 |  |  | $ | 5,021 |  |  | $ | 13,344 |  |  | $ | 14,762 |
Income (loss) before income taxes |  | 1,978 |  |  | 127 |  |  | 1,447 |  |  | (1,666) |
Income tax expense |  | 875 |  |  | 37 |  |  | 789 |  |  | 191 |
Net income (loss) |  | $ | 1,103 |  |  | $ | 90 |  |  | $ | 658 |  |  | $ | (1,857) |
Diluted earnings (loss) per common share: |  | $ | 4.29 |  |  | $ | 0.32 |  |  | $ | 2.54 |  |  | $ | (7.20) |

Fiscal 2021 Highlights
Financial highlights for the third quarter and first nine months of fiscal 2021 include the following:
•Revenues for the third quarter and first nine months of fiscal 2021 were $4.3 billion and $13.3 billion, respectively, a decrease of 14.6% and 9.6%, respectively, as compared to the third quarter and first nine months of fiscal 2020. These decreases were primarily due to the disposition of the HHS business at the beginning of the third quarter of fiscal 2021, project terminations, and changes in run volume. The decrease in revenue for the first nine months of fiscal 2021 was partially offset by contributions from our Luxoft acquisition which was executed during the first quarter of fiscal 2020. Refer to the section below captioned "Revenues."
•Net income and diluted earnings per share for the third quarter of fiscal 2021 were $1,103 million and $4.29, respectively. Net income increased by $1,013 million during the third quarter of fiscal 2021 as compared to the same period of the prior fiscal year. The increase was primarily due to gain on disposition of businesses and cost optimization realized in the current year, partially offset by a reduction in revenue previously mentioned and an increase in tax expense from prior year. Refer to the section below captioned "Cost and Expenses." Net income included the cumulative impact of certain items of $882 million during the quarter, reflecting restructuring costs, transaction, separation and integration-related costs, amortization of acquired intangible assets, and gain on disposition of businesses. This compares with net income and diluted earnings per share of $90 million and $0.32, respectively, for the third quarter of fiscal 2020.
•Net income and diluted earnings per share for the first nine months of fiscal 2021 were $658 million and $2.54, respectively. Net income increased by $2,515 million during the first nine months of fiscal 2021 as compared to the same period of the prior fiscal year. The increase was primarily due to goodwill impairment recognized in the prior year and gain on disposition of businesses and cost optimization realized in the current year partially offset by gain on arbitration in the prior year and a reduction in revenue in the current year previously mentioned. Refer to the section below captioned "Cost and Expenses." Net income included the cumulative impact of certain items of $217 million during the period, reflecting restructuring costs, transaction, separation and integration-related costs, amortization of acquired intangible assets, gain on disposition of businesses, pension and other post-retirement benefit ("OPEB") actuarial and settlement losses, and tax adjustment. This compares with net loss and diluted loss per share of $1,857 million and $7.20, respectively, for the first nine months of fiscal 2020.
•Our cash and cash equivalents were $3.9 billion as of December 31, 2020.
•We generated $404 million of cash from operations during the first nine months of fiscal 2021, as compared to $2,062 million during the first nine months of fiscal 2020.
51

Revenues

|  | Three Months Ended |  |  |  |
(in millions) |  | December 31, 2020 |  | December 31, 2019 |  | Change |  | Percentage Change
GBS |  | $ | 1,921 |  |  | $ | 2,359 |  |  | $ | (438) |  |  | (18.6) | %
GIS |  | 2,367 |  |  | 2,662 |  |  | (295) |  |  | (11.1) | %
Total Revenues |  | $ | 4,288 |  |  | $ | 5,021 |  |  | $ | (733) |  |  | (14.6) | %

|  | Nine Months Ended |  |  |  |
(in millions) |  | December 31, 2020 |  | December 31, 2019 |  | Change |  | Percentage Change
GBS |  | $ | 6,337 |  |  | $ | 6,803 |  |  | $ | (466) |  |  | (6.8) | %
GIS |  | 7,007 |  |  | 7,959 |  |  | (952) |  |  | (12.0) | %
Total Revenues |  | $ | 13,344 |  |  | $ | 14,762 |  |  | $ | (1,418) |  |  | (9.6) | %

The decrease in revenues for the third quarter and first nine months of fiscal 2021, compared with the same periods in fiscal 2020, reflects the disposition of the HHS business at the beginning of the third quarter of fiscal 2021, project terminations, and changes in run volume. The decrease in revenue for the first nine months of fiscal 2021 was partially offset by contributions from our Luxoft acquisition which was executed during the first quarter of fiscal 2020. Revenues for the third quarter and first nine months of fiscal 2021 included favorable foreign currency exchange rate impacts of 2.3% and 0.6%, respectively. These impacts were primarily driven by the weakening of the U.S. dollar against the Euro, Australian Dollar, and British Pound during the third quarter and first nine months of fiscal 2021.
52

During the third quarters and first nine months of fiscal 2021 and fiscal 2020, the distribution of our revenues across geographies was as follows:
53

For the discussion of risks associated with our foreign operations, see Part 1, Item 1A "Risk Factors" of our Annual Report on Form 10-K for the fiscal year ended March 31, 2020.
As a global company, over 65% of our revenues for the first nine months of fiscal 2021 were earned internationally. As a result, the comparison of revenues denominated in currencies other than the U.S. dollar, from period to period, is impacted by fluctuations in foreign currency exchange rates. Constant currency revenues are a non-GAAP measure calculated by translating current period activity into U.S. dollars using the comparable prior period’s currency conversion rates. This information is consistent with how management views our revenues and evaluates our operating performance and trends. The table below summarizes our constant currency revenues:

|  | Three Months Ended |  |  |  |
(in millions) |  | Constant Currency December 31, 2020 |  | December 31, 2019 |  | Change |  | Percentage Change
GBS |  | $ | 1,868 |  |  | $ | 2,359 |  |  | $ | (491) |  |  | (20.8) | %
GIS |  | 2,302 |  |  | 2,662 |  |  | (360) |  |  | (13.5) | %
Total |  | $ | 4,170 |  |  | $ | 5,021 |  |  | $ | (851) |  |  | (16.9) | %

|  | Nine Months Ended |  |  |  |
(in millions) |  | Constant Currency December 31, 2020 |  | December 31, 2019 |  | Change |  | Percentage Change
GBS |  | $ | 6,287 |  |  | $ | 6,803 |  |  | $ | (516) |  |  | (7.6) | %
GIS |  | 6,962 |  |  | 7,959 |  |  | (997) |  |  | (12.5) | %
Total |  | $ | 13,249 |  |  | $ | 14,762 |  |  | $ | (1,513) |  |  | (10.2) | %

54

Global Business Services
Our GBS revenues were $1,921 million in the third quarter and $6,337 million in the first nine months of fiscal 2021, a decrease of 18.6% and 6.8%, respectively, compared to the corresponding periods in fiscal 2020. GBS revenue in constant currency decreased 20.8% and 7.6% in the third quarter and first nine months of fiscal 2021, respectively, as compared to the corresponding periods in fiscal 2020. The decrease in GBS revenues for the third quarter and first nine months of fiscal 2021 were primarily due to the disposition of the HHS business at the beginning of the third quarter of fiscal 2021, project terminations, and change in run volumes. The decrease in revenue for the first nine months of fiscal 2021 was partially offset by contributions from our Luxoft acquisition which was executed during the first quarter of fiscal 2020.
For the third quarter and first nine months of fiscal 2021, GBS contract awards were $2.7 billion and $8.6 billion, respectively, as compared to $2.5 billion and $6.8 billion in the corresponding periods of fiscal 2020.
Global Infrastructure Services
Our GIS revenues were $2,367 million in the third quarter and $7,007 million in the first nine months of fiscal 2021, a decrease of 11.1% and 12.0%, respectively, compared to the corresponding periods in fiscal 2020. GIS revenue in constant currency decreased 13.5% and 12.5% in the third quarter and first nine months of fiscal 2021, respectively, as compared to the corresponding periods in fiscal 2020. The decrease in GIS revenues for the third quarter and first nine months of fiscal 2021 reflects project terminations, change in run volumes, and price-downs.
For the third quarter and first nine months of fiscal 2021, GIS contract awards were $2.2 billion and $6.5 billion, respectively, as compared to $2.8 billion and $6.5 billion in the corresponding periods of fiscal 2020.
55

Costs and Expenses
Our total costs and expenses are shown in the tables below:

|  | Three Months Ended |  |
|  | Amount | Percentage of Revenues |  | Percentage Point Change
(in millions) |  | December 31, 2020 |  | December 31, 2019 |  | December 31, 2020 |  | December 31, 2019 |
Costs of services (excludes depreciation and amortization and restructuring costs) |  | $ | 3,333 |  |  | $ | 3,827 |  |  | 77.8 | % |  | 76.2 | % |  | 1.6 |
Selling, general, and administrative (excludes depreciation and amortization and restructuring costs) |  | 517 |  |  | 518 |  |  | 12.1 |  |  | 10.3 |  |  | 1.8 |
Depreciation and amortization |  | 475 |  |  | 479 |  |  | 11.1 |  |  | 9.5 |  |  | 1.6 |
Goodwill impairment losses |  | — |  |  | 53 |  |  | — |  |  | 1.1 |  |  | (1.1) |
Restructuring costs |  | 104 |  |  | 74 |  |  | 2.4 |  |  | 1.5 |  |  | 0.9 |
Interest expense |  | 82 |  |  | 93 |  |  | 1.9 |  |  | 1.9 |  |  | — |
Interest income |  | (28) |  |  | (33) |  |  | (0.7) |  |  | (0.7) |  |  | — |
Gain on disposition of businesses |  | (2,046) |  |  | — |  |  | (47.7) |  |  | — |  |  | (47.7) |
Other income, net |  | (127) |  |  | (117) |  |  | (3.0) |  |  | (2.3) |  |  | (0.7) |
Total costs and expenses |  | $ | 2,310 |  |  | $ | 4,894 |  |  | 53.9 | % |  | 97.5 | % |  | (43.6) |

|  | Nine Months Ended |  |
|  | Amount | Percentage of Revenues |  | Percentage Point Change
(in millions) |  | December 31, 2020 |  | December 31, 2019 |  | December 31, 2020 |  | December 31, 2019 |
Costs of services (excludes depreciation and amortization and restructuring costs) |  | $ | 10,525 |  |  | $ | 11,128 |  |  | 78.9 | % |  | 75.3 | % |  | 3.6 |
Selling, general, and administrative (excludes depreciation and amortization and restructuring costs) |  | 1,595 |  |  | 1,514 |  |  | 12.0 |  |  | 10.3 |  |  | 1.7 |
Depreciation and amortization |  | 1,492 |  |  | 1,416 |  |  | 11.2 |  |  | 9.6 |  |  | 1.6 |
Goodwill impairment losses |  | — |  |  | 2,940 |  |  | — |  |  | 19.9 |  |  | (19.9) |
Restructuring costs |  | 441 |  |  | 248 |  |  | 3.3 |  |  | 1.7 |  |  | 1.6 |
Interest expense |  | 284 |  |  | 288 |  |  | 2.1 |  |  | 2.0 |  |  | 0.1 |
Interest income |  | (76) |  |  | (130) |  |  | (0.6) |  |  | (0.9) |  |  | 0.3 |
Gain on disposition of businesses |  | (2,046) |  |  | — |  |  | (15.3) |  |  | — |  |  | (15.3) |
Gain on arbitration award |  | — |  |  | (632) |  |  | — |  |  | (4.3) |  |  | 4.3 |
Other income, net |  | (318) |  |  | (344) |  |  | (2.4) |  |  | (2.3) |  |  | (0.1) |
Total costs and expenses |  | $ | 11,897 |  |  | $ | 16,428 |  |  | 89.2 | % |  | 111.3 | % |  | (22.1) |

The 43.6 and 22.1 point decrease in total costs and expenses as a percentage of revenue for the third quarter and first nine months of fiscal 2021 primarily reflects the gain on disposition of businesses in the current year and our goodwill impairment losses incurred during the third quarter and first nine months of fiscal 2020 that didn’t occur in fiscal 2021.
Costs of Services
Costs of services, excluding depreciation and amortization and restructuring costs ("COS"), was $3.3 billion and $10.5 billion for the third quarter and first nine months of fiscal 2021, respectively. COS decreased $494 million and $603 million during the third quarter and first nine months of fiscal 2021, respectively, as compared to the same periods of the prior fiscal year. These decreases were primarily due to cost optimization savings realized during fiscal 2021. COS as a percentage of revenue increased 1.6 and 3.6 points, respectively, as compared to the same periods of the prior fiscal year. These point increases were driven by a reduction in revenue during the same periods of the current fiscal year.
56

Selling, General, and Administrative
Selling, general, and administrative expense, excluding depreciation and amortization and restructuring costs ("SG&A"), was $517 million for the third quarter of fiscal 2021, consistent with the same period of the prior fiscal year. SG&A was $1,595 million for the first nine months of fiscal 2021, an increase of $81 million compared to the same period of the prior fiscal year. The increase during the first nine months of fiscal 2021 was driven by higher transaction, separation and integration-related costs.
Transaction, separation and integration-related costs of $96 million and $307 million were included in SG&A for the third quarter and first nine months of fiscal 2021, respectively, as compared to $68 million and $226 million for the comparable period of the prior fiscal year.
Depreciation and Amortization
Depreciation expense was $185 million and $563 million for the third quarter and first nine months of fiscal 2021, respectively. Depreciation expense increased $49 million and $91 million during the third quarter and first nine months of fiscal 2021, respectively, as compared to the same periods of the prior fiscal year. The net increase in depreciation expense for the third quarter and first nine months of fiscal 2021 was due to an increase in assets placed into service.
Amortization expense was $290 million and $929 million for the third quarter and first nine months of fiscal 2021, respectively. Amortization expense decreased $53 million and $15 million during the third quarter and first nine months of fiscal 2021, respectively, as compared to the same periods of the prior fiscal year. These decreases were primarily due to customer related intangibles related to the disposition of the HHS business at the beginning of the third quarter of fiscal 2021. See Note 4 - "Divestitures" for additional information.
Goodwill Impairment Losses
DXC recognized goodwill impairment charges totaling $53 million and $2,940 million for the third quarter and first nine months of fiscal 2020, respectively. The impairment charge was primarily as a result of a decline in market capitalization during the second quarter of fiscal 2020. See Note 11 - "Goodwill" for additional information.
Restructuring Costs
During fiscal 2021, management approved global cost savings initiatives designed to better align our workforce and facility structures. During the third quarter and first nine months of fiscal 2021, restructuring costs, net of reversals, were $104 million and $441 million, respectively, as compared to $74 million and $248 million during the same periods of the prior fiscal year. In addition, during the third quarter of fiscal 2021 workforce reductions includes a $14 million adjustment to restructuring expense related to the prior year.
For an analysis of changes in our restructuring liabilities by restructuring plan, see Note 14 - "Restructuring Costs" to the financial statements.
57

Interest Expense and Interest Income
Interest expense was $82 million and $284 million for third quarter and first nine months of fiscal 2021, respectively. Interest expense decreased $11 million and $4 million during the third quarter and first nine months of fiscal 2021, respectively, as compared to the same periods of the prior fiscal year. These decreases were primarily driven by lower interest rates on finance leases and a reduction in interest charges within our multicurrency cash pools. The decrease in interest expense for the first nine months of fiscal 2021 was partially offset by increased amounts drawn on our revolving credit facility.
Interest income was $28 million and $76 million for third quarter and first nine months of fiscal 2021, respectively. Interest income decreased $5 million and $54 million during the third quarter and first nine months of fiscal 2021, respectively, as compared to the same periods of the prior fiscal year. The decrease during the third quarter of fiscal 2021 was primarily driven by lower income from our multicurrency cash pools and money market accounts. The decrease during the first nine months of fiscal 2021 was primarily driven by interest income in the second quarter of fiscal year 2020 related to arbitration discussed below under the caption “Gain on Arbitration Award."
Gain on Dispositions
During the third quarter of fiscal 2021, DXC sold its U.S. State and Local Health and Human Services business for a total enterprise value of $5.0 billion and resulted in an estimated pre-tax gain on sale of $2,041 million, net of closing costs. An insignificant business was also sold during the quarter that resulted in a gain of $5 million.
Gain on Arbitration Award
During the second quarter of fiscal 2020, DXC received final arbitration award proceeds of $666 million related to the HPE Enterprise Services merger completed in fiscal 2018. The arbitration award included $632 million in damages that were recorded as a gain. The remaining $34 million of the award related to pre-award interest. Dispute details are subject to confidentiality obligations.
Other Income, Net
Other income, net comprises non-service cost components of net periodic pension income, movement in foreign currency exchange rates on our foreign currency denominated assets and liabilities and the related economic hedges, equity earnings of unconsolidated affiliates and other miscellaneous gains and losses.
Other income was $127 million and $318 million for the third quarter and first nine months of fiscal 2021, respectively, as compared to $117 million and $344 million during the same periods of the prior fiscal year.
The $10 million increase in other income, net for the third quarter of fiscal 2021, as compared to the same period of the prior fiscal year, was primarily due to a year-over-year increase in other gains related to sales of non-operating assets partially offset by foreign exchange hedging and revaluations.
The $26 million decrease in other income, net for the first nine months of fiscal 2021, as compared to the same period of the prior fiscal year, was primarily due to foreign exchange hedging and revaluations, partially offset by a year-over-year increase in gains related to sales of non-operating assets.
58

Taxes
Our effective tax rate ("ETR") was 44.2% and 29.1% for the three months ended December 31, 2020 and December 31, 2019, respectively, and 54.5% and (11.5)% for the nine months ended December 31, 2020 and December 31, 2019, respectively. For the three and nine months ended December 31, 2020, the primary drivers of the ETR were the gain on sale of HHS Business, global mix of income and foreign tax credits. For the three months ended December 31, 2019, the primary drivers of the ETR were the impact of previously unrecognized tax effects on the tax deductible goodwill impaired during the fiscal 2020 second quarter, the global mix of income, an increase in prior year U.S. federal research and development income tax credits, and an increase in unrecognized tax benefits primarily related to audit activity. For the nine months ended December 31, 2019, the primary drivers of the ETR were the impact of the non-deductible goodwill impairment charge, the non-taxable gain on the arbitration award, the global mix of income, an increase in unrecognized tax benefits primarily related to audit activity, and an increase in prior year U.S. federal research and development income tax credits, net.
Earnings (Loss) Per Share
Diluted earnings per share for the third quarter and first nine months of fiscal 2021 was $4.29 and $2.54, respectively. Diluted earnings per share increased $3.97 and $9.74 during the third quarter and first nine months of fiscal 2021, respectively, as compared to the same periods of the prior fiscal year. This increase was due to an increase of $1,013 million and $2,515 million in net income for the third quarter and first nine months of fiscal 2021, respectively, over the same periods in the prior fiscal year.
Diluted earnings per share for the third quarter of fiscal 2021 includes $0.36 per share of restructuring costs, $0.31 per share of transaction, separation and integration-related costs, $0.34 per share of amortization of acquired intangible assets, and $(4.47) per share of gain on disposition of businesses.
Diluted earnings per share for the first nine months of fiscal 2021 includes $1.43 per share of restructuring costs, $0.93 per share of transaction, separation and integration-related costs, $1.25 per share of amortization of acquired intangible assets, $(4.48) per share of gain on disposition of businesses, $0.01 per share of pension and OPEB actuarial and settlement losses, and $0.01 of tax adjustment.
59

Non-GAAP Financial Measures
We present non-GAAP financial measures of performance which are derived from the statements of operations of DXC. These non-GAAP financial measures include earnings before interest and taxes ("EBIT"), adjusted EBIT, non-GAAP income before income taxes, non-GAAP net income and non-GAAP EPS, constant currency revenues, net debt and net debt-to-total capitalization.
We present these non-GAAP financial measures to provide investors with meaningful supplemental financial information, in addition to the financial information presented on a GAAP basis. Non-GAAP financial measures exclude certain items from GAAP results which DXC management believes are not indicative of core operating performance. DXC management believes these non-GAAP measures allow investors to better understand the financial performance of DXC exclusive of the impacts of corporate-wide strategic decisions. DXC management believes that adjusting for these items provides investors with additional measures to evaluate the financial performance of our core business operations on a comparable basis from period to period. DXC management believes the non-GAAP measures provided are also considered important measures by financial analysts covering DXC, as equity research analysts continue to publish estimates and research notes based on our non-GAAP commentary, including our guidance around diluted non-GAAP EPS targets.
Non-GAAP financial measures exclude certain items from GAAP results which DXC management believes are not indicative of operating performance such as the amortization of acquired intangible assets, transaction, separation and integration-related costs, and gains and losses on dispositions of businesses.
Incremental amortization of intangible assets acquired through business combinations may result in a significant difference in period over period amortization expense on a GAAP basis. We exclude amortization of certain acquired intangibles assets as these non-cash amounts are inconsistent in amount and frequency and are significantly impacted by the timing and/or size of acquisitions. Although DXC management excludes amortization of acquired intangible assets primarily customer related intangible assets, from its non-GAAP expenses, we believe that it is important for investors to understand that such intangible assets were recorded as part of purchase accounting and support revenue generation. Any future transactions may result in a change to the acquired intangible asset balances and associated amortization expense.
There are limitations to the use of the non-GAAP financial measures presented in this report. One of the limitations is that they do not reflect complete financial results. We compensate for this limitation by providing a reconciliation between our non-GAAP financial measures and the respective most directly comparable financial measure calculated and presented in accordance with GAAP. Additionally, other companies, including companies in our industry, may calculate non-GAAP financial measures differently than we do, limiting the usefulness of those measures for comparative purposes between companies.
Selected references are made on a “constant currency basis” so that certain financial results can be viewed without the impact of fluctuations in foreign currency rates, thereby providing comparisons of operating performance from period to period. Financial results on a “constant currency basis” are non-GAAP measures calculated by translating current period activity into U.S. dollars using the comparable prior period’s currency conversion rates. This approach is used for all results where the functional currency is not the U.S. dollar. Please see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Results of Operations—Fiscal 2021 Highlights.”
60

Certain non-GAAP financial measures and the respective most directly comparable financial measures calculated and presented in accordance with GAAP include:

|  | Three Months Ended |  |  |  |
(in millions) |  | December 31, 2020 |  | December 31, 2019 |  | Change |  |
Income before income taxes |  | $ | 1,978 |  |  | $ | 127 |  |  | $ | 1,851 |  |  |
Non-GAAP income before income taxes |  | $ | 246 |  |  | $ | 468 |  |  | $ | (222) |  |  |
Net Income |  | $ | 1,103 |  |  | $ | 90 |  |  | $ | 1,013 |  |  |
Adjusted EBIT |  | $ | 300 |  |  | $ | 528 |  |  | $ | (228) |  |  |

|  | Nine Months Ended |  |  |  |
(in millions) |  | December 31, 2020 |  | December 31, 2019 |  | Change |  |
Income (loss) before income taxes |  | $ | 1,447 |  |  | $ | (1,666) |  |  | $ | 3,113 |  |  |
Non-GAAP income before income taxes |  | $ | 565 |  |  | $ | 1,551 |  |  | $ | (986) |  |  |
Net income (loss) |  | $ | 658 |  |  | $ | (1,857) |  |  | $ | 2,515 |  |  |
Adjusted EBIT |  | $ | 773 |  |  | $ | 1,709 |  |  | $ | (936) |  |  |

Reconciliation of Non-GAAP Financial Measures
Our non-GAAP adjustments include:
•Restructuring costs - reflects costs, net of reversals, related to workforce optimization and real estate charges.
•Transaction, separation and integration-related (“TSI”) costs - reflects costs to execute on strategic alternatives, costs related to integration, planning, financing and advisory fees associated with the HPES Merger and other acquisitions and costs related to the separation of USPS and other divestitures.(1)
•Amortization of acquired intangible assets - reflects amortization of intangible assets acquired through business combinations.
•Gain on disposition of businesses - Reflects gains and losses related to sales of businesses.
•Pension and OPEB actuarial and settlement gains and losses - reflects pension and OPEB actuarial and settlement gains and losses.
•Goodwill impairment losses - reflects impairment losses on goodwill.
•Gain on arbitration award - reflects a gain related to the HPES merger arbitration award.
•Tax adjustment - for fiscal 2021 periods, reflects the impact of tax entries related to prior restructuring charges and an adjustment to the tax expense relating to USPS, and for fiscal 2020 periods, reflects the impact of tax entries related to prior restructuring charges. Income tax expense of non-GAAP adjustments is computed by applying the jurisdictional tax rate to the pre-tax adjustments on a jurisdictional basis.
(1) TSI costs for all periods presented include fees and other internal and external expenses associated with legal, accounting, consulting, due diligence, investment banking advisory, and other services, as well as financing fees, retention incentives, and resolution of transaction related claims in connection with, or resulting from, exploring or executing potential acquisitions, dispositions and strategic alternatives, whether or not announced or consummated.
TSI-Related Costs for Q3 FY21 include $77 million of costs to execute the strategic alternatives (including $52M for the sale of HHS which closed in October 2020 and $23M for the sale of the healthcare software business which is expected to close later this year); $7 million in expenses related to integration projects resulting from the CSC – HPE ES merger (including costs associated with continuing efforts to separate certain IT systems) and $12 million of costs incurred in connection with activities related to other acquisitions and divestitures.
61

A reconciliation of reported results to non-GAAP results is as follows:

|  | Three Months Ended December 31, 2020
(in millions, except per-share amounts) |  | As Reported |  | Restructuring Costs |  | Transaction, Separation and Integration-Related Costs |  | Amortization of Acquired Intangible Assets |  | Gain on Disposition of Businesses |  |  |  | Non-GAAP Results
Costs of services (excludes depreciation and amortization and restructuring costs) |  | $ | 3,333 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  |  |  | $ | 3,333 |
Selling, general, and administrative (excludes depreciation and amortization and restructuring costs) |  | 517 |  |  | — |  |  | (96) |  |  | — |  |  | — |  |  |  |  | 421 |
Income (loss) before income taxes |  | 1,978 |  |  | 104 |  |  | 96 |  |  | 114 |  |  | (2,046) |  |  |  |  | 246 |
Income tax expense (benefit) |  | 875 |  |  | 11 |  |  | 16 |  |  | 26 |  |  | (903) |  |  |  |  | 25 |
Net income (loss) |  | 1,103 |  |  | 93 |  |  | 80 |  |  | 88 |  |  | (1,143) |  |  |  |  | 221 |
Less: net income attributable to non-controlling interest, net of tax |  | 5 |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |  | 5 |
Net income (loss) attributable to DXC common stockholders |  | $ | 1,098 |  |  | $ | 93 |  |  | $ | 80 |  |  | $ | 88 |  |  | $ | (1,143) |  |  |  |  | $ | 216 |
Effective Tax Rate |  | 44.2 | % |  |  |  |  |  |  |  |  |  |  |  | 10.2 | %
Basic EPS |  | $ | 4.32 |  |  | $ | 0.37 |  |  | $ | 0.31 |  |  | $ | 0.35 |  |  | $ | (4.49) |  |  |  |  | $ | 0.85 |
Diluted EPS |  | $ | 4.29 |  |  | $ | 0.36 |  |  | $ | 0.31 |  |  | $ | 0.34 |  |  | $ | (4.47) |  |  |  |  | $ | 0.84 |
Weighted average common shares outstanding for: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic EPS |  | 254.32 |  |  | 254.32 |  |  | 254.32 |  |  | 254.32 |  |  | 254.32 |  |  |  |  | 254.32 |
Diluted EPS |  | 255.75 |  |  | 255.75 |  |  | 255.75 |  |  | 255.75 |  |  | 255.75 |  |  |  |  | 255.75 |

|  | Nine Months Ended December 31, 2020
(in millions, except per-share amounts) |  | As Reported |  | Restructuring Costs |  | Transaction, Separation and Integration-Related Costs |  | Amortization of Acquired Intangible Assets |  | Gain on Disposition of Businesses |  | Pension and OPEB Actuarial and Settlement Losses |  | Tax Adjustment |  | Non-GAAP Results
Costs of services (excludes depreciation and amortization and restructuring costs) |  | $ | 10,525 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 10,525 |
Selling, general, and administrative (excludes depreciation and amortization and restructuring costs) |  | 1,595 |  |  | — |  |  | (314) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 1,281 |
Income (loss) before income taxes |  | 1,447 |  |  | 441 |  |  | 307 |  |  | 414 |  |  | (2,046) |  |  | 2 |  |  | — |  |  | 565 |
Income tax expense (benefit) |  | 789 |  |  | 75 |  |  | 70 |  |  | 95 |  |  | (903) |  |  | — |  |  | (2) |  |  | 124 |
Net income (loss) |  | 658 |  |  | 366 |  |  | 237 |  |  | 319 |  |  | (1,143) |  |  | 2 |  |  | 2 |  |  | 441 |
Less: net income attributable to non-controlling interest, net of tax |  | 9 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 9 |
Net income (loss) attributable to DXC common stockholders |  | $ | 649 |  |  | $ | 366 |  |  | $ | 237 |  |  | $ | 319 |  |  | $ | (1,143) |  |  | $ | 2 |  |  | $ | 2 |  |  | $ | 432 |
Effective Tax Rate |  | 54.5 | % |  |  |  |  |  |  |  |  |  |  |  |  |  | 21.9 | %
Basic EPS |  | $ | 2.55 |  |  | $ | 1.44 |  |  | $ | 0.93 |  |  | $ | 1.26 |  |  | $ | (4.50) |  |  | $ | 0.01 |  |  | $ | 0.01 |  |  | $ | 1.70 |
Diluted EPS |  | $ | 2.54 |  |  | $ | 1.43 |  |  | $ | 0.93 |  |  | $ | 1.25 |  |  | $ | (4.48) |  |  | $ | 0.01 |  |  | $ | 0.01 |  |  | $ | 1.69 |
Weighted average common shares outstanding for: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic EPS |  | 254.03 |  |  | 254.03 |  |  | 254.03 |  |  | 254.03 |  |  | 254.03 |  |  | 254.03 |  |  | 254.03 |  |  | 254.03 |
Diluted EPS |  | 255.20 |  |  | 255.20 |  |  | 255.20 |  |  | 255.20 |  |  | 255.20 |  |  | 255.20 |  |  | 255.20 |  |  | 255.20 |

62

|  | Three Months Ended December 31, 2019
(in millions, except per-share amounts) |  | As Reported |  | Restructuring Costs |  | Transaction, Separation and Integration-Related Costs |  | Amortization of Acquired Intangible Assets |  | Goodwill Impairment Losses |  |  |  | Tax Adjustment |  | Non-GAAP Results
Costs of services (excludes depreciation and amortization and restructuring costs) |  | $ | 3,827 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  |  |  | $ | — |  |  | $ | 3,827 |
Selling, general, and administrative (excludes depreciation and amortization and restructuring costs) |  | 518 |  |  | — |  |  | (68) |  |  | — |  |  | — |  |  |  |  | — |  |  | $ | 450 |
Income before income taxes |  | 127 |  |  | 74 |  |  | 68 |  |  | 146 |  |  | 53 |  |  |  |  | — |  |  | 468 |
Income tax expense (benefit) |  | 37 |  |  | 10 |  |  | 16 |  |  | 34 |  |  | 53 |  |  |  |  | (10) |  |  | 140 |
Net income |  | 90 |  |  | 64 |  |  | 52 |  |  | 112 |  |  | — |  |  |  |  | 10 |  |  | 328 |
Less: net income attributable to non-controlling interest, net of tax |  | 8 |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |  | — |  |  | 8 |
Net income attributable to DXC common stockholders |  | $ | 82 |  |  | $ | 64 |  |  | $ | 52 |  |  | $ | 112 |  |  | $ | — |  |  |  |  | $ | 10 |  |  | $ | 320 |
Effective Tax Rate |  | 29.1 | % |  |  |  |  |  |  |  |  |  |  |  |  |  | 29.9 | %
Basic EPS |  | $ | 0.32 |  |  | $ | 0.25 |  |  | $ | 0.20 |  |  | $ | 0.44 |  |  | $ | — |  |  |  |  | $ | 0.04 |  |  | $ | 1.25 |
Diluted EPS |  | $ | 0.32 |  |  | $ | 0.25 |  |  | $ | 0.20 |  |  | $ | 0.44 |  |  | $ | — |  |  |  |  | $ | 0.04 |  |  | $ | 1.25 |
Weighted average common shares outstanding for: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic EPS |  | 255.09 |  |  | 255.09 |  |  | 255.09 |  |  | 255.09 |  |  | 255.09 |  |  |  |  | 255.09 |  |  | 255.09 |
Diluted EPS |  | 256.05 |  |  | 256.05 |  |  | 256.05 |  |  | 256.05 |  |  | 256.05 |  |  |  |  | 256.05 |  |  | 256.05 |

|  | Nine Months Ended December 31, 2019
(in millions, except per-share amounts) |  | As Reported |  | Restructuring Costs |  | Transaction, Separation and Integration-Related Costs |  | Amortization of Acquired Intangible Assets |  | Goodwill Impairment Losses |  | Gain on Arbitration Award |  | Tax Adjustment |  | Non-GAAP Results
Costs of services (excludes depreciation and amortization and restructuring costs) |  | $ | 11,128 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 11,128 |
Selling, general, and administrative (excludes depreciation and amortization and restructuring costs) |  | 1,514 |  |  | — |  |  | (226) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | $ | 1,288 |
(Loss) income before income taxes |  | (1,666) |  |  | 248 |  |  | 226 |  |  | 435 |  |  | 2,940 |  |  | (632) |  |  | — |  |  | 1,551 |
Income tax expense (benefit) |  | 191 |  |  | 42 |  |  | 43 |  |  | 99 |  |  | 53 |  |  | — |  |  | (39) |  |  | 389 |
Net (loss) income |  | (1,857) |  |  | 206 |  |  | 183 |  |  | 336 |  |  | 2,887 |  |  | (632) |  |  | 39 |  |  | 1,162 |
Less: net income attributable to non-controlling interest, net of tax |  | 17 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 17 |
Net (loss) income attributable to DXC common stockholders |  | $ | (1,874) |  |  | $ | 206 |  |  | $ | 183 |  |  | $ | 336 |  |  | $ | 2,887 |  |  | $ | (632) |  |  | $ | 39 |  |  | $ | 1,145 |
Effective Tax Rate |  | (11.5) | % |  |  |  |  |  |  |  |  |  |  |  |  |  | 25.1 | %
Basic EPS |  | $ | (7.20) |  |  | $ | 0.79 |  |  | $ | 0.70 |  |  | $ | 1.29 |  |  | $ | 11.09 |  |  | $ | (2.43) |  |  | $ | 0.15 |  |  | $ | 4.40 |
Diluted EPS |  | $ | (7.20) |  |  | $ | 0.79 |  |  | $ | 0.70 |  |  | $ | 1.28 |  |  | $ | 11.03 |  |  | $ | (2.42) |  |  | $ | 0.15 |  |  | $ | 4.38 |
Weighted average common shares outstanding for: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic EPS |  | 260.24 |  |  | 260.24 |  |  | 260.24 |  |  | 260.24 |  |  | 260.24 |  |  | 260.24 |  |  | 260.24 |  |  | 260.24 |
Diluted EPS |  | 260.24 |  |  | 261.69 |  |  | 261.69 |  |  | 261.69 |  |  | 261.69 |  |  | 261.69 |  |  | 261.69 |  |  | 261.69 |

63

A reconciliation of net income to EBIT and adjusted EBIT is as follows:

|  | Three Months Ended |  | Nine Months Ended
(in millions) |  | December 31, 2020 |  | December 31, 2019 |  | December 31, 2020 |  | December 31, 2019
Net income (loss) |  | $ | 1,103 |  |  | $ | 90 |  |  | $ | 658 |  |  | $ | (1,857) |
Income tax expense |  | 875 |  |  | 37 |  |  | 789 |  |  | 191 |
Interest income |  | (28) |  |  | (33) |  |  | (76) |  |  | (130) |
Interest expense |  | 82 |  |  | 93 |  |  | 284 |  |  | 288 |
EBIT |  | 2,032 |  |  | 187 |  |  | 1,655 |  |  | (1,508) |
Restructuring costs |  | 104 |  |  | 74 |  |  | 441 |  |  | 248 |
Transaction, separation and integration-related costs |  | 96 |  |  | 68 |  |  | 307 |  |  | 226 |
Amortization of acquired intangible assets |  | 114 |  |  | 146 |  |  | 414 |  |  | 435 |
Gain on disposition of businesses |  | (2,046) |  |  | — |  |  | (2,046) |  |  | — |
Pension and OPEB actuarial and settlement losses |  | — |  |  | — |  |  | 2 |  |  | — |
Goodwill impairment losses |  | — |  |  | 53 |  |  | — |  |  | 2,940 |
Gain on arbitration award |  | — |  |  | — |  |  | — |  |  | (632) |
Adjusted EBIT |  | $ | 300 |  |  | $ | 528 |  |  | $ | 773 |  |  | $ | 1,709 |

64

Liquidity and Capital Resources
Cash and Cash Equivalents and Cash Flows
As of December 31, 2020, our cash and cash equivalents ("cash") was $3.9 billion, of which $1.1 billion was held outside of the U.S. We maintain various multi-currency, multi-entity, cross-border, physical and notional cash and pool arrangements with various counterparties to manage liquidity efficiently that enables participating subsidiaries to draw on the Company’s pooled resources to meet liquidity needs.
A significant portion of the cash held by our foreign subsidiaries is not expected to be impacted by U.S. federal income tax upon repatriation. However, a portion of this cash may still be subject to foreign and U.S. state income tax consequences upon future remittance. Therefore, if additional funds held outside the U.S. are needed for our operations in the U.S., we plan to repatriate these funds not designated as indefinitely reinvested.
We have $0.5 billion in cash held by foreign subsidiaries used for local operations that is subject to country-specific limitations which may restrict or result in increased costs in the repatriation of these funds. In addition, other practical considerations may limit our use of consolidated cash. This includes cash of $0.5 billion held in a German financial services subsidiary subject to regulatory requirements, and $0.2 billion held by majority owned consolidated subsidiaries where third-parties hold minority interests.
The following table summarizes our cash flow activity:

|  | Nine Months Ended |  |
(in millions) |  | December 31, 2020 |  | December 31, 2019 |  | Change
Net cash provided by operating activities |  | $ | 404 |  |  | $ | 2,062 |  |  | $ | (1,658) |
Net cash provided by (used in) investing activities |  | 4,500 |  |  | (2,122) |  |  | 6,622 |
Net cash used in financing activities |  | (4,671) |  |  | (305) |  |  | (4,366) |
Effect of exchange rate changes on cash and cash equivalents |  | 20 |  |  | 26 |  |  | (6) |
Cash classified within current assets held for sale |  | (13) |  |  | — |  |  | (13) |
Net increase (decrease) in cash and cash equivalents |  | $ | 240 |  |  | $ | (339) |  |  | $ | 579 |
Cash and cash equivalents at beginning of year |  | 3,679 |  |  | 2,899 |  |  |
Cash and cash equivalents at end of period |  | $ | 3,919 |  |  | $ | 2,560 |  |  |

Operating cash flow
Net cash provided by operating activities during the first nine months of fiscal 2021 was $404 million as compared to $2,062 million during the comparable period of the prior fiscal year. The decrease of $1,658 million was due to a decrease in net income, net of adjustments of $2,687 million, including $272 million of repurchased receivables previously sold under the Milano Receivables Facility and $12 million of prepaid maintenance related to the sale of the HHS business. The decrease was partially offset by a decrease in working capital cash outflows of $1,029 million. Net loss, net of adjustments includes cash received on arbitration award of $668 million in the prior fiscal year.
Investing cash flow
Net cash provided by (used in) investing activities during the first nine months of fiscal 2021 was $4,500 million as compared to $(2,122) million during the comparable period of the prior fiscal year. The decrease in cash used of $6,622 million was primarily due to cash received from business dispositions of $4,942 million in fiscal 2021, a decrease in cash paid for acquisitions of $1,987 million, and the absence of short-term investing of $75 million in fiscal 2020. This was partially offset by a decrease in cash collections related to deferred purchase price receivable of $354 million and a $48 million increase in payments for software licenses related to the sale of the HHS business.
65

Financing cash flow
Net cash used in financing activities during the first nine months of fiscal 2021 was $4,671 million as compared to $305 million during the comparable period of the prior fiscal year. The $4,366 million increase in cash used was primarily due to an increase in repayments, net of borrowings, of $3,102 million on term loans and other long-term debt, $1,500 million on lines of credit, and $590 million on commercial paper. In total, we used $3.5 billion of the net proceeds from the sale of the HHS business to repay debt during the quarter. These increases were partially offset by the absence of common stock repurchases and advance payment for accelerated share repurchase of $736 million in fiscal 2020, and a decrease in dividend payments of $108 million.
Capital Resources
See Note 21 - "Commitments and Contingencies" for a discussion of the general purpose of guarantees and commitments. The anticipated sources of funds to fulfill such commitments are listed below and under the subheading "Liquidity."
The following table summarizes our total debt:

|  | As of
(in millions) |  | December 31, 2020 |  | March 31, 2020
Short-term debt and current maturities of long-term debt |  | $ | 795 |  |  | $ | 1,276 |
Long-term debt, net of current maturities |  | 5,444 |  |  | 8,672 |
Total debt |  | $ | 6,239 |  |  | $ | 9,948 |

The $3.7 billion decrease in total debt during the first nine months of fiscal 2021 was primarily attributed to the prepayment of $1.5 billion of Revolver Credit Facility outstanding at fiscal year-end March 31, 2020, €402 million of Euro commercial paper, and the following term loan facilities: €750 million of Euro Term Loan due fiscal 2022 and 2023, A$800 million of AUD Term Loan due fiscal 2022, £450 million of GBP Term Loan due fiscal 2022, $481 million of USD Term Loan due fiscal 2025, and €350 million of Euro Term Loan due fiscal 2024. These were partially offset by the issuance of new senior notes with an aggregate principal of $1.0 billion, consisting of (i) $500 million of 4.00% Senior Notes due fiscal 2024 and (ii) $500 million of 4.13% Senior Notes due fiscal 2026.
During the first quarter of fiscal 2021, we applied for and were confirmed eligible to participate in the Bank of England’s (“BOE”) COVID Corporate Funding Facility, a BOE program that provides term liquidity funding to investment grade corporate issuers with significant operations in the UK, in order to stabilize and facilitate continued access to sterling commercial paper markets. At our option, we can borrow up to a maximum of €1.0 billion or its equivalent in Euro, British Pound and U.S. dollar. On June 15, 2020, DXC Capital Funding DAC (previously named DXC Capital Funding Limited), an indirect subsidiary of the Company, issued £600 million in commercial paper maturing May 2021 under its existing €1.0 billion commercial paper program via direct sale to the BOE.
In October 2020, we sold the HHS business and used approximately $3.5 billion of the proceeds to prepay $1,250 million of Revolver Credit Facility, £600 million of GBP commercial paper (approximately $772 million), €350 million of Euro Term Loan due fiscal 2024 (approximately $410 million), $381 million of USD Term loan due fiscal 2025, A$500 million of AUD Term Loan due fiscal 2022 (approximately $358 million), and €250 million of Euro Term Loan due fiscal 2022 and 2023 (approximately $292 million).
During fiscal 2021, we borrowed the remaining $2.5 billion under the $4.0 billion credit facility agreement and repaid the full $4.0 billion on the same. The purpose of the borrowing was to mitigate our reliance on volatile short-term commercial paper markets and to strengthen our cash and liquidity position given the uncertainties related to COVID-19 pandemic and its potential impact on our clients and our business. The credit facility repayment resulted from the availability of other liquidity resources. The entire $4.0 billion credit facility is available for redraw at our request.
We were in compliance with all financial covenants associated with our borrowings as of December 31, 2020 and December 31, 2019.
66

The debt maturity chart below summarizes the future maturities of long-term debt principal for fiscal years subsequent to December 31, 2020, and excludes maturities of borrowings for assets acquired under long-term financing and finance lease liabilities. See Note 12 - "Debt" for more information.
The following table summarizes our capitalization ratios:

|  | As of
(in millions) |  | December 31, 2020 |  | March 31, 2020
Total debt |  | $ | 6,239 |  |  | $ | 9,948 |
Cash and cash equivalents(1) |  | 3,919 |  |  | 3,679 |
Net debt(2) |  | $ | 2,320 |  |  | $ | 6,269 |
Total debt |  | $ | 6,239 |  |  | $ | 9,948 |
Equity |  | 5,995 |  |  | 5,129 |
Total capitalization |  | $ | 12,234 |  |  | $ | 15,077 |
Debt-to-total capitalization |  | 51.0 | % |  | 66.0 | %
Net debt-to-total capitalization(2) |  | 19.0 | % |  | 41.6 | %

(1) Includes previously described cash held outside of the U.S., at a German financial services subsidiary, and at majority owned consolidated subsidiaries.
(2) Net debt and Net debt-to-total capitalization are non-GAAP measures used by management to assess our ability to service our debts using only our cash and cash equivalents. We present these non-GAAP measures to assist investors in analyzing our capital structure in a more comprehensive way compared to gross debt based ratios alone.
67

Our credit ratings are as follows:

Rating Agency |  | Long Term Ratings |  | Short Term Ratings |  | Outlook
Fitch |  | BBB |  | F-2 |  | Stable
Moody's |  | Baa2 |  | P-2 |  | Negative
S&P |  | BBB- |  | - |  | Stable

See Note 21 - "Commitments and Contingencies" for a discussion of the general purpose of guarantees and commitments. The anticipated sources of funds to fulfill such commitments are listed below at "Liquidity."
Liquidity
We expect our existing cash and cash equivalents, together with cash generated from operations, will be sufficient to meet our normal operating requirements for the next 12 months. We expect to continue using cash generated by operations as a primary source of liquidity; however, should we require funds greater than that generated from our operations to fund discretionary investment activities, such as business acquisitions, we have the ability to raise capital through debt financing and the issuance of capital market debt instruments. In addition, we currently utilize and will further utilize our cross currency cash pool for liquidity needs. However, there is no guarantee that we will be able to obtain debt financing, if required, on terms and conditions acceptable to us, if at all, in the future.
Our exposure to operational liquidity risk is primarily from long-term contracts which require significant investment of cash during the initial phases of contracts. The recovery of these investments is over the life of contracts and is dependent upon our performance as well as customer acceptance.
The following table summarizes our total liquidity:

|  | As of
(in millions) |  | December 31, 2020
Cash and cash equivalents |  | $ | 3,919 |
Available borrowings under our revolving credit facility |  | 4,000 |
Total liquidity |  | $ | 7,919 |

Share Repurchases
During the first quarter of fiscal 2018, our Board of Directors authorized the repurchase of up to $2.0 billion of our common stock and during the third quarter of fiscal 2019, our Board of Directors approved an incremental $2.0 billion share repurchase. This program became effective on April 3, 2017 with no end date established. There were no share repurchases during the third quarter ended December 31, 2020.
Dividends
To maintain our financial flexibility we continue to suspend payment of quarterly dividends.
68

Off-Balance Sheet Arrangements
In the normal course of business, we are party to arrangements that include guarantees, the receivables securitization facility and certain other financial instruments with off-balance sheet risk, such as letters of credit and surety bonds. We also use performance letters of credit to support various risk management insurance policies. No liabilities related to these arrangements are reflected in our condensed consolidated balance sheets. There have been no material changes to our off-balance-sheet arrangements reported under Part II, Item 7 of our Annual Report on Form 10-K other than as disclosed below and in Note 6 - "Receivables" and Note 21 - "Commitments and Contingencies" to the financial statements in this Quarterly Report on Form 10-Q.
Contractual Obligations
With the exception of the new senior notes with an aggregate principal amount of $1.0 billion, consisting of (i) $500 million of 4.00% Senior Notes due fiscal 2024; and (ii) $500 million of 4.13% Senior Notes due fiscal 2026; prepayment of $1.5 billion of Revolver Credit Facility, €402 million of Euro commercial paper, and term loan facilities consisting of (i) €750 million of Euro Term Loan due fiscal 2023, (ii) A$800 million of AUD Term Loan due fiscal 2022, (iii) £450 million of GBP Term Loan due fiscal 2022, (iv) $481 million of USD Term Loan due fiscal 2025, and (v) €350 million of Euro Term Loan due fiscal 2024 as discussed above under the subheading "Capital Resources," there have been no material changes, outside the ordinary course of business, to our contractual obligations since March 31, 2020. For further information see "Contractual Obligations" in Item 7 of Part II of our Annual Report on Form 10-K for the fiscal year ended March 31, 2020.
Critical Accounting Policies and Estimates
The preparation of consolidated financial statements in accordance with U.S. GAAP requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, as well as the disclosure of contingent assets and liabilities. These estimates may change in the future if underlying assumptions or factors change. Accordingly, actual results could differ materially from our estimates under different assumptions, judgments or conditions. We consider the following policies to be critical because of their complexity and the high degree of judgment involved in implementing them: revenue recognition, income taxes, business combinations, defined benefit plans and valuation of assets. We have discussed the selection of our critical accounting policies and the effect of estimates with the audit committee of our board of directors. During the three months ended December 31, 2020, there were no changes to our accounting estimates from those described in our fiscal 2020 Annual Report on Form 10-K except as mentioned in Note 1 - "Summary of Significant Accounting Policies."
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
For quantitative and qualitative disclosures about market risk affecting DXC, see "Quantitative and Qualitative Disclosures About Market Risk" in Item 7A of Part II of our Annual Report on Form 10-K for the fiscal year ended March 31, 2020. Our exposure to market risk has not changed materially since March 31, 2020.
69

ITEM 4. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
Our management, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated, as of the end of the period covered by this Quarterly Report on Form 10-Q, the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)). Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of December 31, 2020 because of the material weakness in our internal control over financial reporting described below.
Control Activities
As previously disclosed during the third quarter of fiscal 2020, Management concluded there was a material weakness in internal controls over financial reporting related to the design and implementation of effective control activities based on the criteria established in the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) in Internal Control – Integrated Framework (2013). These control deficiencies constituted a material weakness in the aggregate related to reassessing policies and procedures, to determine their continued relevance, as impacted by complex transactions and processes.
As a result, we have concluded that there is a reasonable possibility that a material misstatement to our Condensed Consolidated Financial Statements would not be prevented or detected on a timely basis and therefore we concluded that the aggregation of these deficiencies represents a material weakness in our internal control over financial reporting as of December 31, 2020.
Notwithstanding the identified material weakness, management believes that the Condensed Consolidated Financial Statements and related financial information included in this 10-Q fairly present, in all material respects, our balance sheets, statements of operations, comprehensive (loss) income and cash flows as of and for the periods presented.
Remediation Plan
Management has taken and will continue to take significant and comprehensive actions to remediate the material weakness. Management has completed a detailed root cause analysis, which was designed to identify areas of focus where enhancements can be made to the internal control environment. While we have made progress in remediation of certain of the identified deficiencies that led to the material weakness, our focus is on creating a sustainable controls environment as we build out our remediation program.
The following activities are designed as part of this remediation plan:
•Align the Sarbanes-Oxley Act (“SOX") risk assessment and testing function under the newly appointed Chief Risk Officer with the traditional SOX controls responsibilities including material weakness remediation activities aligned directly under our new Chief Financial Officer.
•Established an enhanced material weakness remediation progress reporting process to the Audit Committee in Q4 FY20.
•Assessed and augmented personnel to ensure appropriate resources are in place to strengthen the overall control environment. We appointed a new Chief Financial Officer in Q3 FY21 with previous experience as a Chief Accounting Officer and in the remediation of material weaknesses. In addition, we hired new leadership in the Finance and Risk organizations with relevant controls and remediation experience in FY21.
•Evaluate and assess key enterprise controls and relevant policies focusing on thresholds, ownership, and accountability.
•Enhance our financial cadence and discipline including reviewing the underlying performance of the business and related balance sheet accounts.
•Standardize processes and rationalize controls across the enterprise to focus on risk.
70

These additional remediation efforts, identified to comprehensively address our analysis of the root causes, have begun and are expected to be completed in the subsequent quarters. Given the additional remediation activities we do not expect to be completed by the end of the fiscal year. After management’s remediation efforts are complete, subsequent testing is required to conclude that a material weakness no longer exists.
Our goal is to have enhanced control policies, procedures, processes in place as promptly as practicable, however we are not in a position to complete our remediation plan and concluded that our internal control over financial reporting is not designed or operating effectively as of the quarter ended December 31, 2020.
Changes in Internal Control over Financial Reporting
In addition to the remediation efforts described above, we adopted ASC 326 effective April 1, 2020, as described in Note 2 - “Recent Accounting Pronouncements” to the financial statements during the first quarter of fiscal 2021. We began using a new model and redesigned certain processes and controls relating to our reserves and expected losses.
There were no changes in our internal control over financial reporting during the three months ended December 31, 2020 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
71

PART II
ITEM 1. LEGAL PROCEEDINGS
See Note 21 - "Commitments and Contingencies" to the financial statements under the caption “Contingencies” for information regarding legal proceedings in which we are involved.
ITEM 1A. RISK FACTORS
Our operations and financial results are subject to various risks and uncertainties, which may materially and adversely affect our business, financial condition, and results of operations, and the actual outcome of matters as to which forward-looking statements are made in this Quarterly Report on Form 10-Q. In such case, the trading price for DXC common stock could decline, and you could lose all or part of your investment. Past performance may not be a reliable indicator of future financial performance and historical trends should not be used to anticipate results or trends in future periods. There have been no material changes in the three months ended December 31, 2020 to the risk factors described in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended March 31, 2020 and in Part II, Item 1A of our Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2020 and September 30, 2020, which are hereby incorporated by reference herein. Future performance and historical trends may be adversely affected by the aforementioned risks, and other variables and risks and uncertainties not currently known or that are currently expected to be immaterial may also materially and adversely affect our business, financial condition, and results of operations or the price of our common stock in the future.
72

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Unregistered Sales of Equity Securities
None during the period covered by this report.
Use of Proceeds
Not applicable.
Issuer Purchases of Equity Securities
On April 3, 2017, DXC announced the establishment of a share repurchase plan approved by the Board of Directors with an initial authorization of $2.0 billion for future repurchases of outstanding shares of DXC common stock. On November 8, 2018, DXC's Board of Directors approved an incremental $2.0 billion share repurchase. An expiration date has not been established for this repurchase plan. Share repurchases may be made from time to time through various means, including in open market purchases, 10b5-1 plans, privately-negotiated transactions, accelerated stock repurchases, block trades and other transactions, in compliance with Rule 10b-18 under the Exchange Act, as well as, to the extent applicable, other federal and state securities laws and other legal requirements. The timing, volume, and nature of share repurchases pursuant to the share repurchase plan are at the discretion of management and may be suspended or discontinued at any time.
There was no share repurchase activity during the three months and nine months ended December 31, 2020.
ITEM 3. DEFAULT UPON SENIOR SECURITIES
None.
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
ITEM 5. OTHER INFORMATION
None.
73

ITEM 6. EXHIBITS

Exhibit Number | Description of Exhibit
31.1* | Section 302 Certification of the Chief Executive Officer
31.2* | Section 302 Certification of the Chief Financial Officer
32.1** | Section 906 Certification of Chief Executive Officer
32.2** | Section 906 Certification of Chief Financial Officer
101.INS | Interactive Data Files
101.SCH | XBRL Taxonomy Extension Schema
101.CAL | XBRL Taxonomy Extension Calculation
101.LAB | XBRL Taxonomy Extension Labels
101.PRE | XBRL Taxonomy Extension Presentation
104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

* Filed herewith
** Furnished herewith
74

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

|  |  | DXC TECHNOLOGY COMPANY
Dated: | February 4, 2021 | By: | /s/ Neil A. Manna
|  | Name: | Neil A. Manna
|  | Title: | Senior Vice President, Corporate Controller Principal Accounting Officer and Authorized Signatory

75